Our Produts
Home  |  Our Products
All Products
Oral Liquids
Capsules
Tablets
External Applications
Beta Tablets
Beta Capsules
Beta Dry Syrup
Dry Injections
All Products
All Products
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Paracetamol Paediatric Oral Suspension I.P. 125 mg | Each 5 ml contains: Paracetamol IP 125 mg In a flavoured syrups base q.s. Colour: Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) |
| 2 | Paracetamol Paediatric Oral Suspension I.P. 250 mg | Each 5 ml contains : Paracetamol IP 250 mg In a flavoured syrups base q.s. Colour:Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) |
| 3 | Cetirizne Syrup I.P. 5 mg | Each 5 ml contains : Cetirizne Hydrocloride IP 5 mg Pleasantly Flavoured syrups base q.s. Colour: sunset yellow FCF |
| 4 | Lactulose Solution U.S.P. 10 mg | Each 15 ml contains: Lactulose Concentrate U.S.P. eq. to Lactulose 10 mg In a palatable non-syrupy base Colour: Caramel I.P. |
| 5 | Magaldrate & Simethicone Oral Suspension U.S.P. | Each 5 ml Contains: Magaldrate IP 10 mg eq. to Anhydrous Magaldrate 400 mg Simethicone IP 50 mg In a flavoured non-syrupy base Colour: Brilliant Blue FCF & Tartrazine |
| 6 | Ofloxacin Oral Suspension I.P. 100 mg | Each 5 ml Contains: Ofloxacin IP 100 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 7 | Cyproheptadine Hydrochloride Syrup I.P. 2 mg | Each 5 ml contains: Cyproheptadine Hydrochloride IP eq. to Anhydrous Cyproheptadine Hydrochloride 2 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 8 | Albendazole Oral Suspension I.P. 400 mg | Each 10 ml contains: Albendazole IP 400 mg In a flavoured non-syrupy base Colour: Sunset Yellow FCF |
| 9 | Ofloxacin Oral Suspension I.P. 50 mg | Each 5 ml contains: Ofloxacin IP 50 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 10 | Potassium Citrate, Magnesium Citrate & Pyridoxine Hydrochloride Oral Solution | Each 5 ml contains: Potassium Citrate IP 1100 mg Magnesium Citrate USP 375 mg Pyridoxine Hydrochloride IP 20 mg In a flavoured non-syrupy base Colour: Caramel IP Appropriate overages of vitamin added to compensate for loss on storage |
| 11 | Ferrous Ascorbate & Folic Acid Oral Suspension | Each 5 ml contains: Ferrous Ascorbate 30 mg (eq. to elemental iron) Folic Acid IP 550 mg In a flavoured suspension base Colour: Caramel IP Appropriate overages of vitamin added to compensate for loss on storage |
| 12 | Cholecalciferol Oral Drops 800 I.U. | Each ml contains: Cholecalciferol IP (As Stabilized) 800 IU In a flavoured non-syrupy base Appropriate overages of vitamin added to compensate for loss on storage |
| 13 | Azithromycin Oral Suspension 100 mg | Each 5 ml contains: Azithromycin Dihydrate IP 100 mg (Anhydrous Azithromycin) In a flavoured syrupy base Colour: Quinoline Yellow |
| 14 | Azithromycin Oral Suspension 100 mg I.P. | Each 5 ml contains: Azithromycin Dihydrate IP 200 mg (Anhydrous Azithromycin) In a flavoured syrupy base Colour: Quinoline Yellow |
| 15 | Cholecalciferol Oral Drops 400 I.U. | Each ml contains: Cholecalciferol IP (As Stabilized) 400 IU In a flavoured non-syrupy base Colour: Sunset Yellow FCF Appropriate overages of vitamin added to compensate for loss on storage |
| 16 | Ferrous Sulphate and Folic Acid Syrup I.P. | Each 5 ml syrup contains: Ferrous Sulphate IP (eq. to elemental Iron) 100 mg Folic Acid 0.5 mg In a flavoured syrupy base Colour: Caramel |
| 17 | Paracetamol Paediatric Syrup I.P. | Each 5 ml syrup contains: Paracetamol IP 125 mg In a flavoured syrupy base Colour: Sunset Yellow |
| 18 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops I.P. | Each 1 ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a flavoured syrupy base Colour: Ponceau 4R |
| 19 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops I.P. | Each 5 ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 20 | Piperazine Citrate Syrup I.P. | Each 5 ml syrup contains: Piperazine Citrate IP 125 mg (eq. to Piperazine Hydrate 100 mg) In a flavoured Syrupy Base Colour: Sunset Yellow |
| 21 | Promethazine Hydrochloride Syrup I.P. | Each 5 ml syrup contains: Promethazine Hydrochloride IP 5 mg In a flavoured Syrupy Base Colour: Caramel |
| 22 | Hydroxyzine Oral Solution I.P. | Each 5 ml syrup contains: Hydroxyzine Hydrochloride IP 10 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 23 | Hydroxyzine Oral Solution I.P. | Each 5 ml syrup contains: Hydroxyzine Hydrochloride IP 25 mg In a flavoured Syrupy Base Colour: Tartrazine |
| 24 | Ambroxol Hydrochloride, Salbutamol, Guaiphenesin and Menthol Syrup | Each 5 ml syrup contains: Ambroxol Hydrochloride IP 15 mg Salbutamol 1 mg Guaiphenesin IP 50 mg Menthol 1 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 25 | Codeine Phosphate and Syrup I.P. | Each 5 ml syrup contains: Codeine Phosphate IP 10 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 26 | Desloratadine, Ambroxol, Guiphenasine and Menthol Syrup | Each 5 ml syrup contains: Desloratadine IP 2.5 mg Ambroxol Hydrochloride 30 mg Guaiphenesin IP 50 mg Menthol 1 mg In a flavoured Syrupy Base Colour: Sunset Yellow |
| 27 | Levocetrizine Hydrochloride and Ambroxol Hydrochloride Syrup | Each 5 ml syrup contains: Levocetrizine Hydrochloride IP 2.5 mg Ambroxol Hydrochloride IP 30 mg In a flavoured Syrupy Base Colour: Sunset Yellow |
| 28 | Levocetrizine Hydrochloride and Ambroxol Hydrochloride Syrup | Each 5 ml syrup contains: Levocetrizine Hydrochloride IP 5 mg Ambroxol Hydrochloride IP 30 mg In a flavoured Syrupy Base Colour: Erythrosine |
| 29 | Phenylephrine, Chlorpheniramine maleate, Paracetamol, Sodium Citrate and Menthol Syrup | Each 5 ml syrup contains: Phenylephrine Hydrochloride IP 5 mg Chlorphenaramine Maleate IP 0.5 mg Paracetamol IP 125 mg Sodium Citrate 60 mg Menthol 1 mg In a flavoured Syrupy Base Colour: Tartrazine |
| 30 | Doxyphylline and Terbutaline Syrup | Each 5 ml syrup contains: Doxyphylline IP 2 mg Terbutaline IP 120 mg In a flavoured Syrupy Base Colour: Sunset Yellow |
| 31 | Levodropropizine and Chlorpheniramine Maleate Syrup | Each 5 ml syrup contains: Levodropropizine Eur. Ph. 30 mg Chlorpheniramine Maleate IP 2 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 32 | Citicoline and Piracetam Syrup | Each 5 ml syrup contains: Citicoline Sodium IP eq. to Citicoline 500 mg Piracetam IP 400 mg In a flavoured Syrupy Base Colour: Erythrosine |
| 33 | Ambroxol, Terbutaline, Guaiphenesin and Menthol Syrup | Each 5 ml syrup contains: Ambroxol Hydrochloride IP 15 mg Terbutaline Sulphate IP 1.25 mg Guaiphenesin IP 50 mg Menthol 2.5 mg In a palatable syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 34 | Dextromethorphan and Chlorphenaramine Syrup | Each 5 ml syrup contains: Dextromethorphan Hydrobromide IP 10 mg Chlorphenaramine Maleate IP 2 mg In a palatable syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 35 | Doxyphylline and Terbutaline Syrup | Each 5 ml syrup contains: Doxyphylline IP 120 mg Terbutaline Sulphate IP 2 mg In a palatable syrup base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 36 | Ambroxol, Terbutaline and Guaiphenesin Syrup | Each 10 ml syrup contains: Ambroxol Hydrochloride IP 30 mg Terbutaline Sulphate IP 2.5 mg Guaiphenesin IP 100 mg In a palatable mentholated syrup base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 37 | Zinc Sulphate Oral Solution IP | Each 5 ml contains: Zinc Sulphate Monohydrate IP 20 mg eq. to elemental Zinc IP 7.5 mg In a palatable syrup base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 38 | Citicoline and Piracetam Syrup | Each 5 ml contains: Citicoline Sodium IP eq. to Citicoline 500 mg Piracetam IP 400 mg In a palatable syrup base Colour: Erythrosine Dose: As directed by the physician |
| 39 | Piracetam Syrup | Each 5 ml contains: Piracetam IP 500 mg In a palatable syrup base Colour: Erythrosine Dose: As directed by the physician |
| 40 | Sucralfate Suspension 1 gm | Each 10 ml contains: Sucralfate IP 1 gm In a suspension base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 41 | Sodium picosulfate Oral Solution BP | Each 5 ml contains: Sodium picosulfate BP 5 mg In a flavoured Syrupy Base Colour: Tartrazine & Brilliant blue FCF Dose: As directed by the physician |
| 42 | Fexofenadine Suspension 30 mg | Each 5 ml contains: Fexofenadine Hydrochloride IP 30 mg In a flavoured Suspension base Colour: Sunset Yellow FCF & Titanium Dioxide IP Dose: As directed by the physician |
| 43 | Cyproheptadine Hydrochloride and Tricholine Citrate Syrup | Each 5 ml contains: Cyproheptadine Hydrochloride IP 2 mg Tricholine Citrate 275 mg In a flavoured syrupy base Colour: Caramel Dose: As directed by the physician |
| 44 | Levocetirizine Hydrochloride and Montelukast Syrup | Each 5 ml contains: Levocetirizine Hydrochloride IP 2.5 mg Montelukast Sodium IP eq. to Montelukast 4 mg In a flavoured syrupy base Colour: Tartrazine Dose: As directed by the physician |
| 45 | Ofloxacin Suspension IP 50 mg | Each 5 ml contains: Ofloxacin IP 50 mg In a suspension base Colour: Tartrazine Dose: As directed by the physician |
| 46 | Ranitidine Oral solution IP 75 mg | Each 5 ml contains: Ranitidine Hydrochloride IP 75 mg In a flavoured syrupy base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 47 | Sucralfate and Oxetacaine Gel | Each 10 ml contains: Sucralfate IP 1 gm Oxetacaine BP 20 mg In a flavoured Suspension base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 48 | Pepsin and Fungal Diatase Syrup | Each 5 ml contains: Pepsin (1:3000) 10 mg Fungal Diatase (1:1200) 50 mg In a flavoured syrupy base Colour: Caramel Dose: As directed by the physician Appropriate Overages added. |
| 49 | Sodium Feredetate Oral Solution BP | Each 5 ml contains: Sodium feredetate BP 231 mg Eq. to elemental Iron 33 mg In a flavoured syrupy base Dose: As directed by the physician |
| 50 | Chlorpheniramine Maleate and Phenylephrine Hydrochloride Syrup IP | Each 5 ml contains: Chlorpheniramine Maleate IP 2 mg Phenylephrine Hydrochloride IP 5 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 51 | Levosalbutamol Syrup | Each 5 ml contains: Levosalbutamol Sulphate IP Eq. to Levosalbutamol 1 mg In a flavoured syrupy base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 52 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each 5 ml contains: Ambroxol Hydrochloride IP 15 mg Levosalbutamol Sulphate IP Eq. to Levosalbutamol 0.5 mg Guaiphenesin IP 50 mg In a flavoured syrupy base Colour: Tartrazine Dose: As directed by the physician |
| 53 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each 5 ml contains: Ambroxol Hydrochloride IP 30 mg Levosalbutamol Sulphate IP Eq. to Levosalbutamol 1 mg Guaiphenesin IP 50 mg In a flavoured syrupy base Colour: Tartrazine Dose: As directed by the physician |
| 54 | Ambroxol, Terbutaline and Guaiphenesin Syrup | Each 5 ml contains: Ambroxol Hydrochloride IP 15 mg Terbutaline Sulphate IP 1.25 mg Guaiphenesin IP 50 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 55 | Levocetirizine Hydrochloride Syrup | Each 5 ml contains: Levocetirizine Hydrochloride IP 5 mg In a flavoured syrupy base Dose: As directed by the physician |
| 56 | Linezolid Oral Suspension 100 mg | Each 5 ml suspension after reconstitution contains: Linezolid IP 100 mg In a palatable base Dose: As directed by the physician |
| 57 | Deflazacort Oral Suspension 6 mg | Each 5 ml contains: Deflazacort 6 mg In a flavoured suspension base Dose: As directed by the physician |
| 58 | Zinc Sulphate Oral Solution IP | Each 5 ml contains: Zinc Sulphate Monohydrate IP 54.90 mg Eq. to elemental Zinc 20 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 59 | Zinc Gluconate Oral Solution | Each 5 ml contains: Zinc Gluconate USP eq. to elemental Zinc 20 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 60 | Lactulose Solution USP | Each 5 ml contains: Lactulose Concentrate USP 3.33 mg In a palatable base Colour: Caramel IP Dose: As directed by the physician |
| 61 | Aluminium, Magnesium and Simethicone Oral Suspension IP | Each 5 ml Suspension contains: Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide IP 250 mg Simethicone Emulsion IP eq. to Simethicone 50 mg In a flavoured Suspension Base Colour: Erythrosine Dose: As directed by the physician |
| 62 | Aluminium, Magnesium and Simethicone Oral Suspension IP | Each 5 ml Suspension contains: Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide IP 250 mg Simethicone Emulsion USP eq. to Simethicone 50 mg In a flavoured Suspension Base Colour: Erythrosine Dose: As directed by the physician |
| 63 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains: Disodium Hydrogen Citrate BP 1.40 gm In a palatable base Colour: Tartrazine Dose: As directed by the physician |
| 64 | Triclofos Oral Solution IP | Each 5 ml contains: Triclofos Sodium IP 500 mg In a palatable base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 65 | Sodium Picosulfate, Liquid Paraffin and Milk of Magnesia Suspension | Each 5 ml contains: Sodium Picosulfate BP 3.33 mg Liquid Paraffin IP 1.25 mg Milk of Magnesia IP 3.75 ml In a flavoured suspension base Colour: Carmosine and Ponceau 4R Dose: As directed by the physician |
| 66 | Ondansetron Oral Solution IP 4 mg | Each 5 ml contains: Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg In a palatable base Colour: Ponceau 4R Dose: As directed by the physician |
| 67 | Hydroxyzine Oral Solution IP | Each 5 ml contains: Hydroxyzine Hydrochloride IP 10 mg In a palatable syrup base Dose: As directed by the physician |
| 68 | Dil Oil, Fennel Oil with Simethicone Drops | Each ml contains: Dil Oil BP 0.005 ml Fennel Oil USP 0.0007 ml Simethicone Emulsion USP eqv to Simethicone 40 mg In a palatable base Dose: As directed by the physician |
| 69 | Ferric Ammonium Citrate, Folic Acid & Vitamin B12 Suspension | Each 15 ml contains: Ferric Ammonium Citrate IP eqv to elemental Iron 32.8 mg Folic Acid IP 1 mg Vitamin B12 IP 7.5 mcg In a palatable base Colour: Caramel & Erythrosine Dose: As directed by the physician |
| 70 | Levocetirizine Hydrochloride Syrup 5 mg/5 ml | Each 5 ml contains: Levocetirizine Hydrochloride IP 5 mg In a palatable base Dose: As directed by the physician |
| 71 | Sucralfate and Oxetacaine Suspension | Each 10 ml contains: Sucralfate IP 500 mg Oxetacaine BP 10 mg In a palatable base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 72 | Sucralfate, Oxetacaine and Simethicone Oral Suspension | Each 10 ml contains: Sucralfate IP 500 mg Oxetacaine BP 10 mg Simethicone Emulsion USP eq. to Simethicone 50 mg In a palatable base Colour: Erythrosine Dose: As directed by the physician |
| 73 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each ml contains: Levosalbutamol Sulphate IP eq. to Levosalbutamol 0.25 mg Ambroxol BP 7.50 mg Guaophenesin USP 12.5 mg In a palatable base Colour: Ponceau 4R Dose: As directed by the physician |
| 74 | Paracetamol, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured suspension base Colour: Ponceau 4R Dose: As directed by the physician |
| 75 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 125 mg Mefenamic Acid IP 50 mg In a mentholated flavoured suspension base Colour: Tartrazine Dose: As directed by the physician |
| 76 | Dextromethorphan Hydrochloride, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 10 mg Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 77 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 250 mg Mefenamic Acid IP 100 mg In a mentholated flavoured suspension base Colour: Tartrazine Dose: As directed by the physician |
| 78 | Levodropropizine and Chlorpheniramine Maleate Syrup | Each 5 ml contains: levodropropizine BP 30 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 79 | Levocloperastine Fendizoate Oral Suspension | Each 5 ml suspension contains: Levocloperastine Fendizoate 35.40 mg eqv. To Levocloperastine Hydrochloride 20.00 mg In a flavoured Suspension Base Colour: Erythrosine Dose: As directed by the physician |
| 80 | Phenylephrine Hydrochloride and Chlorpheniramine maleate Drops | Each ml contains: Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 81 | Aluminium, Magnesium & Simethicone Oral Suspension IP | Each 10 ml contains: Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide IP 250 mg Simethicone Emulsion USP eqv. To Simethicone 50 mg In a Palatable Suspension base Colour: Erythrosine Dose: As directed by the physician |
| 82 | Ondansetron Oral Solution IP | Each 5 ml contains: Ondansetron Hydrochloride IP eqv. To Ondanstron 2 mg In a flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 83 | Codeine Phosphate & Chlorpheniramine Maleate Syrup | Each 5 ml contains: Codeine Phosphate IP 10 mg Chlorpheniramine Maleate IP 4 mg In a flavoured syrup base Colour: Carmoisine & Sunset Yellow FCF Dose: As directed by the physician |
| 84 | Codeine Phosphate & Triprolidine Hydrochloride Syrup | Each 5 ml contains: Codeine Phosphate IP 10 mg Triprolidine Hydrochloride IP 1.25 mg In a flavoured syrup base Colour: Carmoisine Dose: As directed by the physician |
| 85 | Levetiracetam Oral Solution IP 500mg/5ml | Each 5 ml contains: Levetiracetam IP 500 mg Flavoured Syrupy Base Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 86 | Levetiracetam Oral Solution IP 100mg/ml | Each ml contains: Levetiracetam IP 100 mg Flavoured Syrupy Base Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 87 | Racecadotril Suspension 10mg/5ml | Each 5 ml contains: Racecadotril IP 10 mg Flavoured Syrupy base Colour: Sunset yellow FCF Dosage: As directed by the Physician |
| 88 | Levosolbutamol, Ambroxol, and Guaiphensin Syrup | Each 5 ml contains: Levosalbutamol Sulphate eqv. To Levosolbutamol IP 1 mg Ambroxol Hydrochloride IP 15 mg Guaiphensin IP 50 mg Flavoured Syrupy base Colour: Tartrazine Dosage: As directed by the Physician |
| 89 | Levosolbutamol, Ambroxol, and Guaiphensin Drops | Each ml contains: Levosalbutamol Sulphate eqv. To Levosolbutamol IP 0.25 mg Ambroxol Hydrochloride IP 7.5 mg Guaiphensin IP 12.5 mg Flavoured Syrupy base Colour: Tartrazine Dosage: As directed by the Physician |
| 90 | Diphenhydramine, Codeine, Sodium Citrate & Menthol Syrup | Each 5ml dispensry cup contains: Diphenhydramine Hydrochloride BP 13.50 mg (FOR EXPORT) Codeine Phosphate BP 11.95 mg Sodium Citrate BP 54.4 mg Menthol BP 1.1 mg Flavoured Syrupy Base Colour: Approved colours used Dosages: As directed by the physician. |
| 91 | Ursodeoxycholic Acid Oral Suspension BP 125 mg | Each 5 ml contains: Ursodeoxycholic acid IP 125 mg In a Flavoured base Colour: Sunset Yellow FCF Dosages: As directed by the physician. |
| 92 | Potassium Chloride Oral Solution USP | Each 15 ml contains: Potassium Chloride IP 1.5 mg Flavoured Sorbitol 70% Base (Each 15 ml will supply 20 milliequivalent of elemental potassium) Colour: Sunset Yellow FCF |
| 93 | Dextromethorphan Hydrobromide, Ambroxol, Chlorpheniramine Maleate, Phenylephrine Hydrochloride, and Menthol Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 10 mg Ambroxol Hydrochloride IP 15 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine hydrochloride IP 5 mg Menthol IP 1.5 mg Flavoured Base Colour: Ponceau 4R Dosages: As directed by the physician. |
| 94 | Cyproheptadine Hydrochloride and Tricholine Citrate Drops | Each ml contains: Cyproheptadine Hydrochloride IP 1.5 mg Tricholine Citrate IP 55 mg Flavoured Syrupy Sorbitol Base Colour: Caramel Dosage: As directed by the Physician |
| 95 | Cyproheptadine Hydrochloride, Tricholine, and Sorbitol Syrup | Each 5 ml contains: Cyproheptadine Hydrochloride IP 2 mg Tricholine Citrate 275 mg Sorbitol (70%) 2 gm (Non-crystallising) Flavoured Syrupy Base Colour: Caramel Dosage: As directed by the Physician |
| 96 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 10 mg Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Menthol IP 1 mg Flavoured Syrupy Base Colour: Brilliant Blue FCF & Tartrazine Dosage: As directed by the Physician |
| 97 | Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension | Each 5 ml contains: Sodium Alginate IP 250 mg Sodium Bicarbonate IP 133.50 mg Calcium Carbonate IP 80 mg In a flavoured Suspension Base Dosage: As directed by the Physician |
Oral Liquids
Â
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Paracetamol Paediatric Oral Suspension I.P. 125 mg | Each 5 ml contains: Paracetamol IP 125 mg In a flavoured syrups base q.s. Colour: Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) |
| 2 | Paracetamol Paediatric Oral Suspension I.P. 250 mg | Each 5 ml contains : Paracetamol IP 250 mg In a flavoured syrups base q.s. Colour:Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) |
| 3 | Cetirizne Syrup I.P. 5 mg | Each 5 ml contains : Cetirizne Hydrocloride IP 5 mg Pleasantly Flavoured syrups base q.s. Colour: sunset yellow FCF |
| 4 | Lactulose Solution U.S.P. 10 mg | Each 15 ml contains: Lactulose Concentrate U.S.P. eq. to Lactulose 10 mg In a palatable non-syrupy base Colour: Caramel I.P. |
| 5 | Magaldrate & Simethicone Oral Suspension U.S.P. | Each 5 ml Contains: Magaldrate IP 10 mg eq. to Anhydrous Magaldrate 400 mg Simethicone IP 50 mg In a flavoured non-syrupy base Colour: Brilliant Blue FCF & Tartrazine |
| 6 | Ofloxacin Oral Suspension I.P. 100 mg | Each 5 ml Contains: Ofloxacin IP 100 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 7 | Cyproheptadine Hydrochloride Syrup I.P. 2 mg | Each 5 ml contains: Cyproheptadine Hydrochloride IP eq. to Anhydrous Cyproheptadine Hydrochloride 2 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 8 | Albendazole Oral Suspension I.P. 400 mg | Each 10 ml contains: Albendazole IP 400 mg In a flavoured non-syrupy base Colour: Sunset Yellow FCF |
| 9 | Ofloxacin Oral Suspension I.P. 50 mg | Each 5 ml contains: Ofloxacin IP 50 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 10 | Potassium Citrate, Magnesium Citrate & Pyridoxine Hydrochloride Oral Solution | Each 5 ml contains: Potassium Citrate IP 1100 mg Magnesium Citrate USP 375 mg Pyridoxine Hydrochloride IP 20 mg In a flavoured non-syrupy base Colour: Caramel IP Appropriate overages of vitamin added to compensate for loss on storage |
| 11 | Ferrous Ascorbate & Folic Acid Oral Suspension | Each 5 ml contains: Ferrous Ascorbate 30 mg (eq. to elemental iron) Folic Acid IP 550 mg In a flavoured suspension base Colour: Caramel IP Appropriate overages of vitamin added to compensate for loss on storage |
| 12 | Cholecalciferol Oral Drops 800 I.U. | Each ml contains: Cholecalciferol IP (As Stabilized) 800 IU In a flavoured non-syrupy base Appropriate overages of vitamin added to compensate for loss on storage |
| 13 | Azithromycin Oral Suspension 100 mg | Each 5 ml contains: Azithromycin Dihydrate IP 100 mg (Anhydrous Azithromycin) In a flavoured syrupy base Colour: Quinoline Yellow |
| 14 | Azithromycin Oral Suspension 100 mg I.P. | Each 5 ml contains: Azithromycin Dihydrate IP 200 mg (Anhydrous Azithromycin) In a flavoured syrupy base Colour: Quinoline Yellow |
| 15 | Cholecalciferol Oral Drops 400 I.U. | Each ml contains: Cholecalciferol IP (As Stabilized) 400 IU In a flavoured non-syrupy base Colour: Sunset Yellow FCF Appropriate overages of vitamin added to compensate for loss on storage |
| 16 | Ferrous Sulphate and Folic Acid Syrup I.P. | Each 5 ml syrup contains: Ferrous Sulphate IP (eq. to elemental Iron) 100 mg Folic Acid 0.5 mg In a flavoured syrupy base Colour: Caramel |
| 17 | Paracetamol Paediatric Syrup I.P. | Each 5 ml syrup contains: Paracetamol IP 125 mg In a flavoured syrupy base Colour: Sunset Yellow |
| 18 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops I.P. | Each 1 ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a flavoured syrupy base Colour: Ponceau 4R |
| 19 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops I.P. | Each 5 ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 20 | Piperazine Citrate Syrup I.P. | Each 5 ml syrup contains: Piperazine Citrate IP 125 mg (eq. to Piperazine Hydrate 100 mg) In a flavoured Syrupy Base Colour: Sunset Yellow |
| 21 | Promethazine Hydrochloride Syrup I.P. | Each 5 ml syrup contains: Promethazine Hydrochloride IP 5 mg In a flavoured Syrupy Base Colour: Caramel |
| 22 | Hydroxyzine Oral Solution I.P. | Each 5 ml syrup contains: Hydroxyzine Hydrochloride IP 10 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 23 | Hydroxyzine Oral Solution I.P. | Each 5 ml syrup contains: Hydroxyzine Hydrochloride IP 25 mg In a flavoured Syrupy Base Colour: Tartrazine |
| 24 | Ambroxol Hydrochloride, Salbutamol, Guaiphenesin and Menthol Syrup | Each 5 ml syrup contains: Ambroxol Hydrochloride IP 15 mg Salbutamol 1 mg Guaiphenesin IP 50 mg Menthol 1 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 25 | Codeine Phosphate and Syrup I.P. | Each 5 ml syrup contains: Codeine Phosphate IP 10 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 26 | Desloratadine, Ambroxol, Guiphenasine and Menthol Syrup | Each 5 ml syrup contains: Desloratadine IP 2.5 mg Ambroxol Hydrochloride 30 mg Guaiphenesin IP 50 mg Menthol 1 mg In a flavoured Syrupy Base Colour: Sunset Yellow |
| 27 | Levocetrizine Hydrochloride and Ambroxol Hydrochloride Syrup | Each 5 ml syrup contains: Levocetrizine Hydrochloride IP 2.5 mg Ambroxol Hydrochloride IP 30 mg In a flavoured Syrupy Base Colour: Sunset Yellow |
| 28 | Levocetrizine Hydrochloride and Ambroxol Hydrochloride Syrup | Each 5 ml syrup contains: Levocetrizine Hydrochloride IP 5 mg Ambroxol Hydrochloride IP 30 mg In a flavoured Syrupy Base Colour: Erythrosine |
| 29 | Phenylephrine, Chlorpheniramine maleate, Paracetamol, Sodium Citrate and Menthol Syrup | Each 5 ml syrup contains: Phenylephrine Hydrochloride IP 5 mg Chlorphenaramine Maleate IP 0.5 mg Paracetamol IP 125 mg Sodium Citrate 60 mg Menthol 1 mg In a flavoured Syrupy Base Colour: Tartrazine |
| 30 | Doxyphylline and Terbutaline Syrup | Each 5 ml syrup contains: Doxyphylline IP 2 mg Terbutaline IP 120 mg In a flavoured Syrupy Base Colour: Sunset Yellow |
| 31 | Levodropropizine and Chlorpheniramine Maleate Syrup | Each 5 ml syrup contains: Levodropropizine Eur. Ph. 30 mg Chlorpheniramine Maleate IP 2 mg In a flavoured Syrupy Base Colour: Ponceau 4R |
| 32 | Citicoline and Piracetam Syrup | Each 5 ml syrup contains: Citicoline Sodium IP eq. to Citicoline 500 mg Piracetam IP 400 mg In a flavoured Syrupy Base Colour: Erythrosine |
| 33 | Ambroxol, Terbutaline, Guaiphenesin and Menthol Syrup | Each 5 ml syrup contains: Ambroxol Hydrochloride IP 15 mg Terbutaline Sulphate IP 1.25 mg Guaiphenesin IP 50 mg Menthol 2.5 mg In a palatable syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 34 | Dextromethorphan and Chlorphenaramine Syrup | Each 5 ml syrup contains: Dextromethorphan Hydrobromide IP 10 mg Chlorphenaramine Maleate IP 2 mg In a palatable syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 35 | Doxyphylline and Terbutaline Syrup | Each 5 ml syrup contains: Doxyphylline IP 120 mg Terbutaline Sulphate IP 2 mg In a palatable syrup base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 36 | Ambroxol, Terbutaline and Guaiphenesin Syrup | Each 10 ml syrup contains: Ambroxol Hydrochloride IP 30 mg Terbutaline Sulphate IP 2.5 mg Guaiphenesin IP 100 mg In a palatable mentholated syrup base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 37 | Zinc Sulphate Oral Solution IP | Each 5 ml contains: Zinc Sulphate Monohydrate IP 20 mg eq. to elemental Zinc IP 7.5 mg In a palatable syrup base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 38 | Citicoline and Piracetam Syrup | Each 5 ml contains: Citicoline Sodium IP eq. to Citicoline 500 mg Piracetam IP 400 mg In a palatable syrup base Colour: Erythrosine Dose: As directed by the physician |
| 39 | Piracetam Syrup | Each 5 ml contains: Piracetam IP 500 mg In a palatable syrup base Colour: Erythrosine Dose: As directed by the physician |
| 40 | Sucralfate Suspension 1 gm | Each 10 ml contains: Sucralfate IP 1 gm In a suspension base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 41 | Sodium picosulfate Oral Solution BP | Each 5 ml contains: Sodium picosulfate BP 5 mg In a flavoured Syrupy Base Colour: Tartrazine & Brilliant blue FCF Dose: As directed by the physician |
| 42 | Fexofenadine Suspension 30 mg | Each 5 ml contains: Fexofenadine Hydrochloride IP 30 mg In a flavoured Suspension base Colour: Sunset Yellow FCF & Titanium Dioxide IP Dose: As directed by the physician |
| 43 | Cyproheptadine Hydrochloride and Tricholine Citrate Syrup | Each 5 ml contains: Cyproheptadine Hydrochloride IP 2 mg Tricholine Citrate 275 mg In a flavoured syrupy base Colour: Caramel Dose: As directed by the physician |
| 44 | Levocetirizine Hydrochloride and Montelukast Syrup | Each 5 ml contains: Levocetirizine Hydrochloride IP 2.5 mg Montelukast Sodium IP eq. to Montelukast 4 mg In a flavoured syrupy base Colour: Tartrazine Dose: As directed by the physician |
| 45 | Ofloxacin Suspension IP 50 mg | Each 5 ml contains: Ofloxacin IP 50 mg In a suspension base Colour: Tartrazine Dose: As directed by the physician |
| 46 | Ranitidine Oral solution IP 75 mg | Each 5 ml contains: Ranitidine Hydrochloride IP 75 mg In a flavoured syrupy base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 47 | Sucralfate and Oxetacaine Gel | Each 10 ml contains: Sucralfate IP 1 gm Oxetacaine BP 20 mg In a flavoured Suspension base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 48 | Pepsin and Fungal Diatase Syrup | Each 5 ml contains: Pepsin (1:3000) 10 mg Fungal Diatase (1:1200) 50 mg In a flavoured syrupy base Colour: Caramel Dose: As directed by the physician Appropriate Overages added. |
| 49 | Sodium Feredetate Oral Solution BP | Each 5 ml contains: Sodium feredetate BP 231 mg Eq. to elemental Iron 33 mg In a flavoured syrupy base Dose: As directed by the physician |
| 50 | Chlorpheniramine Maleate and Phenylephrine Hydrochloride Syrup IP | Each 5 ml contains: Chlorpheniramine Maleate IP 2 mg Phenylephrine Hydrochloride IP 5 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 51 | Levosalbutamol Syrup | Each 5 ml contains: Levosalbutamol Sulphate IP Eq. to Levosalbutamol 1 mg In a flavoured syrupy base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 52 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each 5 ml contains: Ambroxol Hydrochloride IP 15 mg Levosalbutamol Sulphate IP Eq. to Levosalbutamol 0.5 mg Guaiphenesin IP 50 mg In a flavoured syrupy base Colour: Tartrazine Dose: As directed by the physician |
| 53 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each 5 ml contains: Ambroxol Hydrochloride IP 30 mg Levosalbutamol Sulphate IP Eq. to Levosalbutamol 1 mg Guaiphenesin IP 50 mg In a flavoured syrupy base Colour: Tartrazine Dose: As directed by the physician |
| 54 | Ambroxol, Terbutaline and Guaiphenesin Syrup | Each 5 ml contains: Ambroxol Hydrochloride IP 15 mg Terbutaline Sulphate IP 1.25 mg Guaiphenesin IP 50 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 55 | Levocetirizine Hydrochloride Syrup | Each 5 ml contains: Levocetirizine Hydrochloride IP 5 mg In a flavoured syrupy base Dose: As directed by the physician |
| 56 | Linezolid Oral Suspension 100 mg | Each 5 ml suspension after reconstitution contains: Linezolid IP 100 mg In a palatable base Dose: As directed by the physician |
| 57 | Deflazacort Oral Suspension 6 mg | Each 5 ml contains: Deflazacort 6 mg In a flavoured suspension base Dose: As directed by the physician |
| 58 | Zinc Sulphate Oral Solution IP | Each 5 ml contains: Zinc Sulphate Monohydrate IP 54.90 mg Eq. to elemental Zinc 20 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 59 | Zinc Gluconate Oral Solution | Each 5 ml contains: Zinc Gluconate USP eq. to elemental Zinc 20 mg In a flavoured syrupy base Colour: Ponceau 4R Dose: As directed by the physician |
| 60 | Lactulose Solution USP | Each 5 ml contains: Lactulose Concentrate USP 3.33 mg In a palatable base Colour: Caramel IP Dose: As directed by the physician |
| 61 | Aluminium, Magnesium and Simethicone Oral Suspension IP | Each 5 ml Suspension contains: Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide IP 250 mg Simethicone Emulsion IP eq. to Simethicone 50 mg In a flavoured Suspension Base Colour: Erythrosine Dose: As directed by the physician |
| 62 | Aluminium, Magnesium and Simethicone Oral Suspension IP | Each 5 ml Suspension contains: Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide IP 250 mg Simethicone Emulsion USP eq. to Simethicone 50 mg In a flavoured Suspension Base Colour: Erythrosine Dose: As directed by the physician |
| 63 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains: Disodium Hydrogen Citrate BP 1.40 gm In a palatable base Colour: Tartrazine Dose: As directed by the physician |
| 64 | Triclofos Oral Solution IP | Each 5 ml contains: Triclofos Sodium IP 500 mg In a palatable base Colour: Sunset Yellow FCF Dose: As directed by the physician |
| 65 | Sodium Picosulfate, Liquid Paraffin and Milk of Magnesia Suspension | Each 5 ml contains: Sodium Picosulfate BP 3.33 mg Liquid Paraffin IP 1.25 mg Milk of Magnesia IP 3.75 ml In a flavoured suspension base Colour: Carmosine and Ponceau 4R Dose: As directed by the physician |
| 66 | Ondansetron Oral Solution IP 4 mg | Each 5 ml contains: Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg In a palatable base Colour: Ponceau 4R Dose: As directed by the physician |
| 67 | Hydroxyzine Oral Solution IP | Each 5 ml contains: Hydroxyzine Hydrochloride IP 10 mg In a palatable syrup base Dose: As directed by the physician |
| 68 | Dil Oil, Fennel Oil with Simethicone Drops | Each ml contains: Dil Oil BP 0.005 ml Fennel Oil USP 0.0007 ml Simethicone Emulsion USP eqv to Simethicone 40 mg In a palatable base Dose: As directed by the physician |
| 69 | Ferric Ammonium Citrate, Folic Acid & Vitamin B12 Suspension | Each 15 ml contains: Ferric Ammonium Citrate IP eqv to elemental Iron 32.8 mg Folic Acid IP 1 mg Vitamin B12 IP 7.5 mcg In a palatable base Colour: Caramel & Erythrosine Dose: As directed by the physician |
| 70 | Levocetirizine Hydrochloride Syrup 5 mg/5 ml | Each 5 ml contains: Levocetirizine Hydrochloride IP 5 mg In a palatable base Dose: As directed by the physician |
| 71 | Sucralfate and Oxetacaine Suspension | Each 10 ml contains: Sucralfate IP 500 mg Oxetacaine BP 10 mg In a palatable base Colour: Quinoline Yellow WS Dose: As directed by the physician |
| 72 | Sucralfate, Oxetacaine and Simethicone Oral Suspension | Each 10 ml contains: Sucralfate IP 500 mg Oxetacaine BP 10 mg Simethicone Emulsion USP eq. to Simethicone 50 mg In a palatable base Colour: Erythrosine Dose: As directed by the physician |
| 73 | Levosalbutamol, Ambroxol and Guaiphenesin Syrup | Each ml contains: Levosalbutamol Sulphate IP eq. to Levosalbutamol 0.25 mg Ambroxol BP 7.50 mg Guaophenesin USP 12.5 mg In a palatable base Colour: Ponceau 4R Dose: As directed by the physician |
| 74 | Paracetamol, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured suspension base Colour: Ponceau 4R Dose: As directed by the physician |
| 75 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 125 mg Mefenamic Acid IP 50 mg In a mentholated flavoured suspension base Colour: Tartrazine Dose: As directed by the physician |
| 76 | Dextromethorphan Hydrochloride, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 10 mg Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 77 | Paracetamol and Mefenamic Acid Suspension | Each 5 ml contains: Paracetamol IP 250 mg Mefenamic Acid IP 100 mg In a mentholated flavoured suspension base Colour: Tartrazine Dose: As directed by the physician |
| 78 | Levodropropizine and Chlorpheniramine Maleate Syrup | Each 5 ml contains: levodropropizine BP 30 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 79 | Levocloperastine Fendizoate Oral Suspension | Each 5 ml suspension contains: Levocloperastine Fendizoate 35.40 mg eqv. To Levocloperastine Hydrochloride 20.00 mg In a flavoured Suspension Base Colour: Erythrosine Dose: As directed by the physician |
| 80 | Phenylephrine Hydrochloride and Chlorpheniramine maleate Drops | Each ml contains: Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a mentholated flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 81 | Aluminium, Magnesium & Simethicone Oral Suspension IP | Each 10 ml contains: Dried Aluminium Hydroxide IP 250 mg Magnesium Hydroxide IP 250 mg Simethicone Emulsion USP eqv. To Simethicone 50 mg In a Palatable Suspension base Colour: Erythrosine Dose: As directed by the physician |
| 82 | Ondansetron Oral Solution IP | Each 5 ml contains: Ondansetron Hydrochloride IP eqv. To Ondanstron 2 mg In a flavoured syrup base Colour: Ponceau 4R Dose: As directed by the physician |
| 83 | Codeine Phosphate & Chlorpheniramine Maleate Syrup | Each 5 ml contains: Codeine Phosphate IP 10 mg Chlorpheniramine Maleate IP 4 mg In a flavoured syrup base Colour: Carmoisine & Sunset Yellow FCF Dose: As directed by the physician |
| 84 | Codeine Phosphate & Triprolidine Hydrochloride Syrup | Each 5 ml contains: Codeine Phosphate IP 10 mg Triprolidine Hydrochloride IP 1.25 mg In a flavoured syrup base Colour: Carmoisine Dose: As directed by the physician |
| 85 | Levetiracetam Oral Solution IP 500mg/5ml | Each 5 ml contains: Levetiracetam IP 500 mg Flavoured Syrupy Base Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 86 | Levetiracetam Oral Solution IP 100mg/ml | Each ml contains: Levetiracetam IP 100 mg Flavoured Syrupy Base Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 87 | Racecadotril Suspension 10mg/5ml | Each 5 ml contains: Racecadotril IP 10 mg Flavoured Syrupy base Colour: Sunset yellow FCF Dosage: As directed by the Physician |
| 88 | Levosolbutamol, Ambroxol, and Guaiphensin Syrup | Each 5 ml contains: Levosalbutamol Sulphate eqv. To Levosolbutamol IP 1 mg Ambroxol Hydrochloride IP 15 mg Guaiphensin IP 50 mg Flavoured Syrupy base Colour: Tartrazine Dosage: As directed by the Physician |
| 89 | Levosolbutamol, Ambroxol, and Guaiphensin Drops | Each ml contains: Levosalbutamol Sulphate eqv. To Levosolbutamol IP 0.25 mg Ambroxol Hydrochloride IP 7.5 mg Guaiphensin IP 12.5 mg Flavoured Syrupy base Colour: Tartrazine Dosage: As directed by the Physician |
| 90 | Diphenhydramine, Codeine, Sodium Citrate & Menthol Syrup | Each 5ml dispensry cup contains: Diphenhydramine Hydrochloride BP 13.50 mg (FOR EXPORT) Codeine Phosphate BP 11.95 mg Sodium Citrate BP 54.4 mg Menthol BP 1.1 mg Flavoured Syrupy Base Colour: Approved colours used Dosages: As directed by the physician. |
| 91 | Ursodeoxycholic Acid Oral Suspension BP 125 mg | Each 5 ml contains: Ursodeoxycholic acid IP 125 mg In a Flavoured base Colour: Sunset Yellow FCF Dosages: As directed by the physician. |
| 92 | Potassium Chloride Oral Solution USP | Each 15 ml contains: Potassium Chloride IP 1.5 mg Flavoured Sorbitol 70% Base (Each 15 ml will supply 20 milliequivalent of elemental potassium) Colour: Sunset Yellow FCF |
| 93 | Dextromethorphan Hydrobromide, Ambroxol, Chlorpheniramine Maleate, Phenylephrine Hydrochloride, and Menthol Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 10 mg Ambroxol Hydrochloride IP 15 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine hydrochloride IP 5 mg Menthol IP 1.5 mg Flavoured Base Colour: Ponceau 4R Dosages: As directed by the physician. |
| 94 | Cyproheptadine Hydrochloride and Tricholine Citrate Drops | Each ml contains: Cyproheptadine Hydrochloride IP 1.5 mg Tricholine Citrate IP 55 mg Flavoured Syrupy Sorbitol Base Colour: Caramel Dosage: As directed by the Physician |
| 95 | Cyproheptadine Hydrochloride, Tricholine, and Sorbitol Syrup | Each 5 ml contains: Cyproheptadine Hydrochloride IP 2 mg Tricholine Citrate 275 mg Sorbitol (70%) 2 gm (Non-crystallising) Flavoured Syrupy Base Colour: Caramel Dosage: As directed by the Physician |
| 96 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate Syrup | Each 5 ml contains: Dextromethorphan Hydrobromide IP 10 mg Phenylephrine hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Menthol IP 1 mg Flavoured Syrupy Base Colour: Brilliant Blue FCF & Tartrazine Dosage: As directed by the Physician |
| 97 | Sodium Alginate, Sodium Bicarbonate & Calcium Carbonate Oral Suspension | Each 5 ml contains: Sodium Alginate IP 250 mg Sodium Bicarbonate IP 133.50 mg Calcium Carbonate IP 80 mg In a flavoured Suspension Base Dosage: As directed by the Physician |
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Paracetamol Paediatric Oral Suspension I.P. 125 mg | Each 5 ml contains: Paracetamol IP 125 mg In a flavoured syrups base q.s. Colour: Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) |
| 2 | Paracetamol Paediatric Oral Suspension I.P. 250 mg | Each 5 ml contains : Paracetamol IP 250 mg In a flavoured syrups base q.s. Colour:Eryhrosine Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash.) |
| 3 | Cetirizne Syrup I.P. 5 mg | Each 5 ml contains : Cetirizne Hydrocloride IP 5 mg Pleasantly Flavoured syrups base q.s. Colour: sunset yellow FCF |
| 4 | Lactulose Solution U.S.P. 10 mg | Each 15 ml contains: Lactulose Concentrate U.S.P. eq. to Lactulose 10 mg In a palatable non-syrupy base Colour: Caramel I.P. |
| 5 | Magaldrate & Simethicone Oral Suspension U.S.P. | Each 5 ml Contains: Magaldrate IP 10 mg eq. to Anhydrous Magaldrate 400 mg Simethicone IP 50 mg In a flavoured non-syrupy base Colour: Brilliant Blue FCF & Tartrazine |
| 6 | Ofloxacin Oral Suspension I.P. 100 mg | Each 5 ml Contains: Ofloxacin IP 100 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 7 | Cyproheptadine Hydrochloride Syrup I.P. 2 mg | Each 5 ml contains: Cyproheptadine Hydrochloride IP eq. to Anhydrous Cyproheptadine Hydrochloride 2 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 8 | Albendazole Oral Suspension I.P. 400 mg | Each 10 ml contains: Albendazole IP 400 mg In a flavoured non-syrupy base Colour: Sunset Yellow FCF |
| 9 | Ofloxacin Oral Suspension I.P. 50 mg | Each 5 ml contains: Ofloxacin IP 50 mg In a flavoured syrupy base Colour: Sunset Yellow FCF |
| 10 | Potassium Citrate, Magnesium Citrate & Pyridoxine Hydrochloride Oral Solution | Each 5 ml contains: Potassium Citrate IP 1100 mg Magnesium Citrate USP 375 mg Pyridoxine Hydrochloride IP 20 mg In a flavoured non-syrupy base Colour: Caramel IP Appropriate overages of vitamin added to compensate for loss on storage |
| 11 | Ferrous Ascorbate & Folic Acid Oral Suspension | Each 5 ml contains: Ferrous Ascorbate 30 mg (eq. to elemental iron) Folic Acid IP 550 mg In a flavoured suspension base Colour: Caramel IP Appropriate overages of vitamin added to compensate for loss on storage |
| 12 | Cholecalciferol Oral Drops 800 I.U. | Each ml contains: Cholecalciferol IP (As Stabilized) 800 IU In a flavoured non-syrupy base Appropriate overages of vitamin added to compensate for loss on storage |
| 13 | Azithromycin Oral Suspension 100 mg | Each 5 ml contains: Azithromycin Dihydrate IP 100 mg (Anhydrous Azithromycin) In a flavoured syrupy base Colour: Quinoline Yellow |
| 14 | Azithromycin Oral Suspension 100 mg I.P. | Each 5 ml contains: Azithromycin Dihydrate IP 200 mg (Anhydrous Azithromycin) In a flavoured syrupy base Colour: Quinoline Yellow |
| 15 | Cholecalciferol Oral Drops 400 I.U. | Each ml contains: Cholecalciferol IP (As Stabilized) 400 IU In a flavoured non-syrupy base Colour: Sunset Yellow FCF Appropriate overages of vitamin added to compensate for loss on storage |
| 16 | Ferrous Sulphate and Folic Acid Syrup I.P. | Each 5 ml syrup contains: Ferrous Sulphate IP (eq. to elemental Iron) 100 mg Folic Acid 0.5 mg In a flavoured syrupy base Colour: Caramel |
| 17 | Paracetamol Paediatric Syrup I.P. | Each 5 ml syrup contains: Paracetamol IP 125 mg In a flavoured syrupy base Colour: Sunset Yellow |
| 18 | Phenylephrine Hydrochloride and Chlorpheniramine Maleate Drops I.P. | Each 1 ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg In a flavoured syrupy base Colour: Ponceau 4R |
Capsules
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Rabeprazole Sodium (Enteric Coated) & Domperidone (DSR) Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium I.P. 20 mg (As Enteric Coated Pellets) Domperidone I.P. 30 mg (As Sustained Release Pellets) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 2 | Rabeprazole Sodium (Enteric Coated) & Levosulpiride (DSR) Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium I.P. 20 mg (As Enteric Coated Pellets) Levosulpiride 75 mg (As Sustained Release Pellets) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 3 | Gastro-resistant Pantoprazole Sodium & Domperidone prolonged release Capsules I.P. | Each hard gelatin capsule contains: Pantoprazole Sodium I.P. eq. to Pantoprazole 40 mg (As Gastro-resistant Pellets) Domperidone I.P. 30 mg (As prolonged release Pellets) Approved colour used in empty capsule shells & Pellets |
| 4 | Enteric-coated Esomeprazole Magnesium & Sustained-Release Domperidone Capsules | Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate I.P. Eq. to Esomeprazole 40 mg (As enteric coated Pellets) Domperidone I.P. 30 mg (As Sustained-Release Pellets) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 5 | Enteric-coated Pantoprazole Sodium & Sustained-Release Levosulpiride Capsules | Each hard gelatin capsule contains: Pantoprazole Sodium I.P. eq. to pantoprazole 40 mg (As enteric coated Pellets) Levosulpiride I.P. 75 mg (As Sustained-Release Pellets) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 6 | Tamsulosin Hydrochloride Modified-Release Capsules 0.4 mg | Each hard gelatin capsule contains: Tamsulosin Hydrochloride I.P. 0.4 mg (As Modified-Release Pellets) Excipients q.s. Approved colour used in empty capsule shells |
| 7 | Enteric-coated Omeprazole & Sustained-Release Domperidone Capsules | Each hard gelatin capsule contains: Omeprazole I.P. 20 mg (As enteric coated Pellets) Domperidone I.P. 30 mg (As Sustained-Release Pellets) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 8 | Itraconazole Capsules 100 mg | Each hard gelatin capsule contains: Itraconazole B.P. 100 mg (as pellets form) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 9 | Itraconazole Capsules 200 mg | Each hard gelatin capsule contains: Itraconazole B.P. 200 mg (as pellets form) Excipients q.s. Approved colour used in empty capsule shells & Pellets |
| 10 | Pregabalin Capsules I.P. 50 mg | Each hard gelatin capsule contains: Pregabalin I.P. 50 mg Excipients q.s Approved colour used in empty capsule shells |
| 11 | Methylcobalamin with Alpha Lipoic Acid, Vitamin B1 & Folic Acid Capsules |
Methylcobalamin – 1500 mcg Alpha Lipoic Acid U.S.P. – 100 mg Vitamin B1 I.P. – 3 mg Folic Acid I.P. – 1.5 mg Excipients – q.s For Therapeutic Use Approved colour used in empty capsule shells Dosage: One capsule daily. Appropriate overages of vitamins added to compensate for loss on storage. |
| 12 | Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium, Selenium & Benfotiamine Capsules |
Methylcobalamin – 1500 mcg Alpha Lipoic Acid U.S.P. – 100 mg Inositol U.S.P. – 100 mg Folic Acid I.P. – 1.5 mg Chromium Picolinate U.S.P. – eq. to Chromium – 200 mcg Selenium Dioxide B.P. – eq. to Selenium – 55 mcg Benfotiamine – 150 mg Excipients – q.s Approved colour used in empty capsule shells Dosage: One capsule daily. Appropriate overages of vitamins added to compensate for loss on storage. |
| 13 | Carbonyl Iron, Folic Acid with Zinc Sulphate Capsules |
Carbonyl Iron U.S.P. – 50 mg (eq. to elemental iron) Folic Acid I.P. – 0.5 mg Zinc Sulphate Monohydrate I.P. – 61.8 mg (eq. to elemental Zinc 22.5 mg) Excipients – q.s For Therapeutic Use Approved colour used in empty capsule shells Dosage: One capsule daily. Appropriate overages of vitamins added to compensate for loss on storage. |
| 14 | Pregabalin & Methylcobalamin Capsules |
Each hard gelatin capsule contains : Pregabalin I.P. – 75 mg Methylcobalamin – 750 mcg Excipients – q.s Approved colour used in empty capsule shells Appropriate overages of vitamins added to compensate for loss on storage |
| 15 | Ferrous Fumarate, Folic Acid, Vitamin B12 & Ascorbic Acid Capsules |
Each hard gelatin capsule contains : Ferrous Fumarate I.P. – 350 mg (eq. to 115 mg of elemental Iron) Folic Acid I.P. – 500 mg Vitamin B12 I.P. – 2000 I.U. Ascorbic Acid (coated) I.P. Excipients – q.s Approved colour used in empty capsule shells Appropriate overages of vitamins added to compensate for loss on storage |
| 16 | Prebiotic & Probiotic Capsules |
Each hard gelatin capsule contains : Saccharomyces Boulardii – 5 Billion spores Lactobacillus Acidophilus – 5 Billion spores Bifidobacterium Longum – 5 Billion spores Fructo-oligosaccharides – 100 mg Excipients – q.s Approved colour used in empty capsule shells |
| 17 | Doxycycline & Lactic Acid Bacillus Capsules |
Each hard gelatin capsule contains : Doxycycline Hydrochloride I.P. – eq. to Doxycycline 100 mg Lactic Acid Bacillus – 5 Billion spores Excipients – q.s Approved colour used in empty capsule shells |
| 18 | Prebiotic & Probiotic Capsules |
Each hard gelatin capsule contains : Streptococcus Faecalis – 60 Million Spores Clostridium Butyricum – 4 Million Spores Bacillus Mesentericus – 2 Million Spores Lactic Acid Bacillus – 100 Million Spores Excipients – q.s Approved colour used in empty capsule shells |
| 19 | Omeprazole & Domperidone Capsules |
Each hard gelatin capsule contains : Omeprazole I.P. – 20 mg (As enteric coated Pellets) Domperidone I.P. – 10 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 20 | Rosuvastatin (E.C.), Clopidogrel (E.C.) & Aspirin (I.R.) Capsules |
Each hard gelatin capsule contains: Rosuvastatin Calcium I.P. – Eq. to Rosuvastatin – 20 mg (As Prolonged-release pellets) Clopidogel Bisulphate I.P. – Eq. to Clopidogrel – 75 mg (As Prolonged-release pellets) Aspirin I.P. – 75 mg (As enteric coated pellets) Excipients – q.s. Approved colours used in empty capsule shells |
| 21 | Rabeprazole Sodium (E.C.) & Itopride Hydrochloride (S.R.) capsules |
Each hard gelatin capsule contains: Rabeprazole Sodium I.P. – 20 mg (As Gastro resistant pellets) Itopride Hydrocloride – 150 mg (As Prolonged-release pellets) Excipients – q.s. Approved colours used in empty capsule shells |
| 22 | Rosuvastatin (I.R.), Clopidogrel (I.R.) & Aspirin (E.C.) Capsules |
Each hard gelatin capsule contains: Rosuvastatin Calcium I.P. – Eq. to Rosuvastatin – 20 mg (As Immediate-release pellets) Clopidogel Bisulphate I.P. – Eq. to Clopidogrel – 75 mg (As Immediate-release pellets) Aspirin I.P. – 75 mg (As enteric coated pellets) Excipients – q.s. Approved colours used in empty capsule shells |
| 23 | Thiocolchicoside capsules I.P |
Each hard gelatin capsule contains: Thiocolchicoside I.P. – 8 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 24 | Orlistat Capsules |
Each hard gelatin capsule contains: Orlistat U.S.P. – 60 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 25 | Orlistat Capsules |
Each hard gelatin capsule contains: Orlistat U.S.P. – 120 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 26 | Diacerein Capsules |
Each hard gelatin capsule contains: Diacerein I.P. – 50 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 27 | Diacerein Capsules |
Each hard gelatin capsule contains: Diacerein I.P. – 100 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 28 | Thiocolchicoside Capsules |
Each hard gelatin capsule contains: Thiocolchicoside I.P. – 4 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 29 | Methylcobalamin, Alpha Lipoic Acid, Thiamine Mononitrate, Pyridoxine Hydrochloride & Folic Acid Capsules |
Each hard gelatin capsule contains: Methylcobalamin I.P. – 1500 mcg Alpha Lipoic Acid U.S.P. – 100 mg Thiamine Mononitrate I.P. – 10 mg Pyridoxine Hydrochloride I.P. – 3 mg Folic Acid I.P. – 1.5 mg Excipients Approved colour used in empty hard gelatin capsule shells |
| 30 | Methylcobalamin and Folic Acid Capsules |
Each hard gelatin capsule contains: Methylcobalamin – 1500 mcg Folic Acid – 1.5 mg Excipients – q.s Approved colour used in empty hard gelatin capsule shells |
| 31 | Rosuvastatin Calcium & Aspirin Capsules |
Each hard gelatin capsule contains: Rosuvastatin Calcium I.P. – Eq. to Rosuvastatin – 10 mg (As Immediate-release pellets) Aspirin I.P. – 75 mg (As gastro-resistant pellets) Excipients – q.s. Approved colours used in empty capsule shells and pellets |
| 32 | Enteric-coated Pantoprazole Sodium & Sustained-Release Domperidone Capsules |
Each hard gelatin capsule contains: Pantoprazole Sodium I.P. – 40 mg (As enteric coated pellets) Domperidone – 20 mg (As Sustained-Release pellets) I.P. Domperidone – 10 mg (As immediate-Release pellets) I.P. Excipients – q.s. Approved colours used in empty capsule shells and pellets |
| 33 | Calcitriol, Calcium and Zinc Capsules |
Each hard gelatin capsule contains: Calcitriol IP – 0.25 mcg Calcium Cirtate – Eq. to elemental Calcium – 200 mg Zinc Sulphate Monohydrate IP – Eq. to elemental zinc – 7.5 mg Excipients – q.s. Approved colours used in empty capsule shells |
| 34 | Pantoprazole gastro-resistant and Cinitapride prolonged-release Capsules |
Each hard gelatin capsule contains: Pantoprazole Sodium IP – Eq. to Pantoprazole – 40 mg (as gastro-resistant pellets) Cinitapride Hydrogen Tartrate IP – 3 mg (as gastro-resistant pellets) Excipients – q.s. Approved colours used in empty capsule shells |
| 35 | Lansoprazole gastro-resistant capsules IP |
Each hard gelatin capsule contains: Lansoprazole IP – 30 mg (as gastro-resistant pellets) Dose: As directed by the Physician. |
| 36 | Calcium Dobesolate and Docusate Sodium Capsules |
Each hard gelatin capsule contains: Calcium Dobesilate Monohydarte IP – Eq. to Calcium Dobesilate – 500 mg Docusate Sodium IP – 100 mg Excipients – q.s. Approved colours used in empty hard gelatin capsule shells. Dose: As directed by the physician. |
| 37 | Clindamycin Capsules IP |
Each hard gelatin capsule contains: Clindamycin Hydrochloride IP – Eq. to Clindamycin – 300 mg Excipients – q.s. Approved colours used in empty hard gelatin capsule shells. Dose: As directed by the physician. |
| 38 | Ilaprazole Gastro-resistant and Domperidone Prolonged-release Capsules |
Each hard gelatin capsule contains: Ilaprazole IP – 10 mg (as gastro-resistant pellets) Domperidone IP – 30 mg (as prolonged-release pellets) Approved colours used in empty hard gelatin capsule shells. Dose: As directed by the physician. |
| 39 | Pre and Probiotics Capsules |
Each hard gelatin capsule contains: Total Lactobacillus – 2.5 Billion Spores (Contains Lactic Acid Bacillis, Lactobacillus Ramnosus and Lactobacillus Acidophillus) Total Bifidobacterium – 2.4 Billion Spores (Contains Bifidobacterium Longum and Bifidobacterium Bifidum) Sacchromyces Boulardii – 0.1 Billion Spores Fructooligosachharides – 100 mg Excipients – q.s. Approved colour used in empty hard gelatin capsule shells. |
| 40 | Omeprazole Gastro-resistant Capsules IP |
Each hard gelatin capsule contains: Omeprazole IP – 20 mg (as gastro-resistant pellets) Approved colour used in empty hard gelatin capsules shells. |
| 41 | Lactic Acid Bacillus Capsules |
Each hard gelatin capsule contains: Lactic Acid Bacillus – 60 million spores Excipients – q.s. Dose: As directed by the physician. Approved colour used in empty hard gelatin capsules shells. Appropriate Overages added. |
| 42 | Lactic Acid Bacillus Capsules |
Each hard gelatin capsule contains: Lactic Acid Bacillus – 120 million spores Excipients – q.s. Dose: As directed by the physician. Approved colour used in empty hard gelatin capsules shells. Appropriate Overages added. |
| 43 | Cyclosporine Capsules IP 50 mg |
Each hard gelatin capsule contains: Cyclosporine IP – 50 mg Excipients – q.s. Dose: As directed by the physician. Approved colour used in empty hard gelatin capsules shells. |
| 44 | Cyclosporine Capsules IP 100 mg |
Each hard gelatin capsule contains: Cyclosporine IP – 100 mg Excipients – q.s. Dose: As directed by the physician. Approved colour used in empty hard gelatin capsules shells. |
| 45 | Flupirtine Maleate Capsules 100 mg |
Each hard gelatin capsule contains: Flupirtine Maleate – 100 mg Excipients – q.s. Dose: As directed by the physician. Approved colour used in empty hard gelatin capsule shells. |
| 46 | Dicloxacillin Sodium Capsule IP 250 mg |
Each hard gelatin capsule contains: Dicloxacillin Sodium IP – Eq. to Dicloxacillin – 250 mg Dose: As directed by the physician. Approved colour used in empty hard gelatin capsules shells. |
| 47 | Dicloxacillin Sodium Capsule IP 500 mg |
Each hard gelatin capsule contains: Dicloxacillin Sodium IP – Eq. to Dicloxacillin – 500 mg Dose: As directed by the physician. Approved colour used in empty hard gelatin capsules shells. |
| 48 | Oseltamivir Capsules IP 75 mg |
Each hard gelatin capsule contains: Oseltamivir Phosphate IP – Eq. to Oseltamivir – 75 mg Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 49 | Esomeprazole Gastro-resistant and Levosulpride Prolonged-release Capsules |
Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate IP – Eq. to Esomeprazole – 40 mg Levosulpride – 49 (As Prolonged-release pellets) Excipients – q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 50 | Flupirtine Maleate Capsules 400 mg |
Each hard gelatin capsule contains: Flupirtine Maleate – 400 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 51 | Calcium Dobesilate Capsules 500 mg |
Each hard gelatin capsule contains: Calcium Dobesilate Monohydrate IP – Eq. to Calcium Dobesilate (anhydrous) – 500 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 52 | Orlistat Capsules USP 120 mg |
Each hard gelatin capsule contains: Orlistat USP – 120 mg (as pellets) Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 53 | Venlafaxine Prolonged-release Capsules BP 120 mg |
Each hard gelatin capsule contains: Venlafaxine Hydrochloride BP – Eq. to Venlafaxine – 120 mg (as pellets) Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 54 | Aceclofenac Prolonged-release 200 mg and Thiocolchicoside Prolonged-release 8 mg Capsules |
Each hard gelatin capsule contains: Aceclofenac IP – 200 mg (as prolonged-release pellets) Thiocolchicoside IP – 8 mg (as prolonged-release pellets) Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 55 | Aceclofenac Prolonged-release 200 mg and Thiocolchicoside Prolonged-release 8 mg Capsules |
Each hard gelatin capsule contains: Aceclofenac IP – 100 mg (as prolonged-release pellets) Thiocolchicoside IP – 4 mg (as prolonged-release pellets) Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 56 | Acitretin Capsules IP 25mg |
Each hard gelatin capsule contains: Acitretin IP – 25 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 57 | Acitretin Capsules IP 10mg |
Each hard gelatin capsule contains: Acitretin IP – 10 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 58 | Pre and Probiotic Capsules |
Each hard gelatin capsule contains: Total Lactobacillus – 12.5 Billion Spores (Contains Lactic Acid Bacillus, Lactovacillus Rhamnosus, and Lactobacillus Acidophillus) Total Bifidobacterium – 12.5 Billion Spores (Contains Bifidobacterium Longum and Bifidobacterium Bifidum) Sacchromyces Boulardii – 5 Billion Spores Fructooligosaccharides – 100 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 59 | Acebrophylline Capsules 100mg |
Each hard gelatin capsule contains: Acebrophylline – 100 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 60 | Isotretinoin Capsules IP 20mg |
Each hard gelatin capsule contains: Isotretinoin IP – 20 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 61 | Pregabalin Capsules IP 75 mg |
Each hard gelatin capsule contains: Pregabalin IP – 75 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 62 | Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Chromium Picolinate, and Benfotiamine Capsules |
Each hard gelatin capsule contains: Methylcobalamin IP – 1500 mcg Alpha Lipoic Acid USP – 100 mg Folic Acid IP – 1.5 mg Pyridoxine Hydrochloride IP – 3 mg Chromium Picolinate USP – 200 mg Benfothiamine – 50 mg Excipients – q.s. Appropriate overages added. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 63 | Silodosin Capsules 8 mg |
Each hard gelatin capsule contains: Silodosin – 8 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 64 | Silodosin Capsules 4 mg |
Each hard gelatin capsule contains: Silodosin – 4 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 65 | Tramadol Hydrochloride Capsules 50 mg |
Each hard gelatin capsule contains: Tramadol Hydrochloride IP – 50 mg Excipients – q.s. Approved colour used in empty hard gelatin capsules shells. Dose: As directed by the physician. |
| 66 | Tramadol Capsules BP 200 mg (FOR EXPORT) |
Each hard gelatin capsule contains: Tramadol Hydrochloride BP – 200 mg Excipients – q.s. Approved Colour used in empty capsules shells. Dose: As directed by the physician. |
| 67 | Tramadol Capsules BP 225 mg (FOR EXPORT) |
Each hard gelatin capsule contains: Tramadol Hydrochloride BP – 225 mg Excipients – q.s. Approved Colour used in empty capsules shells. Dose: As directed by the physician. |
| 68 | Lansoprazole Gastro-resistant Capsules IP 15mg |
Each hard gelatin capsule contains: Lansoprazole IP – 15 mg (as pellets) Approved color used in empty hard gelatin capsules shells & pellets |
| 69 | Nitrofurantoin Capsule USP 100mg |
Each hard gelatin capsule contains: Nitrofurantoin IP (Hydrous/Anhydrous) – 100 mg Excipients – q.s Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician. |
| 70 | Racecadotril Capsules IP 100mg |
Each hard gelatin capsule contains: Racecadotril IP – 100 mg Dosage: As directed by the physician Approved colour used in empty hard gelatin capsule shells. |
| 71 | Indomethacin Capsules IP 25 mg |
Each hard gelatin capsule contains: Indomethacin IP – 25 mg Excipients – q.s Approved color used in empty hard gelatin capsules shells & pellets Dosage: As directed by the physician |
| 72 | Indomethacin Extended-release Capsules USP |
Each hard gelatin capsule contains: Indomethacin IP – 75 mg (As sustained-release pellets) Excipients – q.s. Approved color used in empty hard gelatin capsules shells & pellets Dosage: As directed by the physician |
| 73 | Pregabalin Capsules IP 50 mg |
Each hard gelatin capsule contains: Pregabalin IP – 50 mg Approved color used in empty hard gelatin capsules shells Dosage: As directed by the physician |
| 74 | Celecoxib Capsules 100 mg |
Each hard gelatin capsule contains: Celecoxib IP – 100 mg Excipients – q.s. Approved colors used in empty hard gelatin capsule shells Dosages: As directed by the physician |
| 75 | Celecoxib Capsules 200 mg |
Each hard gelatin capsule contains: Celecoxib IP – 200 mg Excipients – q.s. Approved colors used in empty hard gelatin capsule shells Dosages: As directed by the physician |
| 76 | Clindamycin Hydrochloride Capsules IP 150 mg |
Each hard gelatin capsule contains: Clindamycin Hydrochloride IP (eqv. to Clindamycin) – 150 mg Excipients – q.s. Approved colors used in empty hard gelatin capsule shells Dosages: As directed by the physician |
| 77 | Orlistat Capsules USP 60 mg |
Each hard gelatin capsule contains: Orlistat USP – 60 mg (as pellets) Excipients – q.s. Approved colors used in empty hard gelatin capsule shells Dosages: As directed by the physician |
| 78 | Pencreatin Capsules BP 150 mg |
Each hard gelatin capsule contains: Pancreatin IP – 150 mg (As gastro-resistant) eqv. to Lypase activity – 3000 BP Unit Amylase activity – 3600 BP Unit Protease activity – 210 BP Unit Approved colors used in empty hard gelatin capsule shells Appropriate overages added Dosages: As directed by the physician |
| 79 | Pregabalin Capsules IP 150 mg |
Each hard gelatin capsule contains: Pregabalin IP – 150 mg Excipients – q.s. Approved colors used in empty hard gelatin capsule shells Dosages: As directed by the physician |
| 80 | Itraconazole Capsules BP 100 mg | Each hard gelatin capsule contains: Itraconazole IP – 100 mg Excipients – q.s. Approved colours used in empty hard gelatin capsule shells. Dosages: As directed by the physician. |
| 81 | Silodosin and Dutasteride Capsules | Each hard gelatin capsule contains: Silodosin – 8 mg Dutasteride IP – 0.5 mg Excipients – q.s. Approved colours used in empty hard gelatin capsule shells. |
| 82 | Rosuvastatin and Clopidogrel Capsules | Each hard gelatin capsule contains: Rosuvastatin Calcium IP – Eqv. to Rosuvastatin 10 mg (as pellets) Clopidogrel Bisulphate IP – Eqv. to Clopidogrel 75 mg (as pellets) Excipients – q.s. Approved colours used in empty hard gelatin capsule shells. |
| 83 | Esomeprazole Gastro-resistant and Domperidone | Each hard gelatin capsule contains: Prolonged-release Capsules Esomeprazole Magnesium Trihydarte IP – Eqv. to Esomeprazole 20 mg (As Gastro-resistant pellets) Domperidone IP – 30 mg (As Prolonged-release pellets) Excipients – q.s. Colours: Titanium Dioxide IP & Sunset Yellow FCF Approved colours used in empty hard gelatin capsule shells. |
| 84 | Isotretinoin Capsules IP 10 mg | Each hard gelatin capsule contains: Isotretinoin IP – 10 mg Approved colour used in empty hard gelatin capsule shells. Dosages: As directed by the physician. |
| 85 | Gabapentine Capsules IP 400 mg | Each hard gelatin capsule contains: Gabapentin IP – 400 mg Approved colour used in empty hard gelatin capsule shells. Dosages: As directed by the physician. |
| 86 | Rosuvastatin and Clopidogrel Capsules | Each hard gelatin capsule contains: Rosuvastatin Calcium IP – Eqv. to Rosuvastatin 20 mg Clopidogrel Bisulphate IP – Eqv. to Clopidogrel 75 mg (As Pellets) Excipients – q.s. Colours: Titanium Dioxide IP & Sunset Yellow FCF Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician |
| 87 | Silodosin and Dutasteride Capsules | Each hard gelatin capsule contains: Silodosin – 4 mg Dutasteride IP – 0.5 mg Excipients – q.s. Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician |
| 88 | Itraconazole Capsules BP 200 mg | Each hard gelatin capsule contains: Itraconazole IP – 200 mg Excipients – q.s. Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician |
| 89 | Esomeprazole Gastro-resistant & Domperidone | Each hard gelatin capsule contains: Prolonged-release Capsules Esomeprazole Magnesium Trihydarte BP – Eqv. to Esomeprazole 40 mg (As Gastro-resistant pellets) Domperidone BP – 30 mg (As Prolonged-release pellets) Colours: Titanium Dioxide IP & Sunset Yellow FCF Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician |
| 90 | Pre and Probiotic Capsules | Each hard cellulose capsule contains: Sacchromyces Boulardii – 5 Billion Spores Lactobacillus Acidophillus – 5 Billion Spores Bifidobacterium Longum – 5 Billion Spores Fructooligosachharides – 100 mg Excipients – q.s. Approved colour used in empty capsule shells. |
| 91 | Pregabalin Capsules IP 300 mg | Each hard gelatin capsule contains: Pregabalin IP – 300 mg Excipients – q.s. Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician |
| 92 | Pregabalin Capsules IP 300 mg | Each hard gelatin capsule contains: Pregabalin BP – 300 mg Excipients – q.s. Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the physician |
Tablets
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Calcium with Vitamin D3 Tablets U.S.P. |
Each film coated tablet contains: 1.25 g of calcium carbonate I.P. from an organic source (oyster shell), Eq. to elemental calcium Vitamin D3 I.P. Excipients q.s. Colour: Titanium Dioxide I.P. Appropriate overages of vitamin added to compensate for loss on storage 500.00 mg 2000.00 I.U. |
| 2 | Azithromycin Tablets I.P. 500 mg |
Each film coated tablet contains: Azithromycin (As Dihydrate) I.P., Eq. to Anhydrous Azithromycin Excipients q.s. Colour: Yellow oxide of iron and Titanium Dioxide I.P. 500.00 mg |
| 3 | Azithromycin Tablets I.P. 250 mg |
Each film coated tablet contains: Azithromycin (As Dihydrate) I.P., Eq. to Anhydrous Azithromycin Excipients q.s. Colour: Yellow oxide of iron and Titanium Dioxide I.P. 250.00 mg |
| 4 | Roxithromycin Tablets I.P. 150 Mg |
Each film coated tablet contains: Roxithromycin I.P. Excipients q.s. Colour: Brilliant Blue FCF and Titanium Dioxide I.P. 150.00 mg |
| 5 | Ferrous Ascorbate and Folic Acid Tablets |
Each film coated tablet contains: Ferrous Ascorbate I.P., Eq. to elemental Iron Folic Acid I.P. Excipients q.s. Colour: Ferric Oxide (Red) USP-NF 100.00 mg 1.50 mg |
| 6 | Trypsin Chymotrypsin Tablets |
Each enteric coated tablet contains: 100,00 Armour units of enzymatic activity (supplied by a purified concentrate which has specific trypsin and chymotrypsin activity in a ratio of approximately 6:1) Excipients q.s. Colour: Titanium Dioxide I.P. |
| 7 | N-Acetylcysteine and Pyridoxamine Dihydrochloride Tablets |
Each film coated tablet contains: N-Acetylcysteine U.S.P. Pyridoxamine Dihydrochloride Excipients q.s. Colour: Ferric Oxide Red U.S.P. N.F. and Titanium Dioxide I.P. 600.00 mg 50.00 mg |
| 8 | Aceclofenac, Paracetamol and Serratiopeptidase Tablets |
Each film coated tablet contains: Aceclofenac I.P. Paracetamol I.P. Serratiopeptidase I.P. (Eq. to 20,000 Enzymatic Unit.) Excipients q.s. Colour: Lake of Brilliant Blue and Titanium Dioxide I.P. 100.00 mg 325.00 mg 10.00 mg |
| 9 | Aceclofenac and Serratiopeptidase Tablets |
Each film coated tablet contains: Aceclofenac I.P. Serratiopeptidase (30,000 units as enteric coated granules) Excipients q.s. Colour: Lake Sunset Yellow 100.00 mg 15.00 mg |
| 10 | Pantoprazole Gastro-resistant Tablets I.P. 40 mg |
Each Gastro-resistant tablet (enteric-coated) contains: Pantoprazole Sodium I.P., Eq. to Pantoprazole Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. 40.00 mg q.s. |
| 11 | Paracetamol Tablets I.P. 650 mg. |
Each uncoated tablet contains: Paracetamol I.P. Excipients 650.00 mg q.s. |
| 12 | Calcium Acetate Tablets U.S.P. 667 mg |
Each film coated tablet contains: Calcium Acetate U.S.P. Excipients Colour: Titanium Dioxide I.P. 667.00 mg q.s. |
| 13 | Ornidazole Tablets I.P. 500 mg |
Each film coated tablet contains: Ornidazole I.P. Excipients Colour: Titanium Dioxide I.P. 500.00 mg q.s. |
| 14 | Sodium Bicarbonate Tablets U.S.P. 1000 mg |
Each film coated tablet contains: Sodium Bicarbonate U.S.P. Excipients Colour: Titanium Dioxide I.P. U.S.P. 1000.00 mg q.s. |
| 15 | Voglibose Tablets I.P. 0.2 mg |
Each uncoated tablet contains: Voglibose I.P. Excipients 0.20 mg q.s. |
| 16 | Voglibose Tablets I.P. 0.3 mg |
Each uncoated tablet contains: Voglibose I.P. Excipients 0.30 mg q.s. |
| 17 | Levetiracetam Prolonged-Release Tablets IP 500 mg |
Each uncoated Prolonged-Release tablet contains: Levetiracetam I.P. Excipients 500.00 mg q.s. |
| 18 | Betahistine Dihydrochloride Tablets I.P. 16 mg |
Each film coated tablet contains: Betahistine Dihydrochloride I.P. Excipients Colour: Yellow Oxide of Iron, Lake of Indigo Carmine and Titanium Dioxide I.P. 16.00 mg q.s. |
| 19 | Etoricoxib Tablets I.P. 90 mg |
Each film coated tablet contains: Etoricoxib I.P. Excipients Colour: Titanium Dioxide I.P. 90.00 mg q.s. |
| 20 | Metformin Hydrochloride Prolonged-Release Tablets I.P. 1000 mg |
Each uncoated tablet contains: Metformin Hydrochloride I.P. (As Prolonged-Release Form) Excipients 1000.00 mg q.s. |
| 21 | Citicoline and Piracetam Tablets |
Each film coated tablet contains: Citicoline Sodium I.P., Eq. to Citicoline Piracetam I.P. Excipients Colour: Ferric Oxide (Red) U.S.P.-NF 500.00 mg 800.00 mg q.s. |
| 22 | Telmisartan Tablets I.P. 40 mg |
Each uncoated tablet contains: Telmisartan I.P. Excipients 40.00 mg q.s. |
| 23 | Metformin Hydrochloride Prolonged-Release Tablets I.P. 500 mg |
Each uncoated tablet contains: Metformin Hydrochloride I.P. (As Prolonged-Release Form) Excipients 500.00 mg q.s. |
| 24 | Calcium Carbonate Tablets I.P. 500 mg |
Each film coated tablet contains: 1.25 g of Calcium Carbonate I.P. From an organic source (Oyster shell) Eq. to elemental Calcium Excipients Colour: Lake of Brilliant Blue FCF and Titanium Dioxide I.P. 500.00 mg q.s. |
| 25 | Linezolid Tablets I.P. 600 mg |
Each film coated tablet contains: Linezolid I.P. Excipients Colour: Titanium Dioxide I.P. 600.00 mg q.s. |
| 26 | Ondansetron Orally Disintegrating Tablets I.P.4 mg |
Each uncoated orally tablet contains: Ondansetron Hydrochloride I.P. eq. to Ondansetron Excipients Colour: Sunset Yellow FCF 4.00 mg q.s. |
| 27 | Paracetamol and Tramadol Hydrochloride Tablets U.S.P. |
Each film coated tablet contains: Paracetamol I.P. Tramadol Hydrochloride I.P. Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. Warning: Overdose of Paracetamol has the potential for severe liver injury and allergic reactions (e.g. swelling of the face, mouth and throat, difficulty in breathing, itching or rash). 325.00 mg 37.50 mg q.s. |
| 28 | Rabeprazole Sodium Tablets I.P. 20 mg |
Each enteric coated tablet contains: Rabeprazole Sodium I.P. Excipients Colour: Lake of Sunset Yellow FCF and Titanium Dioxide I.P. 20.00 mg q.s. |
| 29 | Pantoprazole Tablets I.P. 40 mg |
Each enteric coated tablet contains: Pantoprazole Sodium I.P., eq. to Pantoprazole Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. 40.00 mg q.s. |
| 30 | Levocetirizine Hydrochloride Tablets I.P. 5 mg |
Each film coated tablet contains: Levocitirizine Hydrochloride I.P. Excipients Colour: Titanium Dioxide I.P. 5.00 mg q.s. |
| 31 | Cetirizine Hydrochloride Tablets I.P. 10 mg |
Each film coated tablet contains: Cetirizine Hydrochloride Excipients Colour: Titanium Dioxide I.P. I.P. 10.00 mg q.s. |
| 32 | Ofloxacin Tablets I.P. |
Each film coated tablet contains: Ofloxacin Excipients Colour: Titanium Dioxide I.P., Lake of Sunset Yellow I.P. 200.00 mg q.s. |
| 33 | Ofloxacin Tablets I.P. |
Each film coated tablet contains: Ofloxacin I.P. Excipients Colour: Titanium Dioxide I.P. I.P. 400.00 mg q.s. |
| 34 | Mefenamic Acid and Drotaverine Hydrochloride Tablets |
Each film coated tablet contains: Mefenamic Acid Drotaverine Hydrochloride Excipients Colour: Tartrazine and Titanium Dioxide I.P. I.P. 250.00 mg 80.00 mg q.s. |
| 35 | Domperidone and Naproxen Sodium Tablets |
Each film coated tablet contains: Domperidone Maleate equivalent to Domperidone Naproxen Sodium equivalent to Naproxen Excipients Colour: Ferric Oxide (Red) U.S.P.-NF and Titanium Dioxide I.P. I.P. U.S.P. 10.00 mg 275.00 mg 250.00 mg q.s. |
| 36 | Domperidone and Naproxen Sodium Tablets |
Each film coated tablet contains: Domperidone Maleate equivalent to Domperidone Naproxen Sodium equivalent to Naproxen Excipients Colour: Ferric Oxide (Red) U.S.P.-NF and Titanium Dioxide I.P. I.P. U.S.P. 10.00 mg 550.00 mg 500.00 mg q.s. |
| 37 | Telmisartan and Hydrochlorothiazide Tablets U.S.P. |
Each Uncoated Bi-Layered tablet contains: Telmisartan I.P. Hydrochlorothiazide I.P. Excipients Colour: Sunset Yellow FCF 40.00 mg 12.50 mg q.s. |
| 38 | Levofloxacin Tablets I.P. |
Each film coated tablet contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Colour: Ferric Oxide(Red)USP-NF and Titanium Dioxide I.P. I.P. 500.00 mg q.s. |
| 39 | Tolperisone Hydrochloride Tablets |
Each film coated tablet contains: Tolperisone Hydrochloride Excipients Colour: Titanium Dioxide I.P. J.P. 150.00 mg q.s. |
| 40 | Atenolol Tablets B.P. |
Each Uncoated tablet contains: Atenolol Excipients B.P. 50.00 mg q.s. |
| 41 | Amlodipine Tablets U.S.P. |
Each Uncoated tablet contains: Amlodipine Besylate Eq to Amlodipine Excipients USP 5.00 mg q.s. |
| 42 | Amlodipine Tablets U.S.P. |
Each Uncoated tablet contains: Amlodipine Besylate Eq to Amlodipine Excipients USP 10.00 mg q.s. |
| 43 | Montelukast and Levocetirizine Tablets |
Each film coated tablet contains: Montelukast Sodium Eq to Montelukast Levocetirizine Excipients Colour: Titanium Dioxide I.P., Lake of Quinoline Yellow and Lake of Brilliant Blue I.P. I.P. 10.00 mg 5.00 mg q.s. |
| 44 | Nimesulide and Paracetamol Tablets |
Each Uncoated tablet contains: Nimesulide Paracetamol Excipients Colour: Titanium Dioxide I.P. B.P. I.P. 100.00 mg 325.00 mg q.s. |
| 45 | Aceclofenac and Paracetamol Tablets |
Each Uncoated tablet contains: Aceclofenac Paracetamol Excipients Colour: Sunset Yellow FCF I.P. I.P. 100.00 mg 325.00 mg q.s. |
| 46 | Artemether and Lumefantrine Tablets |
Each film coated tablet contains: Artemether Lumefantrine Excipients Colour: Lake of Quinnoline Yellow and Titanium Dioxide I.P. B.P. I.P. I.P. q.s. 80.00 mg 480.00 mg |
| 47 | Ofloxacin and Ornidazole Tablets |
Each film coated tablet contains: Ofloxacin Ornidazole Excipients Colour: Lake of Sunset Yellow FCF, Tartrazine and Titanium Dioxide I.P. I.P. I.P. q.s. 200.00 mg 500.00 mg |
| 48 | Ketoconazole Tablets I.P. 200 mg |
Each Uncoated tablet contains: Ketoconazole Excipients I.P. q.s. 200.00 mg |
| 49 | Deflazacort Tablets 30 mg |
Each Uncoated tablet contains: Deflazacort Excipients Colour: Tartrazine I.P. q.s. 30.00 mg |
| 50 | Aceclofenac and Drotaverine Hydrochloride Tablets |
Each film coated tablet contains: Drotaverine Hydrochloride Aceclofenac Excipients Colour: Yellow Oxide Of Iron I.P. I.P. q.s. 80.00 mg 100.00 mg |
| 51 | Etoricoxib and Thiocolchicoside Tablets |
Each film coated tablet contains: Etoricoxib Thiocolchicoside Excipients Colour: Quinoline Yellow and Titanium Dioxide I.P. I.P. I.P. q.s. 60.00 mg 4.00 mg |
| 52 | Drotaverine 80mg Tablets I.P. |
Each film coated tablet contains: Drotaverine Hydrochloride Eq. to Drotaverine Excipients Colour: Sunset Yellow I.P. q.s. 80.00 mg |
| 53 | Levoflaxacin and Ornidazole Tablets |
Each film coated tablet contains: Levoflaxacin Eq. to levofloxacin Ornidazole Excipients Colour: Not specified I.P. I.P. q.s. 250.00 mg 500.00 mg |
| 54 | Etizolam,Propranolol Tablets |
Each film coated tablet contains: Etizolam Propranolol Excipients Colour: Not specified I.P. q.s. 0.50 mg 20.00 mg |
| 55 | Levetiracetam Tablets |
Each film uncoated tablet contains: Levetiracetam Excipients Colour: Ferric oxide Red and titanium dioxide I.P. q.s. 750.00 mg |
| 56 | Methyl Prednisolone I.P. Tablets |
Each uncoated tablet contains: Methyl Prednisolone Excipients Colour: Not specified I.P. q.s. 8.00 mg |
| 57 | Ursodeoxycholic Acid Tablets |
Each film coated tablet contains: Ursodeoxycholic Acid Excipients Colour: Sunset Yellow I.P. q.s. 150.00 mg |
| 58 | Ursodeoxycholic Acid Tablets |
Each film coated tablet contains: Ursodeoxycholic Acid Excipients Colour: Sunset Yellow I.P. q.s. 300.00 mg |
| 59 | Drotaverine HCL and Paracetamol Tablets |
Each film coated tablet contains: Drotaverine HCL Paracetamol Excipients Colour: Sunset Yellow I.P. I.P. q.s. 80.00 mg 325.00 mg |
| 60 | Pantoprazole and Domperidone Tablets |
Each enteric coated tablet contains: Pantoprazole Sodium eq. to Pantoprazole Domperidone Excipients Colour: Ponceau-4R I.P. I.P. q.s. 40.00 mg 10.00 mg |
| 61 | Alprazolam Tablets |
Each uncoated tablet contains: Alprazolam Excipients Colour: Sunset Yellow I.P. q.s. 0.25 mg |
| 62 | Ofloxacin and Nitazoxanide Tablets |
Each film coated tablet contains: Ofloxacin Nitazoxanide Excipients Colour: Not specified I.P. I.P. q.s. 200.00 mg 500.00 mg |
| 63 | Rifaximin Tablets 200 mg |
Each film coated tablet contains: Rifaximin Ph. Eur Excipients Colour: Sunset Yellow B.P. q.s. 200.00 mg |
| 64 | Rifaximin Tablets 400 mg |
Each film coated tablet contains: Rifaximin Ph. Eur Excipients Colour: Sunset Yellow B.P. q.s. 400.00 mg |
| 65 | Aceclofenac, Paracetamol and Trypsin-Chymotrypsin Tablets |
Each film coated tablet contains: Aceclofenac Paracetamol Trypsin-Chymotrypsin 1,00,000 Armour units of enzymatic acitivity (As enteric coated granules) (Supplied by a purified concentrate which has specific Trypsin and Chymotrypsin activity in a ratio of approximately six to one) Excipients Colour: Lake of Quinoline Yellow and Titanium Dioxide I.P. I.P. I.P. q.s 100.00 mg 325.00 mg |
| 66 | Trypsin, Bromelain, Rutoside Trihydrate and Aceclofenac Tablets |
Each enteric coated tablet contains: Trypsin Bromelain Rutoside Trihydrate Aceclofenac Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. Total Proteolytic Activity not less than 1095 FIP units per tablet (Papain Method) B.P. B.P. I.P. q.s. 48.00 mg 90.00 mg 100.00 mg 100.00 mg |
| 67 | Trypsin, Bromelain, Rutoside Trihydrate and Diclofenac Tablets |
Each enteric coated tablet contains: Trypsin Bromelain Rutoside Trihydrate Diclofenac Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. Total Proteolytic Activity not less than 1095 FIP units per tablet (Papain Method) B.P. B.P. I.P. q.s. 48.00 mg 90.00 mg 100.00 mg 50.00 mg |
| 68 | Etoricoxib and Serratiopeptidase tablet |
Each film coated tablet contains: Etoricoxib Serratiopeptidase (equivalent to 20,000 units of serratiopeptidase) (As enteric coated) Excipients Colour: Titanium Dioxide I.P. I.P. I.P. q.s. 60.00 mg 10.00 mg |
| 69 | Etoricoxib and Serratiopeptidase tablet |
Each film coated tablet contains: Etoricoxib Serratiopeptidase (equivalent to 30,000 units of serratiopeptidase) (As enteric coated) Excipients Colour: Titanium Dioxide I.P. I.P. I.P. q.s. 60.00 mg 15.00 mg |
| 70 | Doxofylline Tablets I.P. |
Each film coated tablet contains: Doxofylline Excipients Colour: Sunset Yellow I.P. q.s. 400.00 mg |
| 71 | Ferrous Ascorbate and Folic Acid Tablets |
Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron Folic Acid Excipients Colour: Red Oxide Of Iron Appropriated overages of vitamins added to compensate loss on storage I.P. I.P. q.s. 100.00 mg 1.50 mg |
| 72 | Terbinafine Tablets |
Each uncoated tablet contains: Terbinafine HCL Eq. to Terbinafine Excipients B.P. q.s. 250.00 mg |
| 73 | Aceclofenac (SR) 100 Mg Tablets |
Each Sustained release tablet contains: Aceclofenac Excipients I.P. 100.00 mg q.s. mg |
| 74 | Aceclofenac (SR) 200 Mg Tablets |
Each Sustained release tablet contains: Aceclofenac Excipients I.P. 200.00 mg q.s. mg |
| 75 | Aceclofenac Thiocolchicoside Tablets I.P. |
Each film coated tablet contains: Aceclofenac Thiocolchicoside Excipients Colour: Yellow iron oxide and Lake of Quinoline Yellow 100.00 mg 4.00 mg q.s. mg |
| 76 | Aceclofenac Thiocolchicoside Tablets I.P. |
Each film coated tablet contains: Aceclofenac Thiocolchicoside Excipients Colour: Quinoline Yellow Lake I.P. I.P. 100.00 mg 8.00 mg q.s. mg |
| 77 | Amlodipine and Atenolol Tablets |
Each uncoated tablet contains: Amlodipine Besylate Eq. to Amlodipine Atenolol Excipients I.P. I.P. 5.00 mg 50.00 mg q.s. mg |
| 78 | Paracetamol, Phenylephrine hydrochloride |
Each uncoated tablet contains: Bromhexine hydrochloride Guaiphenesin Paracetamol Chlorpheniramine Maleate Phenylephrine hydrochloride Excipients Colour: Quinoline Yellow 325.00 mg 10.00 mg 8.00 mg 100.00 mg 2.00 mg q.s. |
| 79 | Atorvastatin Tablets |
Each film coated tablet contains: Atorvastatin Calcium Eq. to Atorvastatin Excipients Colour: Lake sunset Yellow Lake I.P. q.s. 10.00 mg |
| 80 | Atorvastatin Tablets |
Each film coated tablet contains: Atorvastatin Calcium I.P. Eq. to Atorvastatin Excipients Colour: Titanium Dioxide I.P. 20.00 mg q.s. mg |
| 81 | Atorvastatin and Fenofibrate Tablets |
Each film coated tablet contains: Atorvastatin Calcium I.P. Eq. to Atorvastatin Fenofibrate I.P. Excipients Colour: Sunset Yellow Lake 10.00 mg 160.00 mg q.s. mg mg |
| 82 | Baclofen Tablets |
Each uncoated tablet contains: Baclofen Excipients 10.00 mg q.s. mg |
| 83 | Baclofen Tablets |
Each uncoated tablet contains: Baclofen Excipients 25.00 mg q.s. mg |
| 84 | Ivermectin and Albendazole Tablets |
Each uncoated chewable tablet contains: Ivermectin I.P. Albendazole I.P. Excipients Colour: Tartrazine 6.00 mg 400.00 mg q.s. mg mg |
| 85 | Pregabalin and Nortriptyline Tablets |
Each film coated tablet contains: Pregabalin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients Colour: Titanium Dioxide I.P. and Yellow Lake of Iron 75.00 mg 10.00 mg q.s. mg mg |
| 86 | Clarithromycin Tablets |
Each film coated tablet contains: Clarithromycin I.P. Excipients Colour: Quinoline Yellow Lake and Titanium Dioxide I.P. 250.00 mg q.s. mg |
| 87 | Clarithromycin Tablets |
Each film coated tablet contains: Clarithromycin I.P. Excipients Colour: Quinoline Yellow Lake and Titanium Dioxide I.P. 500.00 mg q.s. mg |
| 88 | Cinnarizine and Domperidone Tablets |
Each uncoated tablet contains: Cinnarizine I.P. Domperidone Maleate I.P. Eq. to Domperidone Excipients 20.00 mg 15.00 mg q.s. mg mg |
| 89 | Ciprofloxacin and Tinidazole Tablets |
Each film coated tablet contains: Ciprofloxacin Hydrochloride I.P. Eq. to Ciprofloxacin Tinidazole I.P. Excipients Colour: Yellow Iron Oxide and Titanium Dioxide I.P. 500.00 mg 600.00 mg q.s. mg mg |
| 90 | Citicoline Sodium Tablets |
Each film coated tablet contains: Citicoline Sodium I.P. Eq. to Citicoline Excipients Colour: Iron Oxide Yellow and Titanium Dioxide I.P. 500.00 mg q.s. mg |
| 91 | Clopidogrel Tablets |
Each film coated tablet contains: Clopidogrel Bisulphate Eq. to Clopidogrel Excipients Colour: Red Oxide of Iron 75.00 mg q.s. mg |
| 92 | Clopidogrel and Aspirin Tablets |
Each film coated tablet contains: Clopidogrel Bisulphate Eq. to Clopidogrel Aspirin Excipients Colour: Red Oxide of Iron 75.00 mg 75.00 mg q.s. mg mg |
| 93 | Diclofenac Potassium and Paracetamol Tablets |
Each uncoated tablet contains: Diclofenac Potassium Paracetamol Excipients Colour: Quinoline Yellow Lake 50.00 mg 325.00 mg q.s. mg mg |
| 94 | Piroxicam Dispersible Tablets |
Each uncoated tablet contains: Piroxicam Excipients 20.00 mg q.s. mg |
| 95 | Doxofylline Sustain Release and Montelukast Tablets |
Each uncoated tablet contains: Doxofylline Montelukast Sodium Eq. to Montelukast Excipients Colour: Erythrosine Lake 400.00 mg 10.00 mg q.s. mg mg |
| 96 | Doxofylline and Ambroxol Hydrochloride Tablets |
Each uncoated tablet contains: Doxofylline Ambroxol Hydrochloride Excipients 400.00 mg 30.00 mg q.s. mg mg |
| 97 | Methylergometrine Tablets |
Each uncoated tablet contains: Methylergometrine Maleate Excipients Colour: Quinoline Yellow Lake 0.13 mg q.s. mg |
| 98 | Terbinafine and Itraconazole Tablets |
Each uncoated tablet contains: Terbinafine HCl Eq. to Terbinafine Itraconazole Excipients 250.00 mg 200.00 mg q.s. mg mg |
| 99 | Etoricoxib Tablets |
Each uncoated tablet contains: Etoricoxib Excipients Colour: Ferric Oxide Red and Titanium Dioxide I.P. 60.00 mg q.s. mg |
| 100 | Etodolac and Paracetamol Tablets |
Each uncoated tablet contains: Etodolac Paracetamol Excipients 400.00 mg 325.00 mg q.s. mg mg |
| 101 | Etodolac and Thiocolchicoside Tablets |
Each uncoated tablet contains: Etodolac Thiocolchicoside Excipients Colour: Quinoline Yellow Lake 400.00 mg 4.00 mg q.s. mg mg |
| 102 | Methyl Prednisolone I.P. Tablets |
Each uncoated tablet contains: Methyl Prednisolone Excipients Colour: Quinoline Yellow Lake 4.00 mg q.s. mg |
| 103 | Methyl Prednisolone I.P. Tablets |
Each uncoated tablet contains: Methyl Prednisolone Excipients Colour: Erythrosine Lake 8.00 mg q.s. mg |
| 104 | Esomeprazole Gastro-resistant Tablets |
Each gastro-resistant film-coated tablet contains: Esomeprazole Magnesium Hydrate I.P. Eq. to Esomeprazole Excipients Colour: Red Oxide of Iron and Titanium Dioxide I.P. 40.00 mg q.s. mg |
| 105 | Aceclofenac, Paracetamol and Serratiopeptidase Tablets |
Each film-coated tablet contains: Aceclofenac I.P. Paracetamol I.P. Serratiopeptidase I.P. (Eq. to 30,000 Unit of Serratiopeptidase as gastro-resistant granules) Excipients Colour: Brilliant Blue FCF and Titanium Dioxide I.P. 100.00 mg 325.00 mg 15.00 mg q.s. mg |
| 106 | Methylcobalamin and Folic Acid Tablets |
Each film-coated tablet contains: Methylcobalamin Folic Acid Excipients Colour: Ferric Oxide Red Lake 1500.00 mcg 1.50 mg q.s. mg |
| 107 | Iron, Zinc and Vitamins Tablets |
Each film-coated tablet contains: Iron (As Amino Acid Chelate) Zinc (As Zinc Picolinate) Folic Acid I.P. Cyanocobalamin Excipients Colour: Ponceau-4R and Carmosine 30.00 mg 10.00 mg 1.50 mg 15.00 mcg q.s. mg |
| 108 | Folic Acid Tablets |
Each uncoated tablet contains: Folic Acid I.P. Excipients 5.00 mg q.s. mg |
| 109 | Doxylamine Succinate, Pyridoxine Hydrochloride and Folic Acid Tablets |
Each film-coated tablet contains: Doxylamine Succinate Pyridoxine Hydrochloride Folic Acid Excipients Colour: Tartarzine and Titanium Dioxide I.P. Appropriate overages of vitamins added to compensate for loss on storage 10.00 mg 10.00 mg 2.50 mg q.s. mg |
| 110 | Methylcobalamin, Alpha Lipoic Acid, Biotin and Folic Acid Tablets |
Each film-coated tablet contains: Methylcobalamin I.P. Alpha Lipoic U.S.P. Biotin I.P. Folic Acid I.P. Excipients Colour: Ferric Oxide Red Lake Appropriate overages of vitamins added to compensate for loss on storage 1500.00 mcg 100.00 mg 100.00 mg 1.50 mg q.s. mg |
| 111 | L-Methylfolate, Methylcobalamin, Pyridoxal-5-Phosphate Tablets |
Each film-coated tablet contains: L-Methylfolate Calcium eq. to L-Methylfolate Methylcobalamin Pyridoxal-5-Phosphate Excipients Colour: Red Oxide of Iron Appropriate overages of vitamins added to compensate for loss on storage 3.00 mg 1500.00 mcg 35.00 mg q.s. mg mcg mg |
| 112 | Ferrous Ascorbate and L-Methylfolate Tablets |
Each film-coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron L-Methylfolate Calcium Excipients Colour: Ponceau-4R and Carmosine 100.00 mg 300.00 mcg q.s. mg mcg |
| 113 | Thiocolchicoside Tablets |
Each film-coated tablet contains: Thiocolchicoside Excipients Colour: Erythrosine Lake 8.00 mg q.s. mg |
| 114 | Diacerein Tablets |
Each film-coated tablet contains: Diacerein Excipients Colour: Ponceau-4R and Titanium Dioxide 50.00 mg q.s. mg |
| 115 | Diacerein Tablets |
Each film-coated tablet contains: Diacerein Excipients Colour: Ponceau-4R and Titanium Dioxide 100.00 mg q.s. mg |
| 116 | Disulfiram Tablets |
Each film-coated tablet contains: Disulfiram Excipients Colour: Titanium Dioxide I.P. 250.00 mg q.s. mg |
| 117 | Aceclofenac and Paracetamol Tablets |
Each film-coated tablet contains: Aceclofenac Paracetamol Excipients Colour: Sunset Yellow FCF 100.00 mg 325.00 mg q.s. mg mg |
| 118 | Clomifene Citrate Tablets |
Each uncoated tablet contains: Clomifene Citrate Excipients 50.00 mg q.s. mg |
| 119 | Fexofenadine Hydrochloride and Montelukast Tablets |
Each film-coated tablet contains: Fexofenadine Hydrochloride Montelukast Sodium Eq. to Montelukast Excipients Colour: Sunset Yellow 120.00 mg 10.00 mg q.s. mg mg |
| 120 | Gabapentin and Nortriptyline Tablets |
Each uncoated tablet contains: Gabapentin Nortriptyline Hydrochloride Eq. to Nortriptyline Excipients Colour: Titanium Dioxide I.P. 400.00 mg 10.00 mg q.s. mg mg |
| 121 | Glibenclamide and Metformin Hydrochloride Tablets |
Each uncoated tablet contains: Glibenclamide Metformin Hydrochloride Excipients 5.00 mg 500.00 mg q.s. mg mg |
| 122 | Levocetirizine Hydrochloride Tablets |
Each film-coated tablet contains: Levocetirizine Dihydrochloride Excipients Colour: Titanium Dioxide I.P. and Quinoline Yellow 10.00 mg q.s. mg |
| 123 | Ilaprazole Gastro-Resistant Tablets |
Each gastro-resistant tablet contains: Ilaprazole Excipients Colour: Titanium Dioxide 10.00 mg q.s. mg |
| 124 | Isoxsuprine Tablets |
Each uncoated tablet contains: Isoxsuprine Hydrochloride Excipients 10.00 mg q.s. mg |
| 125 | Isoxsuprine Sustained Release Tablets |
Each uncoated tablet contains: Isoxsuprine Hydrochloride Excipients 30.00 mg q.s. mg |
| 126 | Ketorolac Tromethamine Dispersible Tablets |
Each uncoated dispersible tablet contains: Ketorolac Tromethamine Excipients Colour: Sunset Yellow FCF 10.00 mg q.s. mg |
| 127 | Lansoprazole Orally Disintegrating Tablets |
Each uncoated tablet contains: Lansoprazole (As Enteric coated pellets) Excipients Colour: Titanium Dioxide I.P. and Red Oxide of Iron 15.00 mg q.s. mg |
| 128 | Lansoprazole Orally Disintegrating Tablets |
Each uncoated tablet contains: Lansoprazole (As Enteric coated pellets) Excipients Colour: Titanium Dioxide I.P. and Red Oxide of Iron 30.00 mg q.s. mg |
| 129 | Leflunomide Tablets I.P. |
Each film-coated tablet contains: Leflunomide Excipients Colour: Titanium Dioxide I.P. 20.00 mg q.s. mg |
| 130 | Levosulpiride Tablets |
Each uncoated tablet contains: Levosulpiride Excipients 25.00 mg q.s. mg |
| 131 | Levosulpiride Tablets |
Each uncoated tablet contains: Levosulpiride Excipients 50.00 mg q.s. mg |
| 132 | Lornoxicam and Paracetamol Tablets |
Each uncoated tablet contains: Lornoxicam Paracetamol Excipients Colour: Titanium Dioxide I.P. and Lake Quinoline Yellow 8.00 mg 325.00 mg q.s. mg mg |
| 133 | Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablets |
Each film-coated tablet contains: Levocetirizine Dihydrochloride Ambroxol Hydrochloride Excipients Colour: Sunset Yellow 5.00 mg 60.00 mg q.s. mg mg |
| 134 | Levocetirizine Dihydrochloride and Montelukast Tablets |
Each film-coated tablet contains: Levocetirizine Dihydrochloride Montelukast Sodium Excipients Colour: Sunset Yellow FCF 2.50 mg 4.00 mg q.s. mg mg |
| 135 | Quetiapine Tablets |
Each film-coated tablet contains: Quetiapine Fumarate Excipients Colour: Titanium Dioxide I.P. 100.00 mg q.s. mg |
| 136 | Quetiapine Tablets |
Each film-coated tablet contains: Quetiapine Fumarate Excipients Colour: Titanium Dioxide I.P. 200.00 mg q.s. mg |
| 137 | Cetirizine, Phenylephrine and Paracetamol Tablets |
Each uncoated tablet contains: Cetirizine Hydrochloride Phenylephrine Paracetamol Excipients Colour: 5.00 mg 5.00 mg 325.00 mg q.s. mg mg mg |
| 138 | Metoprolol Succinate Extended Release Tablets (For export) |
Each film-coated extended-release tablet contains: Metoprolol Succinate Excipients Colour: Titanium Dioxide I.P. 25.00 mg q.s. mg |
| 139 | Metoprolol Succinate Extended Release Tablets (For export) |
Each film-coated extended-release tablet contains: Metoprolol Succinate Excipients Colour: Titanium Dioxide I.P. 50.00 mg q.s. mg |
| 140 | Metoprolol Succinate Extended Release Tablets (For export) |
Each uncoated bilayered tablet contains: Metoprolol Succinate Telmisartan Excipients Colour: Red Oxide of Iron Lake 25.00 mg 40.00 mg q.s. mg mg |
| 141 | Moxifloxacin Tablets |
Each uncoated tablet contains: Moxifloxacin Hydrochloride Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. 400.00 mg q.s. mg |
| 142 | Tranexamic Acid and Mefenamic Acid Tablets |
Each film-coated tablet contains: Tranexamic Acid Mefenamic Acid Excipients Colour: Ponceau-4R Lake 500.00 mg 250.00 mg q.s. mg mg |
| 143 | Fluoxetine Hydrochloride and Alprazolam Tablets |
Each film-coated tablet contains: Fluoxetine Hydrochloride Alprazolam Excipients Colour: Sunset Yellow FCF 20.00 mg 0.25 mg q.s. mg mg |
| 144 | Etoricoxib and Paracetamol Tablets |
Each film-coated tablet contains: Etoricoxib Paracetamol Excipients Colour: Sunset Yellow Lake 60.00 mg 325.00 mg q.s. mg mg |
| 145 | Quetiapine Tablets I.P |
Each film-coated tablet contains: Quetiapine Fumarate Excipients Colour: Titanium Dioxide I.P. 25.00 mg q.s. mg |
| 146 | Quetiapine Tablets I.P |
Each film-coated tablet contains: Quetiapine Fumarate Excipients Colour: Titanium Dioxide I.P. 50.00 mg q.s. mg |
| 147 | Nitrofurantoin Sustain release Tablets |
Each uncoated tablet contains: Nitrofurantoin Excipients q.s. 100.00 mg |
| 148 | Paracetamol and Chlorzoxazone Tablets |
Each film-coated tablet contains: Paracetamol Chlorzoxazone Excipients Colour: Quinoline Yellow 300.00 mg 250.00 mg q.s. mg mg |
| 149 | Rabeprazole and Domperidone Gastro resistant Tablets |
Each enteric coated tablet contains: Rabeprazole Sodium Domperidone Excipients Colour: Yellow Oxide of Iron and Titanium Dioxide I.P. 20.00 mg 10.00 mg q.s. mg mg |
| 150 | Rosuvastatin Tablets |
Each film-coated tablet contains: Rosuvastatin Calcium Excipients Colour: Titanium Dioxide I.P. 5.00 mg q.s. mg |
| 151 | Rosuvastatin Tablets |
Each film-coated tablet contains: Rosuvastatin Calcium Excipients Colour: Ferric oxide Red and Titanium Dioxide I.P. 10.00 mg q.s. mg |
| 152 | Rosuvastatin and Fenofibrate Tablets I.P. |
Each film-coated tablet contains: Rosuvastatin Calcium Fenofibrate Excipients Colour: Red Oxide of Iron and Titanium Di oxide I.P. 5.00 mg 160.00 mg q.s. mg mg |
| 153 | Mefenamic Acid and Dicyclomine Hydrochloride Tablets |
Each film-coated tablet contains: Mefenamic Acid Dicyclomine Hydrochloride Excipients Colour: Tartrazine 250.00 mg 10.00 mg q.s. mg mg |
| 154 | Paracetamol and Dicyclomine Hydrochloride Tablets |
Each uncoated tablet contains: Paracetamol Dicyclomine Hydrochloride Excipients Colour: Not specified 325.00 mg 20.00 mg q.s. mg mg |
| 155 | Aceclofenac Paracetamol and Chlorzoxazone Tablets |
Each film-coated tablet contains: Aceclofenac Paracetamol Chlorzoxazone Excipients Colour: Tartrazine and Titanium Dioxide I.P. 100.00 mg 325.00 mg 250.00 mg q.s. mg mg mg |
| 156 | Aceclofenac Paracetamol and Thiocolchicoside Tablets |
Each film-coated tablet contains: Aceclofenac Paracetamol Thiocolchicoside Excipients Colour: Indico Carmine Lake and Titanium Dioxide I.P. 100.00 mg 325.00 mg 4.00 mg q.s. mg mg mg |
| 157 | Diclofenac Sodium Sustained Release Tablets |
Each sustained release tablet contains: Diclofenac Sodium Excipients Colour: Iron Red oxide and Titanium Dioxide I.P. 100.00 mg q.s. mg |
| 158 | Rosuvastatin Tablets |
Each film-coated tablet contains: Rosuvastatin Calcium Excipients Colour: Ferric oxide Red and Titanium Dioxide I.P. 40.00 mg q.s. mg |
| 159 | Torsemide Tablets IP |
Each uncoated tablet contains: Torsemide Excipients q.s. 10.00 mg |
| 160 | Torsemide Tablets |
Each uncoated tablet contains: Torsemide Excipients Colour: Quinoline Yellow 20.00 mg q.s. mg |
| 161 | Torsemide Tablets |
Each uncoated tablet contains: Torsemide Excipients q.s. 100.00 mg |
| 162 | Rosuvastatin Tablets |
Each film-coated tablet contains: Rosuvastatin Calcium Excipients Colour: Titanium Dioxide I.P. and Sunset Yellow 20.00 mg q.s. mg |
| 163 | Letrozole Tablets |
Each film-coated tablet contains: Letrozole Excipients Colour: Titanium Dioxide I.P. and Yellow Oxide of Iron 2.50 mg q.s. mg |
| 164 | Sodium valproate Tablets I.P. |
Each Gastro-resistant tablet contains: Sodium valproate Excipients Colour: Sunset Yellow Lake 200.00 mg q.s. mg |
| 165 | Sodium valproate Tablets I.P. |
Each Gastro-resistant tablet contains: Sodium valproate Excipients Colour: Ferric Oxide Red 300.00 mg q.s. mg |
| 166 | Oxcarbazepine Tablets |
Each film-coated tablet contains: Oxcarbazepine Excipients Colour: Yellow oxide of Iron 150.00 mg q.s. mg |
| 167 | Oxcarbazepine Tablets |
Each film-coated tablet contains: Oxcarbazepine Excipients Colour: Yellow oxide of Iron 300.00 mg q.s. mg |
| 168 | Clopidogrel and Asprin Tablets |
Each film-coated tablets contains: Clopidogrel Bisulphate Asprin Excipients Colour: Erythrosine Lake 75.00 mg 150.00 mg q.s. mg mg |
| 169 | Cinnarizine and Domperidone Tablets |
Each film-coated tablets contains: Cinnarizine Domperidone maleate Excipients 20.00 mg 15.00 mg q.s. mg mg |
| 170 | Losartan potassium and Amlodipine Tablets |
Each film-coated tablets contains: Amlodipine Besilate Losartan potassium Excipients Colour: Titanium Dioxide I.P. and Erythrosine Lake 5.00 mg 50.00 mg q.s. mg mg |
| 171 | Losartan potassium and Hydrochlorothiazide Tablets I.P. |
Each film-coated tablets contains: Losartan potassium Hydrochlorothiazide Excipients Colour: Titanium Dioxide I.P. and Sunset Yellow FCF 50.00 mg 12.50 mg q.s. mg mg |
| 172 | Olmesartan Medoxomil and Hydrochlorothiazide Tablets |
Each film-coated tablet contains: Olmesartan Medoxomil Hydrochlorothiazide Excipients Colour: Titanium Dioxide I.P. and Sunset Yellow FCF 20.00 mg 12.50 mg q.s. mg mg |
| 173 | Olmisartan Medoxomil and Amlodipine Tablets |
Each film-coated tablet contains: Olmisartan Medoxomil Amlodipine Besilate Eq. to Amlodipine Excipients Colour: Titanium Dioxide I.P. and Quinoline Yellow FCF B.P. I.P. q.s. mg mg mg |
| 174 | Clomifene Citrate Tablets I.P. |
Each uncoated tablet contains: Clomifene Citrate Excipients I.P. q.s. mg |
| 175 | Clomifene Citrate Tablets I.P. |
Each uncoated tablet contains: Clomifene Citrate Excipients I.P. q.s. mg |
| 176 | Disulfiram Tablets I.P. |
Each film-coated tablet contains: Disulfiram Excipients Colour: Sunset Yellow Lake I.P. q.s. mg |
| 177 | Febuxostat Tablets |
Each film-coated tablet contains: Febuxostat Excipients Colour: Tatrazine Lake q.s. mg |
| 178 | Febuxostat Tablets |
Each film-coated tablet contains: Febuxostat Excipients Colour: Brilliant Blue q.s. mg |
| 179 | Tadalafil Tablets |
Each film-coated tablet contains: Tadalafil Excipients Colour: Ponceau-4R Lake I.P. q.s. mg |
| 180 | Cabergoline Tablets I.P |
Each uncoated tablet contains: Cabergoline Excipients I.P. q.s. mg |
| 181 | Pantaprazole Gastro-resistant Tablets I.P |
Each gastro-resistant tablets contains: Pantaprazole Sodium (as sesquihydrate) eq. to Pantaprazole Excipients Colour: Titanium Dioxide I.P. and Yellow Oxide of iron I.P. q.s. mg |
| 182 | Cabergoline Tablets I.P |
Each uncoated tablet contains: Cabergoline Excipients I.P. q.s. mg |
| 183 | Ebastine Tablets I.P |
Each film-coated tablet contains: Ebastine Excipients Colour: Titanium Dioxide I.P. and Red oxide of iron I.P. q.s. mg |
| 184 | Ebastine Tablets I.P |
Each film-coated tablet contains: Ebastine Excipients Colour: Titanium Dioxide I.P. I.P. q.s. mg |
| 185 | Minocycline Tablets U.S.P. |
Each film-coated tablet contains: Minocycline Hydrochloride U.S.P. Eq. to Minocycline Excipients Colours: Titanium Dioxide I.P. and Sunset Yellow FCF 100.00 mg |
| 186 | Norfloxacin and Tinidazole Tablets |
Each film-coated tablet contains: Norfloxacin I.P. Tinidazole I.P. Excipients Colours: Titanium Dioxide I.P. and Lake of Quinoline Yellow 400.00 mg 600.00 mg |
| 187 | Gliclazide and Metformin Hydrochloride Tablets |
Each uncoated tablet contains: Gliclazide I.P. Metformin Hydrochloride I.P. Excipients 80.00 mg 500.00 mg |
| 188 | Sparfloxacin Tablets |
Each film-coated tablet contains: Sparfloxacin Excipients Colour: Red Oxide of iron 200.00 mg |
| 189 | Fexofenadine Hydrochloride Tablets |
Each film-coated tablet contains: Fexofenadine Hydrochloride I.P. Excipients Colour: Sunset Yellow 120.00 mg |
| 190 | Fexofenadine Hydrochloride Tablets |
Each film-coated tablet contains: Fexofenadine Hydrochloride I.P. Excipients Colour: Yellow Oxide of iron and Titanium Dioxide I.P. 180.00 mg |
| 191 | Sildenafil Citrate Tablets I.P. |
Each film-coated tablet contains: Sildenafil Citrate I.P. Eq. to Sildenafil Excipients Colour: Indigo Carmine 50.00 mg |
| 192 | Sildenafil Citrate Tablets I.P. |
Each film-coated tablet contains: Sildenafil Citrate I.P. Eq. to Sildenafil Excipients Colour: Indigo Carmine 100.00 mg |
| 193 | Voglibose Tablets I.P |
Each uncoated Mouth Dissolving tablet contains: Voglibose I.P. Excipients Colour: Erythrosine Supra 0.30 mg |
| 194 | Finasteride Tablets I.P |
Each film-coated tablet contains: Finasteride I.P. Excipients Colour: Quinoline Yellow Lake 5.00 mg |
| 195 | Tapentadol Tablets |
Each film-coated tablet contains: Tapentadol Excipients Colour: Red Oxide Of Iron 50.00 mg |
| 196 | Tapentadol Tablets |
Each film-coated tablet contains: Tapentadol Excipients Colour: Red Oxide Of Iron q.s. 100.00 mg |
| 197 | Terbinafine and Itraconazole Tablets |
Each uncoated tablet contains: Terbinafine hydrochloride Eq. to Terbinafine Itraconazole tablets Excipients q.s. 250.00 mg 100.00 mg |
| 198 | Lamivudine Tablets I.P |
Each film-coated tablet contains: Lamivudine Excipients Colour: Red oxide of Iron and Titanium Dioxide I.P. q.s. 100.00 mg |
| 199 | Desloratadine and Montelukast Tablets |
Each film-coated tablet contains: Desloratadine Montelukast Sodium Eq. to Montelukast Excipients Colour: Red oxide of Iron and Titanium Dioxide I.P. q.s. 5.00 mg 10.00 mg |
| 200 | Dapoxetine Tablets IP. |
Each film-coated tablet contains: Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Colour: Tartrazine Lake q.s. 30.00 mg |
| 201 | Dapoxetine Tablets IP. |
Each film-coated tablet contains: Dapoxetine Hydrochloride Eq. to Dapoxetine Excipients Colour: Brilliant Blue FCF q.s. 60.00 mg |
| 202 | Escitalopram and Clonazepam Tablets |
Each film-coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Clonazepam Excipients Colour: Brilliant Blue FCF q.s. 5.00 mg 0.50 mg |
| 203 | Escitalopram and Clonazepam Tablets |
Each film-coated tablet contains: Escitalopram Oxalate Eq. to Escitalopram Clonazepam Excipients Colour: Quinoline Yellow Lake q.s. 10.00 mg 0.50 mg |
| 204 | Pregabalin Sustained-release Tablets |
Each film-coated Prolonged-release tablet contains: Pregabalin Excipients Colour: Red oxide of Iron and Titanium Dioxide I.P. q.s. 75.00 mg |
| 205 | Betahistine Tablets I.P |
Each uncoated tablet contains: Betahistine Hydrichloride Excipients I.P. q.s. 8.00 mg |
| 206 | Betahistine Tablets I.P |
Each uncoated tablet contains: Betahistine Hydrichloride Excipients Colour: Quinoline Yellow Supra I.P. q.s. 24.00 mg |
| 207 | Methyl prednisolone Tablets I.P. |
Each uncoated tablet contains: Methylprednisolone Excipients Colour: Ponceau-4R Supra I.P. q.s. 16.00 mg |
| 208 | Thiocolchicoside Tablets |
Each film-coated tablet contains: Thiocolchicoside Excipients Colour: Erythrosine Lake I.P. q.s. 4.00 mg |
| 209 | Betahistine Tablets I.P |
Each film-coated tablet contains: Betahistine Hydrichloride Excipients Colour: Sunset Yellow FCF I.P. q.s. 8.00 mg |
| 210 | Paracetamol, Phenylephrine HCl, Diphenhydramine and Caffeine Tablets |
Each uncoated tablet contains: Paracetamol Phenylephrine HCl Diphenhydramine HCl Caffeine (anhydrous) Excipients Colour: Sunset Yellow FCF q.s. 325.00 mg 5.00 mg 25.00 mg 30.00 mg |
| 211 | Levetiracetam Prolonged-release Tablets I.P. |
Each uncoated prolonged-release tablet contains: Levetiracetam Excipients I.P. q.s. 750.00 mg |
| 212 | Calcium with Vitamin D3 Tablets |
Each film coated tablet contains: Calcium Carbonate From an organic source (oyster shell) Eqv. To elemental calcium Vitamin D3 Excipients Colour: Titanium Dioxide I.P. q.s. 1250.00 mg 500.00 mg 250.00 IU |
| 213 | Ferrous Ascorbate, Folic Acid, Methylcobalamin and Zinc Sulphate Tablets |
Each film coated tablet contains: Ferrous ascorbate Folic Acid Methylcobalamin Zinc Sulphate Monohydrate Excipients Colour: Red Oxide of Iron and Titanium Dioxide I.P. q.s. 100.00 mg 1.50 mg 1.50 mg 22.50 mg |
| 214 | Deflazacort Tablets 6 mg |
Each uncoated tablet contains: Deflazacort Excipients I.P. q.s. 6.00 mg |
| 215 | Torsemide and Spironolactone Tablets |
Each uncoated tablet contains: Torsemide Spironolactone Excipients I.P. I.P. q.s. 10.00 mg 50.00 mg |
| 216 | Torsemide and Spironolactone Tablets |
Each uncoated tablet contains: Torsemide Spironolactone Excipients I.P. I.P. q.s. 10.00 mg 25.00 mg |
| 217 | Isoxsuprine Hydrocloride Sustained Release Tablets |
Each uncoated sustained release tablet contains: Isoxsuprine Hydrocloride Excipients I.P. q.s. 40.00 mg |
| 218 | Metformin Hydrochloride Prolonged release and Glimepiride Tablets I.P. |
Each uncoated bilayered tablet contains: Glimepiride Metformin Hydrochloride (as prolonged release form) Excipients Colour: Sunset Yellow I.P. I.P. q.s. 1.00 mg 500.00 mg |
| 219 | Albendazole Tablets I.P. 400 mg. |
Each uncoated chewable tablet contains: Albendazole Excipients Colour: Sunset Yellow I.P. q.s. 400.00 mg |
| 220 | Metformin Hydrochloride Prolonged release and Glimepiride Tablets I.P. |
Each uncoated bilayered tablet contains: Glimepiride Metformin Hydrochloride (as prolonged release form) Excipients Colour: Brilliant Blue I.P. I.P. q.s. 2.00 mg 500.00 mg |
| 221 | Calcium with Vitamin D3 Tablets |
Each film coated tablet contains: Calcium Citrate Malate Eqv. To elemental calcium Vitamin D3 Excipients Colour: Titanium Dioxide I.P. q.s. 1000.00 mg 250.00 mg 200 IU |
| 222 | Cholecalciferol 60,000 I.U. chewable tablets |
Each uncoated chewable tablet contains: Cholecalciferol as stabilized Excipients Colour: Sunset Yellow FCF 60,000 IU |
| 223 | Cholecalciferol 10,000 I.U. chewable tablets |
Each uncoated chewable tablet contains: Cholecalciferol as stabilized Excipients Colour: Tartrazine 10,000 IU |
| 224 | Calcium citrate malate, Vitamin D3 & Folic Acid Tablets |
Each film coated tablet contains: Calcium Citrate Malate Eqv. To elemental calcium Vitamin D3 Folic Acid Excipients Colour: Brilliant Blue q.s. 1000.00 mg 250.00 mg 100.00 mcg 50.00 mg |
| 225 | Pancreatin Tablets |
Each gastro-resistant tablet contains: Pancreatin (Including Lipase, Amylase & Protease Activity) Excipients Colour: Titanium Dioxide I.P. q.s. 500.00 mg |
| 226 | Ferrous Ascorbate, Folic Acid Zinc Sulphate Tablets |
Each film coated tablet contains: Ferrous Ascorbate Eq. to elemental Iron Folic Acid Zinc Sulphate Monohydrate Eq. to elemental Zinc Excipients Colour : Red Oxide of Iron & Titanium Dioxide I.P. I.P. I.P. q.s. 100.00 mg 1.50 mg 22.50 mg |
| 227 | Levofloxacin Tablets I.P. 750 mg. |
Each film coated tablet contains: Levofloxacin Hemihydrate Eq. to Levofloxacin Excipients Colour : Ferric Oxide(Yellow)USP-NF and Titanium Dioxide I.P. I.P. 750.00 mg q.s. |
| 228 | Montelukast Sodium and Levocetirizine HCl Tablets I.P. |
Each film coated tablet contains: Montelukast Sodium Eq to Montelukast Levocetirizine Excipients Colour- : Sunset Yellow Lake I.P. I.P. 10.00 mg 5.00 mg q.s. |
| 229 | Montelukast Sodium and Fexofenadine HCl Tablets |
Each film coated tablet contains: Montelukast Sodium Eq to Montelukast Fexofenadine Excipients Colour- : Red Oxide of Iron I.P. I.P. 10.00 mg 120.00 mg q.s. |
| 230 | Pioglitazone Hydrochloride tablets 7.5 mg |
Each uncoated tablet contains: Pioglitazone Hydrochloride Eq to Pioglitazone Excipients I.P. 7.50 mg q.s. |
| 231 | Calcium with Vitamin D3 Tablets |
Each film coated tablet contains: Calcium Carbonate From an organic source (oyster shell) Eqv. To elemental calcium Vitamin D3 Excipients Colour : Titanium Dioxide I.P. I.P. q.s. 1250.00 mg 500.00 mg 200.00 IU |
| 232 | Torsemide Tablets I.P. 5 mg |
Each uncoated tablet contains: Torsemide Excipients I.P. q.s. 5.00 mg |
| 233 | Tamsulosin Hydrochloride Tablets |
Each Film coated tablets contains: Tamsulosin Excipients Colour : Titanium Dioxide I.P. I.P. q.s. 0.40 mg |
| 234 | Clopidogrel Bisulphate Tablets I.P. 75 mg |
Each film coated tablet contains: Clopidogrel Bisulphate eq. to Clopidogrel Excipients Colour :Red Oxide of Iron I.P. q.s. 75.00 mg |
| 235 | Etodolac Prolonged-Release Tablets I.P. 200 mg |
Each film coated prolonged-release tablet contains: Etodolac Excipients Colour :Red Oxide of Iron I.P. q.s. 200.00 mg |
| 236 | Etodolac Prolonged-Release Tablets I.P. 600 mg |
Each film coated prolonged-release tablet contains: Etodolac Excipients colour :Yellow Oxide of Iron I.P. q.s. 600.00 mg |
| 237 | Metformin Hydrochloride Prolonged- release and Glimepiride Tablets |
Each uncoated bilayered tablet contains: Metformin Hydrochloride (as prolonged release form) Glimepiride Excipients colour :Yellow Oxide of Iron I.P. I.P. q.s. 1000.00 mg 2.00 mg |
| 238 | Voglibose dispersible Tablets I.P. |
Each uncoated dispersible tablet contains: Voglibose Excipients colour :Tartrazine IP q.s. 0.20 mg |
| 239 | Voglibose dispersible Tablets I.P. |
Each uncoated dispersible tablet contains: Voglibose Excipients colour :Sunset Yellow IP q.s. 0.30 mg |
| 240 | Metformin Hydrochloride and Glimepiride Tablets |
Each uncoated tablet contains: Metformin Hydrochloride Glimepiride Excipients IP IP q.s. 500.00 mg 1.00 mg |
| 241 | Metformin Hydrochloride and Glimepiride Tablets |
Each uncoated tablet contains: Metformin Hydrochloride Glimepiride Excipients IP IP q.s. 500.00 mg 2.00 mg |
| 242 | Escitalopram Oxalate & Clonazepam Tablets I.P. |
Each film coated tablet contains: Escitalopram Oxalate eq. to Escitalopram Clonazepam Excipients colour :Red Oxide of iron IP IP q.s. 10.00 mg 0.25 mg |
| 243 | Telmisartan Tablets I.P. 20 mg |
Each uncoated tablet contains: Telmisartan Excipients IP q.s. 20.00 mg |
| 244 | Telmisartan Tablets I.P. 40 mg |
Each uncoated tablet contains: Telmisartan Excipients IP q.s. 40.00 mg |
| 245 | Telmisartan Tablets I.P. 80 mg |
Each uncoated tablet contains: Telmisartan Excipients IP q.s. 80.00 mg |
| 246 | Atorvastatin Calcium and Clopidogrel |
Each film coated tablet contains: Bisulphate Tablets Atorvastatin Calcium IP eq. to Atorvastatin 10.00 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75.00 mg Excipients q.s. Colour: Red Oxide of iron |
| 247 | Calcium Orotate Tablets |
Each film coated tablet contains: Calcium Orotate Dyhydrate eq. to Calcium Orotate 740.00 mg Excipients Colour: Titanium Dioxide IP |
| 248 | Atorvastatin Calcium and Clopidogrel |
Each film coated tablet contains: Bisulphate Tablets Atorvastatin Calcium IP eq. to Atorvastatin 20.00 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75.00 mg Excipients q.s. Colour: Red Oxide of iron |
| 249 | Calcium Orotate and Vitamin D3 Tablets |
Each film coated tablet contains: Calcium Orotate Dyhydrate eq. to Calcium Orotate 740.00 mg Vitamin D3 500.00 IU Excipients Colour: Titanium Dioxide IP |
| 250 | Zinc Sulphate Dispersible Tablets I.P. |
Each uncoated dispersible tablet contains: Zinc Sulphate Monohydrate eq. to elemental Zinc 20.00 mg Excipients Colour: Sunset Yellow IP |
| 251 | Olmesartan Tablets I.P. 20 mg |
Each uncoated tablet contains: Olmesartan 20.00 mg Excipients Colour: Titanium Dioxide IP |
| 252 | Nicorandil Tablets I.P. 10 mg |
Each uncoated tablet contains: Nicorandil 10.00 mg Excipients |
| 253 | Nicorandil Tablets I.P. 20 mg |
Each uncoated tablet contains: Nicorandil 20.00 mg Excipients |
| 254 | Nicorandil Tablets I.P. 5 mg |
Each uncoated tablet contains: Nicorandil 5.00 mg Excipients |
| 255 | Cilnidipine Tablets I.P. 5 mg |
Each film coated tablet contains: Cilnidipine 5.00 mg Excipients Colour: Yellow Oxide of Iron IP |
| 256 | Cilnidipine Tablets I.P. 10 mg |
Each film coated tablet contains: Cilnidipine Excipients Colour: Yellow Oxide of Iron IP q.s. 10.00 mg |
| 257 | Cilnidipine Tablets I.P. 20 mg |
Each film coated tablet contains: Cilnidipine Excipients Colour: Yellow Oxide of Iron IP q.s. 20.00 mg |
| 258 | Nicorandil Prolonged-release Tablets I.P. 10 mg |
Each uncoated prolonged-release tablet contains: Nicorandil Excipients IP q.s. 10.00 mg |
| 259 | Nicorandil Prolonged-release Tablets I.P. 20 mg |
Each uncoated prolonged-release tablet contains: Nicorandil Excipients IP q.s. 20.00 mg |
| 260 | Olmesartan Tablets I.P. 40 mg |
Each uncoated tablet contains: Olmesartan Excipients Colour: Titanium Dioxide IP q.s. 40.00 mg |
| 261 | Etoricoxib and Paracetamol Tablets |
Each film coated tablet contains: Etoricoxib Paracetamol Excipients Colour: Red Oxide of iron IP q.s. 60.00 mg 325.00 mg |
| 262 | Gabapentin Tablets I.P. 100 mg |
Each film coated tablet contains: Gabapentin Excipients Colour: Red Oxide of iron IP q.s. 100.00 mg |
| 263 | Gabapentin Tablets I.P. 300 mg |
Each film coated tablet contains: Gabapentin Excipients Colour: Red Oxide of iron IP q.s. 300.00 mg |
| 264 | Metformin Hydrochloride Prolonged-release and Voglibose Tablets |
Each uncoated bilayered tablet contains: Metformin Hydrochloride (as prolonged release form) Voglibose Excipients Colour: Sunset Yellow IP Colour: Brilliant Blue IP q.s. 500.00 mg 0.20 mg |
| 265 | Metformin Hydrochloride Prolonged-release and Voglibose Tablets |
Each uncoated bilayered tablet contains: Metformin Hydrochloride (as prolonged release form) Voglibose Excipients Colour: Sunset Yellow IP Colour: Brilliant Blue IP q.s. 500.00 mg 0.30 mg |
| 266 | Sulfasalazine Delayed-release Tablets U.S.P. 500 mg |
Each gastro-resistant tablet contains: Sulfasalazine (as delayed-release form) Excipients Colour: Yellow Oxide of Iron U.S.P. q.s. 500.00 mg |
| 267 | Gabapentin and Methylcobalamin Tablets |
Each film coated tablet contains: Gabapentin Methylcobalamin Excipients Colour: Ponceau 4R IP IP q.s. 300.00 mg 500.00 mcg |
| 268 | Vitamin C Tablets I.P. 50 mg |
Each uncoated tablet contains: Vitamin C Excipients Colour: Tartrazine IP q.s. 50.00 mg |
| 269 | Vitamin C Tablets I.P. 100 mg |
Each uncoated tablet contains: Vitamin C Excipients Colour: Sunset Yellow IP q.s. 100.00 mg |
| 270 | Pancreatin and Activated Dimethicone Tablets |
Each enteric coated tablet contains: Pancreatin Activated Dimethicone Excipients Colour: Titanium Dioxide IP IP q.s. 170.00 mg 80.00 mg |
| 271 | Pregabalin Prolonged-release and Methylcobalamin Tablets |
Each uncoated bilayered tablet contains: Pregabalin (as prolonged release form) Methylcobalamin Excipients Colour: Red Oxide of iron IP IP q.s. 75.00 mg 1500.00 mcg |
| 272 | Thiocolchicoside and Ketoprofen Tablets |
Each film coated tablet contains: Thiocolchicoside Ketoprofen Excipients Colour: Quinoline Yellow IP IP 4.00 mg 50.00 mg |
| 273 | Thiocolchicoside and Ketoprofen Tablets |
Each film coated tablet contains: Thiocolchicoside Ketoprofen Excipients Colour: Yellow Oxide of Iron IP IP q.s. 8.00 mg 100.00 mg |
| 274 | Diacerein and Glucosamine Tablets |
Each film coated tablet contains: Diacerein Glucosamine Sulphate Sodium Chloride Excipients Colour: Red Oxide of iron IP IP q.s. 50.00 mg 1500.00 mg |
| 275 | Diacerein and Glucosamine Tablets |
Each film coated tablet contains: Diacerein Glucosamine Sulphate Sodium Chloride Excipients Colour: Red Oxide of iron IP IP q.s. 50.00 mg 500.00 mg |
| 276 | Sumatriptan Succinate and Naproxen Tablets |
Each uncoated dispersible tablet contains: Sumatriptan Succinate eq. to Sumatriptan Naproxen Excipients Colour: Yellow Oxide of Iron IP IP q.s. 50.00 mg 500.00 mg |
| 277 | Controlled Release Tablets of Sodium Valproate and Valproic Acid |
Each film coated controlled release tablet contains: Sodium Valproate Valproic Acid Both together correspond to Sodium Valproate Excipients Colour: Sunset Yellow IP IP q.s. 666.00 mg 290.00 mg 1000.00 mg |
| 278 | Controlled Release Tablets of Sodium Valproate and Valproic Acid |
Each film coated controlled release tablet contains: Sodium Valproate Valproic Acid Both together correspond to Sodium Valproate Excipients Colour: Red Oxide of iron IP IP q.s. 499.50 mg 217.50 mg 750.00 mg |
| 279 | Controlled Release Tablets of Sodium Valproate and Valproic Acid |
Each film coated controlled release tablet contains: Sodium Valproate Valproic Acid Both together correspond to Sodium Valproate Excipients Colour: Tartrazine IP IP q.s. 333.00 mg 133.50 mg 500.00 mg |
| 280 | Controlled Release Tablets of Sodium Valproate and Valproic Acid |
Each film coated controlled release tablet contains: Sodium Valproate Valproic Acid Both together correspond to Sodium Valproate Excipients Colour: Yellow Oxide of Iron IP IP q.s. 145.00 mg 58.00 mg 200.00 mg |
| 281 | Diclofenac Sodium and Paracetamol Tablets |
Each uncoated tablet contains: Diclofenac Sodium IP 50.00 mg Paracetamol IP 325.00 mg Excipients q.s. |
| 282 | Aceclofenac and Paracetamol Tablets |
Each uncoated double layered tablet contains: Aceclofenac IP 100.00 mg Paracetamol IP 325.00 mg Excipients q.s. Colour: Sunset Yellow and Tartrazine |
| 283 | Etodolac and Paracetamol Tablets |
Each film coated tablet contains: Etodolac IP 300.00 mg Paracetamol IP 325.00 mg Excipients q.s. Colour: Brilliant Blue |
| 284 | Ibuprofen and Paracetamol Tablets |
Each uncoated tablet contains: Ibuprofen IP 400.00 mg Paracetamol IP 325.00 mg Excipients q.s. |
| 285 | Etodolac and Tolperisone Tablets |
Each film coated tablet contains: Etodolac IP 400.00 mg Tolperisone Hydrochloride IP 150.00 mg Excipients q.s. Colour: Brilliant Blue |
| 286 | Telmisartan and Amlodipine Besylate Tablets I.P. |
Each uncoated tablet contains: Telmisartan Amlodipine Besylate eq. to Amlodipine Excipients Colour: Ponceau 4R IP IP q.s. 40.00 mg 5.00 mg |
| 287 | Telmisartan and Hydrochlorothiazide Tablets I.P. |
Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Colour: Red Oxide of iron IP IP q.s. 40.00 mg 12.50 mg |
| 288 | Metoprolol Succinate Prolonged release Tablets I.P. 25 mg |
Each film coated Prolonged release tablet contains: Metoprolol Succinate eq. to Metoprolol Tatrate Excipients Colour: Titanium Dioxide IP q.s. 23.75 mg 25.00 mg |
| 289 | Telmisartan and Hydrochlorothiazide Tablets I.P. |
Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Colour: Tartrazine IP IP q.s. 40.00 mg 12.50 mg |
| 290 | Metoprolol Succinate Prolonged release Tablets I.P. 50 mg |
Each film coated Prolonged release tablet contains: Metoprolol Succinate eq. to Metoprolol Tatrate Excipients Colour: Titanium Dioxide IP q.s. 47.50 mg 50.00 mg |
| 291 | Pantoprazole mouth dissolving tablets 20 mg |
Each uncoated mouth dissolving tablet contains: Pantoprazole Sodium Sesquihydrate eq. to Pantoprazole Excipients Colour: Tartrazine IP q.s. 20.00 mg |
| 292 | Lornoxicam and Paracetamol Tablets |
Each film coated tablet contains: Lornoxicam Paracetamol Excipients Colour: Quinoline Yellow IP q.s. 4.00 mg 325.00 mg |
| 293 | Lornoxicam and Paracetamol Tablets |
Each film coated tablet contains: Lornoxicam Paracetamol Excipients Colour: Quinoline Yellow IP q.s. 8.00 mg 325.00 mg |
| 294 | Lornoxicam and Thiocolchicoside Tablets |
Each film coated tablet contains: Lornoxicam Thiocolchicoside Excipients Colour: Sunset Yellow IP q.s. 4.00 mg 8.00 mg |
| 295 | Lornoxicam and Thiocolchicoside Tablets |
Each film coated tablet contains: Lornoxicam Thiocolchicoside Excipients Colour: Sunset Yellow IP q.s. 4.00 mg 4.00 mg |
| 296 | Lornoxicam and Thiocolchicoside Tablets |
Each film coated tablet contains: Lornoxicam Thiocolchicoside Excipients Colour: Tartrazine IP q.s. 8.00 mg 4.00 mg |
| 297 | Lornoxicam and Thiocolchicoside Tablets |
Each film coated tablet contains: Lornoxicam Thiocolchicoside Excipients Colour: Tartrazine IP q.s. 8.00 mg 8.00 mg |
| 298 | Telmisartan and Hydrochlorothiazide Tablets I.P. |
Each uncoated bilayered tablet contains: Telmisartan Hydrochlorothiazide Excipients Colour: Tartrazine IP IP q.s. 80.00 mg 12.50 mg |
| 299 | Telmisartan and Amlodipine Besylate Tablets I.P. |
Each uncoated tablet contains: Telmisartan Amlodipine Besylate eq. to Amlodipine Excipients Colour: Red Oxide of iron IP IP q.s. 40.00 mg 5.00 mg |
| 300 | Telmisartan and Amlodipine Besylate Tablets I.P. |
Each uncoated tablet contains: Telmisartan Amlodipine Besylate eq. to Amlodipine Excipients Colour: Red Oxide of iron IP IP q.s. 80.00 mg 10.00 mg |
| 301 | Telmisartan and Hydrochlorothiazide Tablets I.P. |
Each uncoated tablet contains: Telmisartan Hydrochlorothiazide Excipients Colour: Titanium Dioxide IP q.s. 40.00 mg 12.50 mg |
| 302 | Metformin hydrochloride and Gliclazide Prolonged-release Tablets |
Each uncoated tablet contains: Metformin hydrochloride (as prolonged release form) Gliclazide (as prolonged release form) Excipients Colour: Ponceau 4R IP IP q.s. 500.00 mg 60.00 mg |
| 303 | Metformin hydrochloride and Gliclazide Prolonged-release Tablets |
Each uncoated tablet contains: Metformin hydrochloride (as prolonged release form) Gliclazide (as prolonged release form) Excipients Colour: Red Oxide of iron IP IP q.s. 500.00 mg 80.00 mg |
| 304 | Hydroxyzine Hydrochloride Tablets I.P. 10 mg |
Each film coated tablet contains: Hydroxyzine Hydrochloride Excipients Colour: Titanium Dioxide IP q.s. 10.00 mg |
| 305 | Hydroxyzine Hydrochloride Tablets I.P. 25 mg |
Each film coated tablet contains: Hydroxyzine Hydrochloride Excipients Colour: Tartrazine IP q.s. 25.00 mg |
| 306 | Telmisartan, Amlodipine Besylate and Hydrochlorothiazide Tablets I.P. |
Each uncoated tablet contains: Telmisartan Amlodipine Besylate eq. to Amlodipine Hydrochlorothiazide Excipients Colour: Titanium Dioxide I.P. IP IP q.s. 40.00 mg 5.00 mg 12.50 mg |
| 307 | Telmisartan, Amlodipine Besylate and Hydrochlorothiazide Tablets I.P. |
Each uncoated tablet contains: Telmisartan Amlodipine Besylate eq. to Amlodipine Hydrochlorothiazide Excipients Colour: Titanium Dioxide I.P. IP IP q.s. 20.00 mg 2.50 mg 12.50 mg |
| 308 | Telmisartan, Amlodipine Besylate and Hydrochlorothiazide Tablets I.P. |
Each uncoated tablet contains: Telmisartan Amlodipine Besylate eq. to Amlodipine Hydrochlorothiazide Excipients Colour: Titanium Dioxide I.P. IP IP q.s. 80.00 mg 5.00 mg 12.50 mg |
| 309 | Ferrous Sulphate and Folic Acid Tablet I.P. |
Each film coated tablet contains: Ferrous Sulphate eq. to elemental Iron Folic Acid Excipients Colour: Red Oxide of iron IP q.s. 100.00 mg 1.50 mg |
| 310 | Gabapentin and Methylcobalamin Tablets |
Each film coated tablet contains: Gabapentin Methylcobalamin Excipients Colour: Ponceau 4R IP IP q.s. 100.00 mg 500.00 mcg |
| 311 | Gabapentin prolonged release and Methylcobalamin Tablets |
Each film coated bilayered tablet contains: Methylcobalamin Gabapentin as prolonged release form Excipients Colour: Sunset Yellow IP IP q.s. 1500.00 mcg 600.00 mg |
| 312 | Tranexamic Acid Tablets IP 250 mg |
Each film-coated tablet contains: Tranexamic Acid Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. IP q.s. 250.00 mg |
| 313 | Tranexamic Acid Tablets IP 500 mg |
Tranexamic Acid Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. IP q.s. 500.00 mg |
| 314 | Glimepiride Tablets IP 1 mg |
Each uncoated tablet contains: Glimepiride Excipients Dose: As directed by the physician. IP q.s. 1.00 mg |
| 315 | Glimepiride Tablets IP 2 mg |
Each uncoated tablet contains: Glimepiride Excipients Dose: As directed by the physician. IP q.s. 2.00 mg |
| 316 | Fexofenadine Hydrochloride IP 120 mg |
Each film-coated tablet contains: Fexofenadine Hydrochloride Excipients Colour: Red Oxide of iron Dose: As directed by the physician. IP q.s. 120.00 mg |
| 317 | Silymarin Tablets 70 mg |
Each film-coated tablet contains: Silymarin (as Silybin) Excipients Colour: Sunset Yellow Dose: As directed by the physician. q.s. 70.00 mg |
| 318 | Silymarin Tablets 140 mg |
Each film-coated tablet contains: Silymarin (as Silybin) Excipients Colour: Quinoline Yellow WS Dose: As directed by the physician. q.s. 140.00 mg |
| 319 | Tranexamic Acid and Etamsylate Tablets |
Each film-coated tablet contains: Tranexamic Acid Etamsylate Colour: Erythrosine Dose: As directed by the physician. IP BP q.s. 250.00 mg 250.00 mg |
| 320 | Etamsylate Tablets 250 mg |
Each film-coated tablet contains: Etamsylate Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. BP q.s. 250.00 mg |
| 321 | Etamsylate Tablets 500 mg |
Each film-coated tablet contains: Etamsylate Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. BP q.s. 500.00 mg |
| 322 | Torsemide and Spironolactone Tablets |
Each uncoated tablet contains: Torsemide Spironolactone Excipients Dose: As directed by the physician. IP IP q.s. 20.00 mg 50.00 mg |
| 322 | Torsemide and Spironolactone Tablets |
Each uncoated tablet contains: Torsemide Spironolactone Excipients Dose: As directed by the physician. IP IP q.s. 20.00 mg 50.00 mg |
| 323 | Olmesartan Medoxomil and Amlodipine Besylate Tablets |
Olmesartan Medoxomil Amlodipine Besylate eq. to Amlodipine Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. IP IP q.s. 20.00 mg 5.00 mg |
| 324 | Gliclazide Modified-release Tablets 30 mg |
Each uncoated modified-release tablet contains: Gliclazide Excipients Dose: As directed by the physician. IP q.s. 30.00 mg |
| 325 | Sodium Alendronate Tablets |
Each film-coated tablet contains: Sodium Alendronate trihydrate IP eq. to Alendronic Acid Excipients Colour: Sunset Yellow FCF & Titanium Dioxide IP Dose: As directed by the physician. q.s. 35.00 mg |
| 326 | Risedronate Sodium Tablets IP |
Each film-coated tablet contains: Risedronate Sodium Eq. to Anhydrous Risedronate Sodium Excipients Colour: Sunset Yellow FCF & Titanium Dioxide IP Dose: As directed by the physician. IP q.s. 35.00 mg |
| 327 | Carbimazole Tablets IP |
Each uncoated tablet contains: Carbimazole Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP q.s. 10.00 mg |
| 328 | Etodolac Prolonged-release Tablets IP 300 mg |
Each uncoated prolonged-release tablet contains: Etodolac Excipients Dose: As directed by the physician. IP q.s. 300.00 mg |
| 329 | Etodolac Prolonged-release Tablets IP 600 mg |
Each uncoated prolonged-release tablet contains: Etodolac Excipients Dose: As directed by the physician. IP q.s. 600.00 mg |
| 330 | Telmisartan Immediate-release and Metoprolol Succinate Modified-release Tablets |
Each uncoated bilayered tablet contains: Metoprolol Succinate Eq. to Metoprolol Tartrate (As Modified-release) Telmisartan (As Immediate-release) Excipients Colour: Tartrazine Dose: As directed by the physician. IP IP q.s. 50.00 mg 40.00 mg |
| 331 | Telmisartan Immediate-release and Metoprolol Succinate Modified-release Tablets |
Each uncoated bilayered tablet contains: Metoprolol Succinate eq. to Metoprolol Tartrate (As Modified-release) Telmisartan (As Immediate-release) Excipients Colour: Tartrazine Dose: As directed by the physician. IP q.s. 50.00 mg 40.00 mg |
| 332 | Fluconazole Tablet IP 150 mg |
Each uncoated tablet contains: Fluconazole Excipients Dose: As directed by the physician. IP q.s. 150.00 mg |
| 333 | Aceclofenac and Thiocolchicoside Tablets |
Each film-coated tablet contains: Aceclofenac (as modified-release) Thiocolchicoside Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP IP q.s. 200.00 mg 8.00 mg |
| 334 | Etodolac Prolonged-release Tablets IP |
Each film-coated tablet contains: Etodolac (as prolonged-release) Excipients Colour: Red Oxide of iron Dose: As directed by the physician. IP q.s. 300.00 mg |
| 335 | Rosuvastatin Calcium and Clopidogrel Bisulphate Tablets |
Each film-coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 10.00 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75.00 mg Excipients Colour: Yellow oxide of iron Dose: As directed by the physician. |
| 336 | Rosuvastatin Calcium and Clopidogrel Bisulphate Tablets |
Each film-coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 20.00 mg Clopidogrel Bisulphate IP eq. to Clopidogrel 75.00 mg Excipients Colour: Red Oxide of Iron Dose: As directed by the physician. |
| 337 | Telmisartan Immediate-release and Metoprolol Succinate Modified-release Tablets |
Each uncoated bilayered tablet contains: Metoprolol Succinate IP eq. to Metoprolol Tartrate (As Modified-release) Telmisartan IP (As Immediate-release) Excipients Colour: Quinoline Yellow WS Dose: As directed by the physician. q.s. 25.00 mg 40.00 mg |
| 338 | Amisulpiride Modified-release Tablets |
Each uncoated tablet contains: Amisulpiride (As Modified-release) Excipients Dose: As directed by the physician. IP q.s. 200.00 mg |
| 339 | Montelukast Sodium and Levocetirizine Hydrochloride Mouth Dissolving Tablets |
Each uncoated mouth dissolving tablet contains: Montelukast Sodium eq. to Montelukast Levocetirizine Hydrochloride Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP IP q.s. 4.00 mg 2.50 mg |
| 340 | Atorvastatin Calcium Tablets IP 80 mg |
Each film-coated tablet contains: Atorvastatin Calcium eq. to Atorvastatin Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. IP q.s. 80.00 mg |
| 341 | Atorvastatin Calcium Tablets IP 80 mg |
Each film-coated tablet contains: Atorvastatin Calcium eq. to Atorvastatin Excipients Colour: Titanium Dioxide IP and Sunset Yellow FCF Dose: As directed by the physician. IP q.s. 40.00 mg |
| 342 | Desloratadine Tablet 5 mg |
Each film-coated tablet contains: Desloratadine Excipients Colour: Iron Oxide Yellow and Titanium Dioxide I.P. Dose: As directed by the physician. IP q.s. 5.00 mg |
| 343 | Doxycycline Hydrochloride Tablets |
Each film-coated tablet contains: Doxycycline Hydrochloride eq. to Doxycycline Excipients Colour: Red Oxide Of Iron Dose: As directed by the physician. IP q.s. 100.00 mg |
| 344 | Dexchlorpheniramine Tablets IP 2 mg |
Each film-coated tablet contains: Dexchlorpheniramine Maleate Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. IP q.s. 2.00 mg |
| 345 | Serratiopeptidase Tablets IP 10 mg |
Each film-coated tablet contains: Serratiopeptidase (as gastro-resistant) Excipients Colour: Red Oxide Of Iron Dose: As directed by the physician. IP q.s. 10.00 mg |
| 346 | Ivermectin Tablets 6 mg |
Each uncoated dispersible tablet contains: Ivermectin Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP q.s. 6.00 mg |
| 347 | Ivermectin Tablets 6 mg |
Each uncoated dispersible tablet contains: Ivermectin Excipients Colour: Tartrazine Dose: As directed by the physician. IP q.s. 6.00 mg |
| 348 | Clindamycin Tablets 300 mg |
Each film-coated tablet contains: Clindamycin Hydrochloride eq. to Clindamycin Excipients Colour: Titanium Dioxide I.P. Dose: As directed by the physician. IP q.s. 300.00 mg |
| 349 | Ofloxacin and Nitazoxanide Tablet |
Each film-coated tablet contains: Ofloxacin Nitazoxanide Excipients Colour: Tartrazine Dose: As directed by the physician. IP q.s. 200.00 mg 500.00 mg |
| 350 | Sodium Feredetate, Folic Acid and Vitamin B12 Tablets |
Each film-coated tablet contains: Sodium Feredetate eq. to elemental Iron Folic Acid Vitamin B12 Excipients Appropriate overages added. Colour: Ponceau 4R Dose: As directed by the physician. BP IP IP q.s. 231.00 mg 33.00 mg 1.50 mg 15.00 mcg |
| 351 | Gliclazide and Metformin Hydrochloride Tablets |
Each uncoated tablet contains: Gliclazide Metformin Hydrochloride Excipients Dose: As directed by the physician. IP IP q.s. 40.00 mg 500.00 mg |
| 352 | S (+) Etodolac Prolonged-release Tablets 300 mg |
Each film-coated prolonged-release tablet contains: S (+) Etodolac Excipients q.s. Yellow Oxide of Iron, Indigo Carmine and Titanium Dioxide IP Dose: As directed by the physician. 300.00 mg |
| 353 | Pioglitazone Hydrochloride Tablets IP 15 mg |
Each uncoated tablet contains: Pioglitazone Hydrochloride eq. to Pioglitazone Excipients Dose: As directed by the physician. IP q.s. 15.00 mg |
| 354 | Betahistine Hydrochloride Tablets IP 24 mg |
Each film-coated tablet contains: Betahistine Hydrochloride Excipients Colour: Quinoline Yellow WS Dose: As directed by the physician. IP q.s. 24.00 mg |
| 355 | Trypsin, Bromelain and Rutoside Trihydrate Tablet |
Each gastro-resistant tablet contains: Trypsin Bromelain Rutoside Trihydrate Excipients Colour: Red Oxide Of Iron Dose: As directed by the physician. BP BP q.s. 48.00 mg 90.00 mg 100.00 mg |
| 356 | Gliclazide and Metformin Hydrochloride Tablets |
Each uncoated tablet contains: Gliclazide Metformin Hydrochloride Excipients Dose: As directed by the physician. IP IP q.s. 30.00 mg 500.00 mg |
| 357 | Gliclazide Prolonged-release Tablets 60 mg |
Each uncoated prolonged-release tablet contains: Gliclazide Excipients Dose: As directed by the physician. IP q.s. 60.00 mg |
| 358 | Nimesulide and Paracetamol Tablets |
Each uncoated double-layered tablet contains: Nimesulide Paracetamol Excipients Colour: Sunset Yellow FCF, Quinoline Yellow WS Dose: As directed by the physician. BP IP q.s. 100.00 mg 325.00 mg |
| 359 | Alprazolam Tablets IP 0.25 mg |
Each uncoated tablet contains: Alprazolam Excipients Dose: As directed by the physician. IP q.s. 0.25 mg |
| 360 | Clonazepam Mouth Dissolving Tablets 0.5 mg |
Each uncoated mouth dissolving tablet contains: Clonazepam Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP q.s. 0.50 mg |
| 361 | Divalproex Gastro-resistant Tablets IP 250 mg |
Each gastro-resistant tablet contains: Divalproex Sodium eq. to Valproic Acid Excipients Colour: Yellow oxide of iron Dose: As directed by the physician. IP q.s. 250.00 mg |
| 362 | Divalproex Gastro-resistant Tablets IP 500 mg |
Each gastro-resistant tablet contains: Divalproex Sodium eq. to Valproic Acid Excipients Colour: Red Oxide of iron Dose: As directed by the physician. IP q.s. 500.00 mg |
| 363 | Glimepiride Tablets IP 3 mg |
Each uncoated tablet contains: Glimepiride Excipients Dose: As directed by the physician. IP q.s. 3.00 mg |
| 364 | Glimepiride Tablets IP 4 mg |
Each uncoated tablet contains: Glimepiride Excipients Dose: As directed by the physician. IP q.s. 4.00 mg |
| 365 | Faropenem Sodium Tablets 200 mg |
Each film-coated tablet contains: Faropenem Sodium eq. to Faropenem Excipients Colour: Yellow oxide of iron Dose: As directed by the physician. IP q.s. 200.00 mg |
| 366 | Faropenem Sodium Tablets 300 mg |
Each film-coated tablet contains: Faropenem Sodium eq. to Faropenem Excipients Colour: Red oxide of iron Dose: As directed by the physician. IP q.s. 300.00 mg |
| 367 | Metformin Hydrochloride Prolonged-release and Glimepiride Tablets IP |
Each uncoated bilayered tablet contains: Metformin Hydrochloride (As Prolonged-release) Glimepiride Excipients Colour: Sunset Yellow Dose: As directed by the physician. IP IP q.s. 1000.00 mg 1.00 mg |
| 368 | Methylcobalamin tablets 500 mcg |
Each uncoated tablet contains: Methylcobalamin Excipients Colour: Red oxide of iron Dose: As directed by the physician. IP q.s. 500.00 mcg |
| 369 | Metformin Hydrochloride and Gliclazide Prolonged-release Tablets |
Each uncoated bilayered tablet contains: Metformin Hydrochloride (as prolonged-release) Gliclazide Excipients Colour: Sunset Yellow Dose: As directed by the physician. IP IP q.s. 500.00 mg 30.00 mg |
| 370 | Clonazepam Tablets IP 0.5 mg |
Each uncoated tablet contains: Clonazepam Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP q.s. 0.50 mg |
| 371 | Clonazepam Tablets IP 0.25 mg |
Each uncoated tablet contains: Clonazepam Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. IP q.s. 0.25 mg |
| 372 | Etizolam Tablets 0.25 mg |
Each film-coated tablet contains: Etizolam Excipients Colour: Sunset Yellow FCF Dose: As directed by the physician. 0.25 mg q.s |
| 373 | Etizolam Tablets 0.50 mg |
Each film-coated tablet contains: Etizolam Excipients Colour: Red Oxide of Iron Dose: As directed by the physician. 0.50 mg q.s |
| 374 | Flupentixol Tablets 0.5 mg |
Each film-coated tablet contains: Flupentixol Hydrochloride Excipients Colour: Titanium Dioxide IP Dose: As directed by the physician. BP 0.50 mg q.s |
| 375 | Flavoxate Tablets IP 200 mg |
Each film-coated tablet contains: Flavoxate Hydrochloride Excipients Colour: Titanium Dioxide IP Dose: As directed by the physician. IP 200.00 mg q.s |
| 376 | Sevelamer Carbonate 800 mg Tablet |
Each film-coated tablet contains: Sevelamer Carbonate Excipients Colour: Red Oxide of Iron & Titanium Dose: As directed by the physician. 800.00 mg q.s |
| 377 | Sevelamer Carbonate 400 mg Tablet |
Each film-coated tablet contains: Sevelamer Carbonate Excipients Colour: Yellow Oxide of Iron & Titanium Dose: As directed by the physician. 400.00 mg q.s |
| 378 | Deflazacort Tablets 12 mg |
Each uncoated tablet contains: Deflazacort Excipients Dose: As directed by the physician. 12.00 mg q.s |
| 379 | Spironolactone tablets IP 25 mg |
Each uncoated tablet contains: Spironolactone Excipients Dose: As directed by the physician. IP 25.00 mg q.s |
| 380 | Spironolactone tablets IP 50 mg |
Each uncoated tablet contains: Spironolactone Excipients Dose: As directed by the physician. IP 50.00 mg q.s |
| 381 | Alprazolam Tablets IP 0.50 mg |
Each uncoated tablet contains: Alprazolam Excipients Colour: Tartrazine Dose: As directed by the physician. IP 0.50 mg q.s |
| 382 | Tolperisone Hydrochloride and Paracetamol tablets |
Each film-coated tablet contains: Tolperisone Hydrochloride Paracetamol Excipients Colour: Titanium Dioxide IP Dose: As directed by the physician. IP 100 mg 325 mg q.s |
| 383 | Tramadol Prolonged-release Tablets IP 100 mg |
Each uncoated prolonged-release tablet contains: Tramadol Hydrochloride Excipients Colour: Titanium Dioxide IP Dose: As directed by the physician. IP 100 mg q.s |
| 384 | Tramadol Prolonged-release Tablets IP 50 mg |
Each uncoated prolonged-release tablet contains: Tramadol Hydrochloride Excipients Colour: Tartrazine Dose: As directed by the physician. IP 50 mg q.s |
| 385 | Lamivudine and Zidovudine Tablets |
Each film-coated tablet contains: Lamivudine IP – 150 mg Zidovudine IP – 300 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 386 | Linezolid Dispersible Tablets 100 mg |
Each uncoated dispersible tablet contains: Linezolid IP – 100 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 387 | Ubidecarenone (Co-Enzyme Q10) Tablets 100 mg |
Each film-coated tablet contains: Ubidecarenone (Co-Enzyme Q10) USP – 100 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 388 | L-Carnitine L-Tartrate Tablets |
Each film-coated tablet contains: L-Carnitine L-tartrate eq. to L-Carnitine – 330 mg Colour: Red Oxide of Iron Dose: As directed by the physician. |
| 389 | Moxifloxacin Hydrochloride Tablets 400 mg |
Each film-coated tablet contains: Moxifloxacin Hydrochloride IP – 400 mg Excipients q.s. Colour: Yellow Oxide of Iron Dose: As directed by the physician. |
| 390 | Sodium Bicarbonate Tablets USP 500 mg |
Each film-coated tablet contains: Sodium bicarbonate IP – 500 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 391 | Sodium Bicarbonate Tablets USP 1000 mg |
Each film-coated tablet contains: Sodium bicarbonate IP – 1000 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 392 | Frusemide and Spironolactone Tablets |
Each film-coated tablet contains: Frusemide IP – 20 mg Spironolactone IP – 50 mg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 393 | Frusemide and Spironolactone Tablets |
Each film-coated tablet contains: Frusemide IP – 20 mg Spironolactone IP – 100 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 394 | Escitalopram Oxalate Tablets IP 10 mg |
Each film-coated tablet contains: Escitalopram Oxalate IP eq. to Escitalopram – 10 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 395 | Cinnarizine and Dimenhydrinate Tablets |
Each uncoated tablet contains: Cinnarizine IP – 20 mg Dimenhydrinate BP – 40 mg Excipients q.s. Colour: Tartrazine and Titanium Dioxide IP Dose: As directed by the physician. |
| 396 | N-Acetylcysteine Tablets 600 mg |
Each film-coated tablet contains: N-Acetylcysteine – 600 mg Excipients q.s. Colour: Quinoline Yellow WS & Titanium Dose: As directed by the physician. |
| 397 | Telmisartan Tablets IP 40 mg |
Each uncoated tablet contains: Telmisartan IP – 40 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 398 | Ursodeoxycholic Acid Tablets IP 150 mg |
Each film-coated tablet contains: Ursodeoxycholic Acid IP – 150 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 399 | Ursodeoxycholic Acid Tablets IP 300 mg |
Each film-coated tablet contains: Ursodeoxycholic Acid IP – 300 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 400 | Paracetamol Tablets IP 500 mg |
Each uncoated tablet contains: Paracetamol IP – 500 mg Excipients q.s. Dose: As directed by the physician. |
| 401 | Risperidone Orally Disintegrating Tablets USP 1 mg |
Each uncoated orally disintegrating tablet contains: Risperidone USP – 1 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 402 | Risperidone Orally Disintegrating Tablets USP 2 mg |
Each uncoated orally disintegrating tablet contains: Risperidone USP – 2 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 403 | Aripiprazole Mouth Dissolving Tablets 2 mg |
Each uncoated mouth dissolving tablet contains: Aripiprazole IP – 2 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 404 | Aripiprazole Mouth Dissolving Tablets 5 mg |
Each uncoated mouth dissolving tablet contains: Aripiprazole IP – 5 mg Excipients q.s. Dose: As directed by the physician. |
| 405 | Aripiprazole Mouth Dissolving Tablets 10 mg |
Each uncoated mouth dissolving tablet contains: Aripiprazole IP – 10 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 406 | Aripiprazole Mouth Dissolving Tablets 15 mg |
Each uncoated mouth dissolving tablet contains: Aripiprazole IP – 15 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 407 | Aripiprazole Mouth Dissolving Tablets 20 mg |
Each uncoated mouth dissolving tablet contains: Aripiprazole IP – 20 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 408 | Sertraline Tablets IP 25 mg |
Each film-coated tablet contains: Sertraline Hydrochloride IP eqv. to Sertraline – 25 mg Excipients q.s. Colours: Quinoline Yellow WS and Titanium Dioxide IP Dose: As directed by the physician. |
| 409 | Sertraline Tablets IP 50 mg |
Each film-coated tablet contains: Sertraline Hydrochloride IP eqv. to Sertraline – 50 mg Excipients q.s. Colours: Sunset Yellow FCF and Titanium Dioxide IP Dose: As directed by the physician. |
| 410 | Sertraline Tablets IP 100 mg |
Each film-coated tablet contains: Sertraline Hydrochloride IP eqv. to Sertraline – 100 mg Excipients q.s. Colours: Quinoline Yellow WS and Titanium Dioxide IP Dose: As directed by the physician. |
| 411 | Fluoxetine Tablets IP 20 mg |
Each film-coated tablet contains: Fluoxetine Hydrochloride IP eqv. to Fluoxetine – 20 mg Excipients q.s. Colours: Tartrazine and Titanium Dioxide IP Dose: As directed by the physician. |
| 412 | Fluoxetine Tablets IP 40 mg |
Each film-coated tablet contains: Fluoxetine Hydrochloride IP eqv. to Fluoxetine – 40 mg Excipients q.s. Colours: Sunset Yellow FCF and Titanium Dioxide IP Dose: As directed by the physician. |
| 413 | Fluoxetine Tablets IP 60 mg |
Each film-coated tablet contains: Fluoxetine Hydrochloride IP eqv. to Fluoxetine – 60 mg Excipients q.s. Colours: Brilliant Blue FCF and Titanium Dioxide IP Dose: As directed by the physician. |
| 414 | Lorazepam Tablets IP 1 mg |
Each uncoated tablet contains: Lorazepam IP – 1 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 415 | Lorazepam Tablets IP 2 mg |
Each uncoated tablet contains: Lorazepam IP – 2 mg Excipients q.s. Colour: Sunset yellow FCF Dose: As directed by the physician. |
| 416 | Lorazepam Tablets IP 3 mg |
Each uncoated tablet contains: Lorazepam IP – 3 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 417 | Clomipramine Hydrochloride Tablets 25 mg |
Each film-coated tablet contains: Clomipramine Hydrochloride IP – 25 mg Excipients q.s. Colours: Erythrosine and Titanium Dioxide IP Dose: As directed by the physician. |
| 418 | Clomipramine Hydrochloride Tablets 50 mg |
Each film-coated tablet contains: Clomipramine Hydrochloride IP – 50 mg Excipients q.s. Colours: Brilliant Blue FCF and Titanium Dioxide IP Dose: As directed by the physician. |
| 419 | Clomipramine Hydrochloride Tablets 75 mg |
Each film-coated tablet contains: Clomipramine Hydrochloride IP – 75 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 420 | Clozapine Tablets IP 25 mg |
Each uncoated tablet contains: Clozapine IP – 25 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 421 | Clozapine Tablets IP 50 mg |
Each uncoated tablet contains: Clozapine IP – 50 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 422 | Clozapine Tablets IP 100 mg |
Each uncoated tablet contains: Clozapine IP – 100 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 423 | Clozapine Tablets IP 200 mg |
Each uncoated tablet contains: Clozapine IP – 200 mg Excipients q.s. Colour: Brilliant Blue FCF Dose: As directed by the physician. |
| 424 | Duloxetine Gastro-resistant Tablets IP 20 mg |
Each film-coated tablet contains: Duloxetine Hydrochloride IP eq. to Duloxetine – 20 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 425 | Fluvoxamine Tablets IP 100 mg |
Each film-coated tablet contains: Fluvoxamine Maleate IP – 100 mg Excipients q.s. Colours: Yellow Oxide of iron and Titanium Dioxide IP Dose: As directed by the physician. |
| 426 | Amitriptyline Tablets IP 10 mg |
Each film-coated tablet contains: Amitriptyline Hydrochloride IP – 10 mg Excipients q.s. Colours: Sunset yellow FCF and Titanium Dioxide IP Dose: As directed by the physician. |
| 427 | Amitriptyline Tablets IP 25 mg |
Each film-coated tablet contains: Amitriptyline Hydrochloride IP – 25 mg Excipients q.s. Colours: Brilliant Blue FCF and Titanium Dioxide IP Dose: As directed by the physician. |
| 428 | Azithromycin Tablets IP 250 mg |
Each film-coated tablet contains: Azithromycin IP – 250 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 429 | Fluvoxamine Tablets IP 50 mg |
Each film-coated tablet contains: Fluvoxamine Maleate IP – 50 mg Excipients q.s. Colour: Red Oxide of iron and Titanium Dioxide IP Dose: As directed by the physician. |
| 430 | Azithromycin Tablets IP 500 mg |
Each film-coated tablet contains: Azithromycin IP – 500 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 431 | Etoricoxib and Thiocolchicoside Tablets |
Each film-coated tablet contains: Etoricoxib IP – 60 mg Thiocolchicoside IP – 4 mg Excipients q.s. Colour: Red oxide of iron and Titanium Dioxide IP Dose: As directed by the physician. |
| 432 | Voriconazole Tablets IP 200 mg |
Each film-coated tablet contains: Voriconazole IP – 200 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 433 | Levodopa and Carbidopa Tablets IP |
Each uncoated tablet contains: Levodopa IP – 100 mg Carbidopa (anhydrous) IP – 25 mg Excipients q.s. Dose: As directed by the physician. |
| 434 | Vildagliptin and Metformine Hydrochloride Tablets |
Each film-coated tablet contains: Vildagliptin – 50 mg Metformine Hydrochloride IP – 500 mg Excipients q.s. Colour: Yellow Oxide of iron & Titanium Dioxide IP Dose: As directed by the physician. |
| 435 | Amoxapine Mouth Dissolving Tablets 50 mg |
Each uncoated tablet contains: Amoxapine USP – 50 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 436 | Clonazepam Mouth Dissolving Tablets 0.25 mg |
Each uncoated tablet contains: Clonazepam IP – 0.25 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 437 | Biotin Tablets USP 5 mg |
Each film-coated tablet contains: Biotin USP – 5 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 438 | Olmesartan Medoxomil Tablets IP 20 mg |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 20 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 439 | Olmesartan Medoxomil Tablets IP 40 mg |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 40 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 440 | Olmesartan Medoxomil and hydrochlorothiazide |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 40 mg Hydrochlorothiazide IP – 12.50 mg Excipients q.s. Colour: Tartrazine & Titanium Dioxide IP Dose: As directed by the physician. |
| 441 | Docusate Sodium and senna Extract Tablets |
Each film-coated tablet contains: Docusate Sodium USP – 100 mg Senna Dry Extract IP – Eq. to senosides as calcium salt – 17.20 mg Excipients q.s. Dose: As directed by the physician. |
| 442 | Vitamin C Chewable Tablets IP 500 mg |
Each uncoated chewable tablet contains: Vitamin C IP – 500 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 443 | Piracetam Tablets 800 mg |
Each film-coated tablet contains: Piracetam IP – 800 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 444 | Fluconazole Tablets IP 300 mg |
Each uncoated tablet contains: Fluconazole IP – 300 mg Excipients q.s. Dose: As directed by the physician. |
| 445 | Duloxetine Gastro-resistant Tablets IP 30 mg |
Each gastro-resistant tablet contains: Duloxetine Hydrochloride IP – eqv. To Duloxetine – 30 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 446 | Duloxetine Gastro-resistant Tablets IP 60 mg |
Each gastro-resistant tablet contains: Duloxetine Hydrochloride IP – eqv. To Duloxetine – 60 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 447 | Azithromycin and Lactic Acid Bacillus Tablets |
Each film-coated tablet contains: Azithromycin IP – 250 mg Lactic Acid Bacillus – 60 Million Spores Excipients q.s. Colour: Yellow Oxide of Iron Dose: As directed by the physician. |
| 448 | Azithromycin and Lactic Acid Bacillus Tablets |
Each film-coated tablet contains: Azithromycin IP – 500 mg Lactic Acid Bacillus – 60 Million Spores Excipients q.s. Colour: Yellow Oxide of Iron Dose: As directed by the physician. |
| 449 | Olanzapine Tablets IP 10 mg |
Each film-coated tablet contains: Olanzapine IP – 10 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 450 | Gliclazide Tablets IP 80 mg |
Each uncoated tablet contains: Gliclazide IP – 80 mg Excipients q.s. Dose: As directed by the physician. |
| 451 | Venlafaxine Modified-release Tablets BP |
Each uncoated modified-release tablet contains: Venlafaxine Hydrochloride BP – eq. to Venlafaxine – 120 mg Excipients q.s. Dose: As directed by the physician. |
| 452 | Ramipril Tablets IP 5 mg |
Each uncoated tablet contains: Ramipril IP – 5 mg Excipients q.s. Dose: As directed by the physician. |
| 453 | Escitalopram Tablets IP 5 mg |
Each film-coated tablet contains: Escitalopram Oxalate IP – eq. to Escitalopram – 5 mg Excipients q.s. Colour: Red Oxide of Iron Dose: As directed by the physician. |
| 454 | Acebrophylline and N-Acetylcysteine Tablets |
Each film-coated bilayered tablet contains: Acebrophylline – 100 mg (as prolonged-release) N-Acetylcysteine BP – 600 mg (as Immediate-release) Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 455 | Acebrophylline and Montelukast Tablets |
Each film-coated bilayered tablet contains: Acebrophylline – 200 mg (as prolonged-release) Montelukast Sodium IP – 10 mg (eqv. To Montelukast) (as Immediate-release) Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 456 | Ramipril Tablets IP 2.5 mg |
Each uncoated tablet contains: Ramipril IP – 2.5 mg Excipients q.s. Dose: As directed by the physician. |
| 457 | Tranexamic Acid and Etamsylate Tablets |
Each film-coated tablet contains: Tranexamic Acid IP – 250 mg Etamsylate IP – 500 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 458 | Glucosamine, Methylsulfonylmethane and Diacerein Tablets |
Each film-coated tablet contains: Glucosamine Sulphate Sodium chloride IP – 750 mg Methylsulfonylmethane USP – 250 mg Diacerein IP – 50 mg Excipients q.s. Colour: Red Oxide of Iron Dose: As directed by the physician. |
| 459 | Rivaroxaban Tablets 10 mg |
Each film-coated tablet contains: Rivaroxaban – 10 mg Excipients q.s. Colour: Red Oxide of Iron Dose: As directed by the physician. |
| 460 | Diclofenac Sodium and Paracetamol Tablets IP |
Each film-coated tablet contains: Diclofenac Sodium IP – 50 mg Paracetamol IP – 325 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 461 | Diclofenac Potassium and Paracetamol Tablets IP |
Each film-coated tablet contains: Diclofenac Potassium IP – 50 mg Paracetamol IP – 325 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 462 | Tadalafil Tablets IP 2.5 mg |
Each film-coated tablet contains: Tadalafil IP – 2.5 mg Excipients q.s. Colour: Yellow Oxide of Iron Dose: As directed by the physician. |
| 463 | Tadalafil Tablets IP 5 mg |
Each film-coated tablet contains: Tadalafil IP – 5.0 mg Excipients q.s. Colour: Red Oxide of Iron Dose: As directed by the physician. |
| 464 | Naltrexone Hydrochloride Tablets IP 50 mg |
Each film-coated tablet contains: Naltrexone Hydrochloride IP – 50 mg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 465 | Naltrexone Hydrochloride Tablets IP 100 mg |
Each film-coated tablet contains: Naltrexone Hydrochloride IP – 100 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 466 | Amoxapine Mouth Dissolving Tablets 100 mg |
Each Uncoated tablet contains: Amoxapine USP – 100 mg Excipients q.s. Colour: Tartrazine Dose: As directed by the physician. |
| 467 | Modafinil Tablets IP 100 mg |
Each Uncoated tablet contains: Modafinil IP – 100 mg Excipients q.s. Dose: As directed by the physician. |
| 468 | Armodafinil Tablets 50 mg |
Each Uncoated tablet contains: Armodafinil IP – 50 mg Excipients q.s. Dose: As directed by the physician. |
| 469 | Lithium Carbonate Prolonged-release Tablets IP |
Each uncoated prolonged-release tablet contains: Lithium Carbonate IP – 400 mg Excipients q.s. Dose: As directed by the physician. |
| 470 | Pimozide Tablets IP 4 mg |
Each Uncoated tablet contains: Pimozide IP – 4 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 471 | Bupropion Hydrochloride Extended-release Tablets USP |
Each film-coated extended-release tablet contains: Bupropion Hydrochloride USP – 150 mg Excipients q.s. Colour: Indigo Caramine Dose: As directed by the physician. |
| 472 | Flunarizine Dihydrochloride Tablets 5 mg |
Each Uncoated tablet contains: Flunarizine Dihydrochloride BP – 5 mg Excipients q.s. Dose: As directed by the physician. |
| 473 | Flunarizine Dihydrochloride Tablets 10 mg |
Each Uncoated tablet contains: Flunarizine Dihydrochloride BP – 10 mg Excipients q.s. Dose: As directed by the physician. |
| 474 | Tizanidine Tablets IP 2 mg |
Each Uncoated tablet contains: Tizanidine Hydrochloride IP – 2 mg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 475 | Tizanidine Tablets IP 4 mg |
Each Uncoated tablet contains: Tizanidine Hydrochloride IP – 4 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 476 | Calcium Citrate, Magnesium, Zinc and Vitamin D3 Tablets |
Each film-coated tablet contains: Calcium Citrate Malate – Eq. to elemental Calcium 250 mg Magnesium Hydroxide IP – 100 mg Zinc Sulphate monohydrate IP – Eq. to elemental Zinc 4 mg Vitamin D3 IP – 400 IU Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 477 | Calcium Citrate, Magnesium, Zinc and Vitamin D3 Tablets |
Each film-coated tablet contains: Calcium Citrate IP – Eq. to elemental Calcium 250 mg Magnesium Hydroxide IP – 100 mg Zinc Sulphate monohydrate IP – Eq. to elemental Zinc 4 mg Vitamin D3 IP – 400 IU Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 478 | Gabapentin and Methylcobalamin tablets |
Each film-coated tablet contains: Gabapentin IP – 100 mg Methylcobalamin IP – 500 mcg Excipients q.s. Colour: Indigo Caramine Dose: As directed by the physician. |
| 479 | Gabapentin Tablets IP 200 mg |
Each film-coated tablet contains: Gabapentin IP – 200 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 480 | Oxcarbazepine Tablets IP 600 mg |
Each film-coated tablet contains: Oxcarbazepine IP – 600 mg Excipients q.s. Colour: Brilliant Blue FCF Dose: As directed by the physician. |
| 481 | Methotrexate Tablets IP 2.5mg |
Each uncoated tablet contains: Methotrexate IP – 2.5 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. |
| 482 | Methotrexate Tablets IP 5mg |
Each uncoated tablet contains: Methotrexate IP – 5 mg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 483 | Methotrexate Tablets IP 10mg |
Each uncoated tablet contains: Methotrexate IP – 10 mg Excipients q.s. Colour: Brilliant Blue FCF Dose: As directed by the physician. |
| 484 | Calcium Carbonate, Magnesium, Zinc and Vitamin D3 Tablets |
Each film-coated tablet contains: Calcium Carbonate IP – Eqv. To elemental calcium 500 mg Magnesium Hydroxide IP – 100 mg Zinc Sulphate monohydrate IP – Eqv. To elemental zinc 4 mg Vitamin D3 IP – 400 IU Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 485 | Tramadol Hydrochloride & Acetaminophen Tablets USP |
Each film-coated tablet contains: Tramadol Hydrochloride IP – 18.75 mg Acetaminophen IP – 162.50 mg Excipients q.s. Colour: Yellow Oxide Of Iron Dose: As directed by the physician. |
| 486 | Rabeprazole Sodium Gastro-resistant tablets IP 40mg |
Each gastro-resistant tablet contains: Rabeprazole Sodium IP – 40 mg Excipients q.s. Colour: Red Oxide Of Iron Dose: As directed by the physician. |
| 487 | Levetiracetam Tablets IP 250mg |
Each film-coated tablet contains: Levetiracetam IP – 250 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 488 | Levetiracetam Prolonged-release Tablets IP 250mg |
Each uncoated prolonged-release tablet contains: Levetiracetam IP – 250 mg Excipients q.s. Dose: As directed by the physician. |
| 489 | Dapagliflozin Tablets 10mg |
Each film-coated tablet contains: Dapagliflozin Propanediol Monohydrate – Eqv. To Dapagliflozin 10 mg Excipients q.s. Colour: Yellow Oxide Of Iron Dose: As directed by the physician. |
| 490 | Teneligliptin Tablets 20mg |
Each film-coated tablet contains: Teneligliptin Hydrobromide Hydrate IP – Eqv. To Teneligliptin 20 mg Excipients q.s. Colour: Red Oxide Of Iron Dose: As directed by the physician. |
| 491 | Vildagliptin Tablets 50mg |
Each uncoated tablet contains: Vildagliptin – 50 mg Excipients q.s. Dose: As directed by the physician. |
| 492 | Amisulpride Tablets IP 50mg |
Each uncoated tablet contains: Amisulpride IP – 50 mg Excipients q.s. Dose: As directed by the physician. |
| 493 | Amisulpride Tablets IP 100mg |
Each uncoated tablet contains: Amisulpride IP – 100 mg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 494 | Levocetirizine Dihydrochloride and Montelukast Sodium Tablets IP |
Each uncoated bilayered tablet contains: Levocetirizine Dihydrochloride IP – 5 mg Montelukast Sodium IP – Eqv. To Montelukast 10 mg Excipients q.s. Colour: Ponceau 4R Dose: As directed by the physician. |
| 495 | Lamotrigine Dispersible Tablets IP 50mg |
Each uncoated Dispersible tablet contains: Lamotrigine IP – 50 mg Excipients q.s. Dose: As directed by the physician. |
| 496 | Lamotrigine Dispersible Tablets IP 100mg |
Each uncoated Dispersible tablet contains: Lamotrigine IP – 100 mg Excipients q.s. Dose: As directed by the physician. |
| 497 | Colchicine Tablets IP 250mcg |
Each uncoated tablet contains: Colchicine IP – 250 mcg Excipients q.s. Dose: As directed by the physician. |
| 498 | Colchicine Tablets IP 500mcg |
Each uncoated tablet contains: Colchicine IP – 500 mcg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 499 | Atorvastatin 10mg & Ezetimibe 10mg Tablets |
Each film-coated tablet contains: Atorvastatin calcium IP – 10 mg (Eqv. To Atorvastatin) Ezetimibe IP – 10 mg Excipients q.s. Colour: Yellow Oxide Of Iron Dose: As directed by the physician. |
| 500 | Atorvastatin 20mg & Ezetimibe 10mg Tablets |
Each film-coated tablet contains: Atorvastatin calcium IP – 20 mg (Eqv. To Atorvastatin) Ezetimibe IP – 10 mg Excipients q.s. Colour: Red Oxide Of Iron Dose: As directed by the physician. |
| 501 | Irbesartan Tablets IP 150mg |
Each uncoated tablet contains: Irbesartan IP – 150 mg Excipients q.s. Dose: As directed by the physician. |
| 502 | Irbesartan Tablets IP 300mg |
Each uncoated tablet contains: Irbesartan IP – 300 mg Excipients q.s. Dose: As directed by the physician. |
| 503 | Isotretinoin Tablets 20mg |
Each film-coated tablet contains: Isotretinoin IP – 20 mg Excipients q.s. Colour: Yellow Oxide Of Iron Dose: As directed by the physician. |
| 504 | Paroxetine Tablets IP 10mg |
Each film-coated tablet contains: Paroxetine Hydrochloride Hemihydrate IP (eqv. To Paroxetine) – 10 mg Excipients q.s. Colour: Red Oxide Of Iron Dose: As directed by the physician. |
| 505 | Paroxetine Tablets IP 20mg |
Each Film-coated tablet contains: Paroxetine Hydrochloride Hemihydrate IP (eqv. To Paroxetine) – 20 mg Excipients q.s. Colour: Yellow Oxide Of Iron Dose: As directed by the physician. |
| 506 | Paroxetine Tablets IP 30mg |
Each Film-coated tablet contains: Paroxetine Hydrochloride Hemihydrate IP (eqv. To Paroxetine) – 30 mg Excipients q.s. Colour: Brilliant Blue FCF Dose: As directed by the physician. |
| 507 | Sumatriptan and Naproxen Tablets |
Each Film-coated bilayered tablet contains: Sumatriptan Succinate IP (eqv. To Sumatriptan) – 85 mg Naproxen Sodium (Eqv. To Naproxen) – 500 mg Excipients q.s. Colour: Red Oxide Of Iron Dose: As directed by the physician. |
| 508 | Acebrophylline Modified-release Tablets 200mg |
Each uncoated modified-release tablet contains: Acebrophylline – 200 mg Excipients q.s. Dose: As directed by the physician. |
| 509 | Doxofylline Tablets IP 200mg |
Each Film-coated tablet contains: Doxofylline IP – 200 mg Excipients q.s. Colour: Quinoline Yellow WS Dose: As directed by the physician. |
| 510 | Coral Calcium Tablets |
Each Film-coated tablet contains: Coral Calcium (From Coral Grains) IP (eqv. To elemental Calcium) – 250.00 mg (eqv. To elemental Magnesium) – 12.85 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 511 | Tranexamic Acid & Etamsylate Tablets |
Each Film-coated tablet contains: Tranexamic Acid IP – 500 mg Etamsylate BP – 250 mg Excipients q.s. Colour: Red Oxide Of Iron Dose: As directed by the physician. |
| 512 | Finasteride Tablets IP 1mg |
Each Film-coated tablet contains: Finasteride IP – 1 mg Excipients q.s. Colour: Titanium Dioxide IP Dose: As directed by the physician. |
| 513 | Dapagliflozin and Metformine Hydrochloride |
Each film-coated bilayered tablet contains: Modified-release Tabs Dapagliflozin Propanediol Monohydrate (Eqv. To Dapagliflozin) – 10 mg Metformine Hydrochloride IP (as modified-release) – 500 mg Excipients q.s. Colour: Yellow Oxide Of Iron Dose: As directed by the physician. |
| 514 | Baclofen Tablets IP 5 mg |
Each uncoated tablet contains: Baclofen IP – 5 mg Excipients q.s. Dose: As directed by the physician. |
| 515 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid Tablets |
Each film-coated tablet contains: Pyridoxine Hydrochloride, Thiamine Mononitrate, and Vitamin D3 Tablets Methylcobalamin IP – 1500 mcg Alpha Lipoic Acid USP – 100 mg Folic Acid IP – 1.5 mg Pyridoxine Hydrochloride IP – 3 mg Thiamine Mononitrate IP – 10 mg Vitamin D3 IP – 1000 IU Excipients q.s. Colour: Ponceau 4R & Titanium Dioxide IP Dose: As directed by the physician. Appropriate overages added. |
| 516 | Methylcobalamin, L-Methylfolate, and Pyridoxal-5 Phosphate Tablets |
Each film-coated tablet contains: Methylcobalamin IP – 1500 mcg L-Methylfolate Calcium – 1 mg Pyridoxal-5 Phosphate – 35 mg Excipients q.s. Colour: Ponceau 4R & Titanium Dioxide IP Dose: As directed by the physician. Appropriate overages added. |
| 517 | Sildenafil Tablets 150 mg |
Each film-coated tablet contains: Sildenafil Citrate BP (For Export) – 150 mg Excipients q.s. Colour: Titanium Dioxide IP |
| 518 | Sildenafil Tablets 200 mg |
Each film-coated tablet contains: Sildenafil Citrate BP (For Export) – 200 mg Excipients q.s. Colour: Brilliant Blue FCF |
| 519 | Paracetamol Tablets BP 500 mg |
Each uncoated tablet contains: Paracetamol BP (For Export) – 500 mg Excipients q.s. |
| 520 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine Hydrochloride, and Vitamin D3 Tablets |
Each film-coated tablet contains: Methylcobalamin IP – 1500 mcg Alpha Lipoic Acid USP – 100 mg Folic Acid IP – 1.5 mg Pyridoxine Hydrochloride IP – 3 mg Vitamin D3 IP – 1000 IU Excipients q.s. Colours: Ponceau 4R & Titanium Dioxide IP Dose: As directed by the physician. Appropriate overages added. |
| 521 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine Hydrochloride, and Thiamine Mononitrate Tablets |
Each film-coated tablet contains: Methylcobalamin IP – 1500 mcg Alpha Lipoic Acid USP – 100 mg Folic Acid IP – 1.5 mg Pyridoxine Hydrochloride IP – 3 mg Thiamine Mononitrate IP – 10 mg Excipients q.s. Colour: Ponceau 4R & Titanium Dioxide IP, Sunset Yellow Dose: As directed by the physician. Appropriate overages added. |
| 522 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine Hydrochloride, and Thiamine Mononitrate Tablets |
Each film-coated tablet contains: Methylcobalamin IP – 1500 mcg Alpha Lipoic Acid USP – 100 mg Folic Acid IP – 1.5 mg Pyridoxine Hydrochloride IP – 3 mg Thiamine Mononitrate IP – 10 mg Excipients q.s. Colour: Sunset Yellow FCF Dose: As directed by the physician. Appropriate overages added. |
| 523 | Amitriptyline Hydrochloride Tablets IP 10 mg |
Each film-coated tablet contains: Amitriptyline Hydrochloride IP – 10 mg Excipients q.s. Colour: Sunset Yellow FCF Dosage: As directed by the physician. |
| 524 | Amitriptyline Hydrochloride Tablets IP 25 mg |
Each film-coated tablet contains: Amitriptyline Hydrochloride IP – 25 mg Excipients q.s. Colour: Tartrazine Dosage: As directed by the physician. |
| 525 | Divalproex prolonged-release Tablets IP 250 mg |
Each film-coated prolonged-release tablet contains: Divalproex Sodium (Eqv. To Valproic Acid) – 250 mg Excipients q.s. Colour: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the physician. |
| 526 | Divalproex prolonged-release Tablets IP 500 mg |
Each film-coated prolonged-release tablet contains: Divalproex Sodium (Eqv. To Valproic Acid) – 500 mg Excipients q.s. Colour: Quinoline Yellow WS & Titanium Dioxide IP Dosage: As directed by the physician. |
| 527 | Calcitriol, Calcium Carbonate, and Zinc Tablets |
Each film-coated tablet contains: Calcitriol IP – 0.25 mcg Calcium Carbonate (Eqv. to elemental Calcium) – 500 mg Zinc Sulphate Monohydrate (Eqv. to elemental Zinc) – 7.5 mg Excipients q.s. Colour: Titanium Dioxide IP Dosage: As directed by the physician. |
| 528 | Levetiracetam Tablets IP 250 mg |
Each film-coated tablet contains: Levetiracetam IP – 250 mg Excipients q.s. Colour: Indigo Carmine & Titanium Dioxide IP Dosage: As directed by the physician. |
| 529 | Olanzapine Mouth Dissolving Tablets USP 5 mg |
Each uncoated mouth dissolving tablet contains: Olanzapine IP – 5 mg Excipients q.s. Colour: Quinoline Yellow WS Dosage: As directed by the physician. |
| 530 | Olanzapine Mouth Dissolving Tablets USP 10 mg |
Each uncoated mouth dissolving tablet contains: Olanzapine IP – 10 mg Excipients q.s. Colour: Brilliant Blue FCF Dosage: As directed by the physician. |
| 531 | Propranolol Tablets IP 20 mg |
Each uncoated tablet contains: Propranolol Hydrochloride IP – 20 mg Excipients q.s. Dosage: As directed by the physician. |
| 527 | Flunarizine Tablets 5mg |
Each uncoated tablet contains: Flunarizine Dihydrochloride BP (Eqv. To Flunarizine) – 5 mg Excipients q.s. Colour: Tartrazine Dosage: As directed by the physician. |
| 528 | Flunarizine Tablets 10mg |
Each uncoated tablet contains: Flunarizine Dihydrochloride BP (Eqv. To Flunarizine) – 10 mg Excipients q.s. Colour: Sunset Yellow FCF Dosage: As directed by the physician. |
| 529 | Metoprolol Succinate Prolonged-release and Amlodipine Tablets IP |
Each uncoated bilayered tablet contains: Metoprolol Succinate IP (Eqv. To Metoprolol Tartrate) – 47.5 mg Amlodipine Bisylate IP (Eqv. To Amlodipine) – 5 mg Excipients q.s. Colour: Ponceau 4R Dosage: As directed by the physician. |
| 530 | Telmisartan and Hydrochlorothiazide Tablets IP |
Each uncoated bilayered tablet contains: Telmisartan IP – 40 mg Hydrochlorothiazide IP – 12.5 mg Excipients q.s. Colour: Tartrazine Dosage: As directed by the physician. |
| 531 | L-Carnitine L-Tartrate Tablets 500mg |
Each film-coated tablet contains: L-Carnitine L-Tartrate – 500 mg Excipients q.s. Colour: Titanium Dioxide IP Dosage: As directed by the physician. |
| 532 | Paroxetine Prolonged-release Tablets IP 12.5mg |
Each film-coated prolonged-release tablet contains: Paroxetine Hydrochloride IP (Eqv. To Paroxetine) – 12.5 mg Excipients q.s. Colour: Yellow oxide of Iron & Titanium Dioxide IP Dosage: As directed by the physician. |
| 533 | Paroxetine Prolonged-release Tablets IP 25mg |
Each film-coated prolonged-release tablet contains: Paroxetine Hydrochloride IP (Eqv. To Paroxetine) – 25 mg Excipients q.s. Colour: Ponceau 4R and Titanium Dioxide IP Dosage: As directed by the physician. |
| 534 | Paroxetine Prolonged-release Tablets IP 37.5mg |
Each film-coated prolonged-release tablet contains: Paroxetine Hydrochloride IP (Eqv. To Paroxetine) – 37.5 mg Excipients q.s. Colour: Sunset Yellow FCF and Titanium Dioxide IP Dosage: As directed by the physician. |
| 535 | Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid, and Vitamin D3 Tablets |
Each film-coated tablet contains: Methylcobalamin IP – 1500 mcg Pyridoxine Hydrochloride IP – 3 mg Folic Acid IP – 5 mg Vitamin D3 IP – 1000 IU Excipients q.s. Colour: Ponceau 4R and Titanium Dioxide IP Dosage: As directed by the physician. |
| 536 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate Tablets |
Each uncoated tablet contains: Dexyromethorphan Hydrobromide IP – 10 mg Phenylephrine Hydrochloride IP – 5 mg Chlorpheniramine Maleate IP – 2 mg Excipients q.s. Colour: Quinoline Yellow WS Dosage: As directed by the physician. |
| 537 | Sitagliptin Phosphate Tablets IP 25 mg |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Eqv. To Sitagliptin) – 25 mg Excipients q.s. Colour: Titanium Dioxide IP Dosage: As directed by the physician. |
| 538 | Sitagliptin Phosphate Tablets IP 50 mg |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Eqv. To Sitagliptin) – 50 mg Excipients q.s. Colour: Quinoline Yellow WS Dosage: As directed by the physician. |
| 539 | Sitagliptin Phosphate Tablets IP 100 mg |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Eqv. To Sitagliptin) – 100 mg Excipients q.s. Colour: Sunset Yellow FCF Dosage: As directed by the physician. |
| 540 | Etoricoxib Tablets IP 120 mg |
Each film-coated tablet contains: Etoricoxib IP – 120 mg Excipients q.s. Colour: Yellow Oxide of Iron Dosage: As directed by the physician. |
| 541 | Mebeverine Hydrochloride Tablets IP 135mg |
Each film-coated tablet contains: Mebeverine Hydrochloride IP – 135 mg Excipients q.s. Colour: Yellow oxide of Iron Dosage: As directed by the Physician |
| 542 | Amiodarone Tablets IP 100mg |
Each uncoated tablet contains: Amiodarone Hydrochloride IP – 100 mg Dosage: As directed by the Physician |
| 543 | Teneligliptin and Metformin Hydrochloride Modified-release Tablets |
Each uncoated bilayered tablet contains: Teneligliptin Hydrochloride Hydrate (Equivalent to Teneligliptin) – 20 mg Metformin Hydrochloride IP (As Modified-release form) – 500 mg Excipients q.s. Colour: Yellow oxide of Iron Dosage: As directed by the Physician |
| 544 | Sitagliptin Phosphate and Metformin Hydrochloride Tablets |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Equivalent to Sitagliptin) – 25 mg Metformin Hydrochloride IP – 500 mg Excipients q.s. Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 545 | Sitagliptin Phosphate and Metformin Hydrochloride Tablets |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Equivalent to Sitagliptin) – 50 mg Metformin Hydrochloride IP – 500 mg Excipients q.s. Colour: Yellow oxide of Iron Dosage: As directed by the Physician |
| 546 | Sitagliptin Phosphate and Metformin Hydrochloride Tablets |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Equivalent to Sitagliptin) – 100 mg Metformin Hydrochloride IP – 500 mg Excipients q.s. Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 547 | Paracetamol and Mefenamic Acid Tablets |
Each uncoated tablet contains: Paracetamol IP – 325 mg Mefenamic Acid IP – 500 mg Excipients q.s. Colour: Tartrazine Dosage: As directed by the Physician |
| 548 | Rifaximin Tablets 550mg |
Each film-coated tablet contains: Rifaximin BP – 550 mg Excipients q.s. Colour: Sunset Yellow FCF & Titanium Dioxide Dosage: As directed by the Physician |
| 549 | Amiodarone Tablets IP 200mg |
Each uncoated tablet contains: Amiodarone Hydrochloride IP – 200 mg Excipients q.s. Dosage: As directed by the Physician |
| 550 | Azithromycin Tablets IP 500mg |
Each film-coated tablet contains: Azithromycin IP – 500 mg Excipients q.s. Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 551 | Milnacipran Hydrochloride Tablets 50mg |
Each film-coated tablet contains: Milnacipran Hydrochloride – 50 mg Excipients q.s. Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 552 | N-Acetylcysteine Tablets 600mg |
Each film-coated tablet contains: N-Acetylcysteine BP – 600 mg Excipients q.s. Colour: Red Oxide of Iron Dosage: As directed by the Physician |
| 553 | Diclofenac Sodium And Paracetamol Tablets |
Each uncoated tablet contains: Diclofenac Sodium IP – 50 mg Paracetamol IP – 325 mg Excipients q.s. Dosage: As directed by the Physician |
| 554 | Propranolol Tablets IP 40 mg |
Each uncoated tablet contains: Propranolol Hydrochloride IP – 40 mg Excipients q.s. Colour: Quinoline Yellow Dosage: As directed by the Physician |
| 555 | Terbinafine Tablets IP 250 mg |
Each uncoated tablet contains: Terbinafine Hydrochloride IP (Eq. to terbinafine) – 250 mg Excipients q.s. |
| 556 | Terbinafine Tablets IP 500 mg |
Each uncoated tablet contains: Terbinafine Hydrochloride IP (Eq. to terbinafine) – 500 mg Excipients q.s. |
| 557 | Calcium Carbonate, Vitamin D3, Methylcobalamine, L-Methylfolate, Calcium, and Pyridoxal-5-Phosphate Tablets |
Each film-coated tablet contains: Calcium Carbonate IP (Eqv. To elemental Calcium) – 500 mg Vitamin D3 IP – 2000 IU Methylcobalamin IP – 1500 mcg L-Methylfolate Calcium – 1 mg Pyridoxal-5-Phosphate – 20 mg Excipients q.s. Colour: Red oxide of Iron & Titanium Dioxide IP Appropriate overages added. Dosage: As directed by the physician |
| 558 | Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP |
Each film-coated tablet contains: Montelukast Sodium IP (eqv. to Montelukast) – 10 mg Levocetirizine Hydrochloride IP – 5 mg Excipients Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 569 | Diclofenac Sodium and Serratiopeptidase Tablets |
Each film-coated tablet contains: Diclofenac Sodium IP – 50 mg Serratiopeptidase IP – 10 mg (As gastro-resistant granules) Excipients Colour: Sunset yellow FCF Dosage: As directed by the Physician |
| 560 | Diclofenac Potassium and Serratiopeptidase Tablets |
Each film-coated tablet contains: Diclofenac Potassium IP – 50 mg Serratiopeptidase IP – 10 mg (As gastro-resistant granules) Excipients Colour: Brilliant Blue FCF Dosage: As directed by the Physician |
| 561 | Alprazolam and Propranolol Hydrochloride Tablets |
Each uncoated tablet contains: Alprazolam IP – 0.25 mg Propranolol Hydrochloride IP – 20 mg Excipients Dosage: As directed by the Physician |
| 562 | Tapentadol Tablets 50 mg |
Each film-coated tablet contains: Tapentadol Hydrochloride IP (eqv. to Tapentadol) – 50 mg Excipients Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 563 | Tapentadol Tablets 100 mg |
Each film-coated tablet contains: Tapentadol Hydrochloride IP (eqv. to Tapentadol) – 100 mg Excipients Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 564 | Diclofenac Gastro resistant tablets IP 50 mg |
Each Gastro-resistant tablet contains: Diclofenac Sodium IP – 50 mg Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 565 | Bethanechol Chloride Tablets USP 25mg |
Bethanechol Chloride USP – 25 mg Excipients Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 566 | Bethanechol Chloride Tablets USP 50mg |
Bethanechol Chloride USP – 50 mg Excipients Colour: Tartrazine Dosage: As directed by the Physician |
| 567 | Baclofen Tablets IP 20mg |
Each uncoated tablet contains: Baclofen IP – 20 mg Excipients Dosage: As directed by the Physician |
| 568 | Voglibose Dispersible Tablets 0.2 mg |
Each Uncoated dispersible tablet contains: Voglibose IP – 0.2 mg Excipients Dosage: As directed by the Physician |
| 569 | Voglibose Dispersible Tablets 0.3 mg |
Each Uncoated dispersible tablet contains: Voglibose IP – 0.3 mg Excipients Dosage: As directed by the Physician |
| 570 | Nitrofurantoin Sustained-release Tablets 100 mg |
Each film-coated Sustained-release tablet contains: Nitrofurantoin IP – 100 mg Excipients Colour: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 571 | Paracetamol, phenylephrine, caffeine and Chlorpheniramine maleate Tablets |
Each Uncoated tablet Contains: Paracetamol IP – 500 mg Phenylephrine Hydrochloride IP – 5 mg Caffeine (Anhydrous) IP – 30 mg Chlorpheniramine Maleate IP – 4 mg Excipients Colour: Tartrazine Dosage: As directed by the Physician |
| 572 | Etoricoxib Tablets IP 60 mg |
Each film-coated tablet contains: Etoricoxib IP – 60 mg Excipients Colours: Red Oxide of Iron and Titanium Dioxide IP Dosage: As directed by the Physician |
| 573 | Baclofen Sustained-release Tablets 30mg |
Each film-coated Sustain-release tablet contains: Baclofen IP – 30 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 574 | Nefopam Hydrochloride Tablets 30mg |
Each film-coated tablets contains: Nefopam Hydrochloride IP – 30 mg Excipients Colours: Red Oxide of Iron & Yellow oxide of iron Dosage: As directed by the Physician |
| 575 | Asprin gastro-resistant Tablets IP 75 mg |
Each Gastro-resistant tablet contains: Asprin IP – 75 mg Excipients Colour: Sunset Yellow FCF Dosages: As directed by the Physician |
| 576 | Methotrexate Tablets IP 7.5mg |
Each uncoated tablet contains: Methotrexate IP – 7.5 mg Excipients Dosages: As directed by the Physician |
| 577 | Methotrexate Tablets IP 10 mg |
Each uncoated tablet contains: Methotrexate IP – 10 mg Excipients Colour: Quinoline Yellow Dosages: As directed by the Physician |
| 578 | Levetiracetam Prolonged-release Tablets 1000 mg |
Each film-coated Prolonged-release tablet contains: Levetiracetam IP – 1000 mg Colour: Titanium Dioxide IP Excipients Dosages: As directed by the Physician |
| 579 | Rosuvastatin and fenofibarte Tablets IP |
Each film-coated tablets contains: Rosuvastatine Calcium IP (eqv. to Rosuvastatin) – 10 mg Fenofibrate IP – 160 mg Colour: Yellow oxide of iron Excipients Dosages: As directed by the Physician |
| 580 | Rosuvastatin and fenofibarte Tablets IP |
Each film-coated tablets contains: Rosuvastatine Calcium IP (eqv. to Rosuvastatin) – 20 mg Fenofibrate IP – 160 mg Colour: Red oxide of Iron Excipients Dosages: As directed by the Physician |
| 581 | Olmesartan Medoxomil Tablets IP 10 mg |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 10 mg Colour: Titanium Dioxide IP Excipients Dosages: As directed by the Physician |
| 582 | Diclofenac Gastro resistant tablets IP 50 mg |
Each Gastro-resistant tablet contains: (Not for Veterinary Use) Diclofenac Sodium IP – 50 mg Colour: Ponceau 4R Excipients Dosages: As directed by the Physician |
| 583 | Enalapril Maleate tablets IP 2.5 mg |
Each Uncoated tablet contains: Enalapril maleate IP – 2.5 mg Excipients Dosages: As directed by the Physician |
| 584 | Enalapril Maleate tablets IP 5 mg |
Each Uncoated tablet contains: Enalapril maleate IP – 5 mg Excipients Dosages: As directed by the Physician |
| 585 | Enalapril Maleate tablets IP 10 mg |
Each Uncoated tablet contains: Enalapril maleate IP – 10 mg Excipients Colour: Sunset Yellow FCF Dosages: As directed by the Physician |
| 586 | Gliclazide Tablets IP 40 mg |
Each Uncoated tablet contains: Gliclazide IP – 40 mg Excipients Dosages: As directed by the Physician |
| 587 | Ramipril Tablets 1.25 mg |
Each Uncoated tablets contains: Ramipril IP – 1.25 mg Excipients Dosages: As directed by the Physician |
| 588 | Ramipril and Hydrochlorothiazide Tablets IP |
Each Uncoated tablets contains: Ramipril IP – 2.5 mg Hydrochlorothiazide IP – 12.5 mg Excipients Dosages: As directed by the Physician |
| 589 | Ramipril and Hydrochlorothiazide Tablets IP |
Each Uncoated tablets contains: Ramipril IP – 5 mg Hydrochlorothiazide IP – 12.5 mg Excipients Colour: Tartrazine Dosages: As directed by the Physician |
| 590 | Telmisartan and Chlorthalidone Tablets |
Each uncoated bilayered tablet contains: Telmisartan IP – 40 mg Chlorthalidone IP – 6.25 mg Colour: Tartrazine Excipients Dosages: As directed by the Physician |
| 591 | Voglibose Dispersible Tablets IP 0.3 mg |
Each Uncoated Dispersible tablets contains: Voglibose IP – 0.3 mg Excipients Dosages: As directed by the Physician |
| 592 | Gliclazide Tablets IP 40 mg |
Each Uncoated tablet contains: Gliclazide IP – 40 mg Excipients Dosages: As directed by the Physician |
| 593 | Levetiracetam Prolonged-release Tablets 1000 mg |
Each film-coated Prolonged-release tablet contains: Levetiracetam IP – 1000 mg Colour: Titanium Dioxide IP Excipients Dosages: As directed by the Physician |
| 594 | Riboflavin, Folic Acid, Niacinamide and Lactic Acid Bacillus Spores Tablets |
Each Uncoated tablets contains: Roboflavin IP – 10 mg Folic Acid IP – 1.5 mg Niacinamide IP – 100 mg Lactic Acid Bacillus (60 million spores) Excipients Dosages: As directed by the Physician |
| 595 | Riboflavin, Folic Acid, Niacinamide, Biotin and Lactic Acid Bacillus Tablets |
Each Uncoated tablets contains: Roboflavin IP – 10 mg Folic Acid IP – 1.5 mg Niacinamide IP – 100 mg Biotin IP – 1 mg Lactic Acid Bacillus (60 million spores) Excipients Dosages: As directed by the Physician |
| 596 | Acebrophyllin, Desloratadine and Montelukast Tablets |
Each film-coated tablet contains: Acebrophylline (As Modified-release) – 200 mg Desloratadine BP – 5 mg Montelukast Sodium IP (eqv. to Montelukast) – 10 mg Excipients Colour: Quinoline Yellow Dosages: As directed by the Physician |
| 597 | Aciclovir Tablets IP 200mg |
Each Uncoated tablet contains: Aciclovir IP – 200 mg Excipients Dosage: As directed by the physician |
| 598 | Aciclovir Tablets IP 250mg |
Each Uncoated tablet contains: Aciclovir IP – 250 mg Excipients Dosage: As directed by the physician |
| 599 | Aciclovir Tablets IP 400mg |
Each Uncoated tablet contains: Aciclovir IP – 400 mg Excipients Dosage: As directed by the physician |
| 600 | Aciclovir Tablets IP 800mg |
Each Uncoated tablet contains: Aciclovir IP – 800 mg Excipients Dosage: As directed by the physician |
| 601 | Allopurinol Tablets IP 300mg |
Each Uncoated tablet contains: Allopurinol IP – 300 mg Excipients Dosage: As directed by the physician |
| 602 | Amiodarone Hydrochloride Tablets IP 100 mg |
Each Uncoated tablet contains: Amiodarone hydrochloride IP – 100 mg Excipients Dosage: As directed by the physician |
| 603 | Amiodarone Hydrochloride Tablets IP 200 mg |
Each Uncoated tablet contains: Amiodarone hydrochloride IP – 200 mg Excipients Dosage: As directed by the physician |
| 604 | Amitriptyline Hydrochloride Tablets IP 10 mg |
Each Uncoated tablet contains: Amitriptyline Hydrochloride IP – 10 mg Excipients Colour: Tartrazine Dosage: As directed by the physician |
| 605 | Amitriptyline Hydrochloride Tablets IP 50 mg |
Each Uncoated tablet contains: Amitriptyline Hydrochloride IP – 50 mg Excipients Colour: Sunset Yellow FCF Dosage: As directed by the physician |
| 606 | Amitriptyline Hydrochloride Tablets IP 75 mg |
Each Uncoated tablet contains: Amitriptyline Hydrochloride IP – 75 mg Excipients Colour: Brilliant Blue FCF Dosage: As directed by the physician |
| 607 | Amitriptyline Hydrochloride Tablets IP 100 mg |
Each Uncoated tablet contains: Amitriptyline Hydrochloride IP – 100 mg Excipients Colour: Sunset Yellow FCF Dosage: As directed by the physician |
| 608 | Atenolol Tablets IP 100 mg |
Each Uncoated tablet contains: Atenolol IP – 100 mg Excipients Dosage: As directed by the Physician |
| 609 | Atorvastatin 10 mg and Clopidogrel 75 mg Tablets |
Each film-coated tablets contains: Atorvastatin Calcium IP (Eqv. to Atorvastatin) – 10 mg Clopidogrel Bisulphate IP (Eqv. to Clopidogrel) – 75 mg Excipients Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 610 | Atorvastatin 20 mg and Clopidogrel 75 mg Tablets |
Each film-coated tablets contains: Atorvastatin Calcium IP (Eqv. to Atorvastatin) – 20 mg Clopidogrel Bisulphate IP (Eqv. to Clopidogrel) – 75 mg Excipients Colour: Red Oxide Of iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 611 | Azelnidipine Tablets IP 8 mg |
Each Uncoated tablet contains: Azelnidipine IP – 8 mg Excipients Dosage: As directed by the Physician |
| 612 | Azelnidipine Tablets IP 16 mg |
Each Uncoated tablet contains: Azelnidipine IP – 16 mg Excipients Dosage: As directed by the Physician |
| 613 | Azilsartan Medoxomil Tablets 40 mg |
Each Uncoated tablet contains: Azilsartan Kamedoxomil (Eqv. to Azilsartan Medoxomil) – 40 mg Excipients Dosage: As directed by the Physician |
| 614 | Bilastine Tablets 20 mg |
Each film-coated tablet contains: Bilastine IP – 20 mg Excipients Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 615 | Bilastine 20 mg and Montelukast 10 mg Tablets |
Each film-coated tablet contains: Bilastine IP – 20 mg Montelukast Sudium IP (Eqv. Montelukast) – 10 mg Excipients Colour: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 616 | Calcium Acetate Tablets 667 mg |
Each film-coated tablet contains: Calcium Acetate USP – 667 mg Excipients Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 617 | Candesartan Cilexetil Tablets IP 16 mg |
Each Uncoated tablet contains: Candesartan Cilexetil – 16 mg Excipients Dosage: As directed by the Physician |
| 618 | Candesartan Cilexetil Tablets IP 8 mg |
Each Uncoated tablet contains: Candesartan Cilexetil – 8 mg Excipients Dosage: As directed by the Physician |
| 619 | Candesartan Cilexetil Tablets IP 4 mg |
Each Uncoated tablet contains: Candesartan Cilexetil – 4 mg Excipients Dosage: As directed by the Physician |
| 620 | Clotrimazole Vaginal Tablets IP 100 mg |
Each Uncoated vaginal tablet contains: Clotrimazole IP – 100 mg Excipients Dosage: As directed by the Physician |
| 621 | Depoxetine Hydrochloride Tablets IP 30 mg |
Each film-coated tablet contains: Dapoxetine Hydrochloride IP (Eqv. to Dapoxetine) – 30 mg Colours: Brilliant Blue FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 622 | Enalapril Maleate 5 mg and Hydrochlorothiazide 12.5 mg Tablets |
Each film-coated tablet contains: Enalapril maleate IP – 5 mg Hydrochlorothiazide IP – 12.5 mg Excipients Colours: Tartrazine & Titanium Dioxide IP Dosage: As directed by the Physician |
| 623 | Enalapril Maleate Tablets IP 2.5 mg |
Each Uncoated tablet contains: Enalapril maleate IP – 2.5 mg Excipients Dosages: As directed by the Physician |
| 624 | Enalapril Maleate tablets IP 10 mg |
Each Uncoated tablet contains: Enalapril maleate IP – 10 mg Excipients Colours: Sunset Yellow FCF Dosage: As directed by the Physician |
| 625 | Enalapril Maleate tablets IP 5 mg |
Each Uncoated tablet contains: Enalapril maleate IP – 5 mg Excipients Colours: Quinoline Yellow WS Dosage: As directed by the Physician |
| 626 | Fenofibrate Tablets IP 200 mg |
Each film-coated tablet contains: Fenofibrate IP – 200 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 627 | Glibenclamide Tablets IP 10 mg |
Each Uncoated tablet contains: Glibenclamide IP – 10 mg Excipients Dosage: As directed by the Physician |
| 628 | Metformin Hydrochloride Prolonged-release 1000 mg and Glimepiride 0.5 mg Tablets |
Each uncoated bilayered tablet contains: Metformin Hydrochloride IP – 1000 mg (As Prolonged-release) Glimepiride IP – 0.5 mg Excipients Colours: Tartrazine Dosage: As directed by the Physician |
| 629 | Metformin Hydrochloride Prolonged-release 500 mg and Glimepiride 0.5 mg Tablets |
Each uncoated bilayered tablet contains: Metformin Hydrochloride IP – 500 mg (As Prolonged-release) Glimepiride IP – 0.5 mg Excipients Colours: Sunset Yellow FCF Dosage: As directed by the Physician |
| 630 | Hydrochlorothiazide Tablets IP 12.5 mg Tabs |
Each Uncoated tablet contains: Hydrochlorothiazide IP – 12.5 mg Excipients Dosage: As directed by the Physician |
| 631 | Hydroxychloroquine Tablets IP 200 mg |
Each film-coated tablet contains: Hydroxychloroquine Sulphate IP – 200 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 632 | Isoxsuprine Hydrochloride Tablets IP 10 mg |
Each Uncoated tablet contains: Isoxsuprine Hydrochloride IP – 10 mg Excipients Dosage: As directed by the Physician |
| 633 | Itopride Hydrochloride Tablets IP 50 mg |
Each Uncoated tablet contains: Itopride Hydrochloride – 50 mg Excipients Dosage: As directed by the Physician |
| 634 | Ivermectin Tablets IP 3 mg |
Each Uncoated tablet contains: Ivermectin IP – 3 mg Excipients Dosage: As directed by the Physician |
| 635 | Lamotrigine Dispersible tablets IP 100 mg |
Each Uncoated Dispersible tablet contains: Lamotrigine IP – 100 mg Excipients Dosage: As directed by the Physician |
| 636 | Lamotrigine Dispersible tablets IP 25 mg |
Each Uncoated Dispersible tablet contains: Lamotrigine IP – 25 mg Excipients Dosages: As directed by the Physician |
| 637 | Lamotrigine Dispersible tablets IP 50 mg |
Each Uncoated Dispersible tablet contains: Lamotrigine IP – 50 mg Excipients Dosage: As directed by the Physician |
| 638 | Levosulpiride Tablets 75 mg |
Each Uncoated tablet contains: Levosulpiride – 75 mg Excipients Dosage: As directed by the Physician |
| 639 | Lisinopril Tablets IP 10 mg |
Each Uncoated tablet contains: Lisinopril IP – 10 mg (As anhydrous) Excipients Dosage: As directed by the Physician |
| 640 | Lisinopril Tablets IP 20 mg |
Each Uncoated tablet contains: Lisinopril IP – 20 mg (As anhydrous) Excipients Dosage: As directed by the Physician |
| 641 | Losartan Tablets IP 100 mg |
Each film-coated tablet contains: Losartan Potassium IP – 100 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 642 | Meloxicam Tablets BP 15 mg |
Each Uncoated tablet contains: Meloxicam IP – 15 mg Excipients Colours: Tartrazine Dosage: As directed by the Physician |
| 643 | Meloxicam Tablets BP 7.5 mg |
Each Uncoated tablet contains: Meloxicam IP – 7.5 mg Excipients Dosages: As directed by the Physician |
| 644 | Memantine Hydrochloride Tablets IP 10 mg |
Each film-coated tablet contains: Memantine Hydrochloride IP – 10 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 645 | Memantine Hydrochloride Tablets IP 5 mg |
Each film-coated tablet contains: Memantine Hydrochloride IP – 5 mg Excipients Colours: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 646 | Metformin Hydrochloride Tablets IP 500 mg |
Each Uncoated tablet contains: Metformin Hydrochloride IP – 500 mg Excipients Dosage: As directed by the Physician |
| 647 | Montelukast Sodium Tablets IP 5 mg |
Each film-coated tablet contains: Montelukast Sodium IP – 5 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 638 | Levosulpiride Tablets 75 mg |
Each Uncoated tablet contains: Levosulpiride – 75 mg Excipients Dosage: As directed by the Physician |
| 639 | Lisinopril Tablets IP 10 mg |
Each Uncoated tablet contains: Lisinopril IP – 10 mg (As anhydrous) Excipients Dosage: As directed by the Physician |
| 640 | Lisinopril Tablets IP 20 mg |
Each Uncoated tablet contains: Lisinopril IP – 20 mg (As anhydrous) Excipients Dosage: As directed by the Physician |
| 641 | Losartan Tablets IP 100 mg |
Each film-coated tablet contains: Losartan Potassium IP – 100 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 642 | Meloxicam Tablets BP 15 mg |
Each Uncoated tablet contains: Meloxicam IP – 15 mg Excipients Colours: Tartrazine Dosage: As directed by the Physician |
| 643 | Meloxicam Tablets BP 7.5 mg |
Each Uncoated tablet contains: Meloxicam IP – 7.5 mg Excipients Dosages: As directed by the Physician |
| 644 | Memantine Hydrochloride Tablets IP 10 mg |
Each film-coated tablet contains: Memantine Hydrochloride IP – 10 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 645 | Memantine Hydrochloride Tablets IP 5 mg |
Each film-coated tablet contains: Memantine Hydrochloride IP – 5 mg Excipients Colours: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 646 | Metformin Hydrochloride Tablets IP 500 mg |
Each Uncoated tablet contains: Metformin Hydrochloride IP – 500 mg Excipients Dosage: As directed by the Physician |
| 647 | Montelukast Sodium Tablets IP 5 mg |
Each film-coated tablet contains: Montelukast Sodium IP – 5 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 648 | Moxifloxacin Hydrochloride Tablets 400 mg |
Each film-coated tablet contains: Moxifloxacin Hydrochloride IP – 400 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 649 | Nicoumalone Tablets IP 1 mg |
Each Uncoated tablet contains: Nicoumalone IP – 1 mg Excipients Dosages: As directed by the Physician |
| 650 | Nicoumalone Tablets IP 3 mg |
Each Uncoated tablet contains: Nicoumalone IP – 3 mg Excipients Dosage: As directed by the Physician |
| 651 | Nicoumalone Tablets IP 4 mg |
Each Uncoated tablet contains: Nicoumalone IP – 4 mg Excipients Dosage: As directed by the Physician |
| 652 | Cilnidipine 10 mg and Olmisartan Medoxomil 20 mg Tablets |
Each film-coated tablet contains: Cilnidipine IP – 10 mg Olmisartan Medoxomil IP – 20 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosages: As directed by the Physician |
| 653 | Cilnidipine 10 mg and Olmisartan Medoxomil 40 mg Tablets |
Each film-coated tablet contains: Cilnidipine IP – 10 mg Olmisartan Medoxomil IP – 40 mg Colours: Yellow Oxide of Iron and Titanium Dioxide IP Dosage: As directed by the Physician |
| 654 | Metoprolol Succinate Modified release and Olmisartan Medoxomil Tablets |
Each film-coated Modified-release tablet contains: Metoprolol Succinate IP – 47.5 mg (Eqv. to Metopralol tatrate 50 mg) Olmisartan Medoxomil IP – 40 mg Excipients Colours: Sunset yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 655 | Omeprazole Magnesium Tablets 40 mg |
Each gastro-resistant tablet contains: Omeprazole Magnesium USP – 40 mg (Eqv. to Omeprazole) Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 656 | Cilnidipine, Olmisartan medoxomil and Clorthalidone Tablets |
Each film-coated tablet contains: Cilnidipine IP – 10 mg Olmisartan Medoxomil IP – 20 mg Clorthalidone IP – 12.5 mg Excipients Colours: Brilliant Blue FCF and Titanium Dioxide Dosage: As directed by the Physician |
| 657 | Paroxetine Tablets IP 12.5 mg |
Each film-coated tablet contains: Paroxetine Hydrochloride Hemihydrate IP (Eqv. to Paroxetine) – 12.5 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 658 | Paroxetine Tablets IP 25 mg |
Each film-coated tablet contains: Paroxetine Hydrochloride Hemihydrate IP (Eqv. to Paroxetine) – 25 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 659 | Paroxetine Tablets IP 37.5 mg |
Each film-coated tablet contains: Paroxetine Hydrochloride Hemihydrate IP (Eqv. to Paroxetine) – 37.5 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 660 | Amlodipine 10 mg and Perindopril 4 mg Tablets |
Each Uncoated tablet contains: Amlodipine Besylate IP (Eqv. to Amlodipine) – 10 mg Perindopril erbrumine IP – 4 mg Excipients Dosage: As directed by the Physician |
| 661 | Amlodipine 10 mg and Perindopril 8 mg Tablets |
Each Uncoated tablet contains: Amlodipine Besylate IP (Eqv. to Amlodipine) – 10 mg Perindopril erbrumine IP – 8 mg Excipients Dosage: As directed by the Physician |
| 662 | Phenytoin Sodium Tablets IP 50 mg |
Each film-coated tablet contains: Phenytoin sodium IP – 50 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 663 | Piracetam Tablets 1200 mg |
Each film-coated tablet contains: Piracetam IP – 1200 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 664 | Piracetam Tablets 400 mg |
Each film-coated tablet contains: Piracetam IP – 400 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 665 | Propranolol Hydrochloride Tablets IP 10 mg |
Each Uncoated tablet contains: Propranolol Hydrochloride IP – 10 mg Excipients Dosage: As directed by the Physician |
| 666 | Sodium Picosulphate Tablets 10 mg |
Each Uncoated tablet contains: Sodium Picosulphate BP – 10 mg Excipients Dosage: As directed by the Physician |
| 667 | Telmisartan 80 mg and Chlorthalidone 12.5 mg Tablets |
Each Uncoated tablet contains: Telmisartan IP – 80 mg Chlorthalidone IP – 12.5 mg Excipients Dosage: As directed by the Physician |
| 668 | Valsartan Tablets IP 40 mg |
Each film-coated tablet contains: Valsartan IP – 40 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 669 | Valsartan Tablets IP 80 mg |
Each film-coated tablet contains: Valsartan IP – 80 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 670 | Zolpidem Tartrate tablets BP 10 mg |
Each film-coated tablet contains: Zolpidem Tartrate BP – 10 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 671 | Tamsulosin Hydrochloride Modified-release Tablets 0.4 mg |
Each film-coated tablet contains: Tamsulosin Hydrochloride IP – 0.4 mg (As Modified-release) Dutasteride IP – 0.5 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 672 | Rifaximin and Metronidazole Tablets |
Each film-coated tablet contains: Rifaximin BP – 200 mg Metronidazole Benzoate IP (Eqv. to Metronidazole) – 400 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 673 | Omeprazole Magnesium Tablets |
Each gastro-resistant tablet contains: Omeprazole Magnesium USP (Eqv. to Omeprazole) – 20 mg Excipients Colours: Sunset Yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 674 | Omeprazole Magnesium and Domeperidone Tablets |
Each gastro-resistant tablet contains: Omeprazole Magnesium USP (Eqv. to Omeprazole) – 20 mg Domeperidone IP – 10 mg Colours: Brilliant Blue FCF and Titanium Dioxide IP Excipients Dosage: As directed by the Physician |
| 675 | Amlodipine Besylate Tablets IP 2.5 mg |
Each Uncoated tablet contains: Amlodipine Besylate IP (Eqv. to Amlodipine) – 2.5 mg Excipients Dosage: As directed by the Physician |
| 676 | Bisoprolol Fumarate and Hydrochlorothiazide Tablets IP |
Each film-coated tablet contains: Bisoprolol Fumarate IP – 5 mg Hydrochlorothiazide IP – 6.25 mg Excipients Colours: Sunset Yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 677 | Amlodipine and Hydrochlorothiazide Tablets |
Each film-coated tablet contains: Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Hydrochlorothiazide IP – 12.5 mg Colours: Titanium Dioxide IP Excipients Dosage: As directed by the Physician |
| 678 | Acarbose Tablets IP 50 mg |
Each Uncoated tablet contains: Acarbose IP – 50 mg Excipients Dosage: As directed by the Physician |
| 679 | Fenofibrate Tablets IP 160 mg |
Each film-coated tablet contains: Fenofibrate IP – 160 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 680 | Amlodipine Besylate Tablets IP 5 mg |
Each Uncoated tablet contains: Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Excipients Dosage: As directed by the Physician |
| 681 | Losartan Potassium Tablets IP 25 mg |
Each film-coated tablet contains: Losartan Potassium IP – 25 mg Excipients Colours: Sunset Yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 682 | Digoxin Tablets IP 0.25 mg |
Each Uncoated tablet contains: Digoxin IP – 0.25 mg Excipients Dosage: As directed by the Physician |
| 683 | Cinnarizine Tablets IP 25 mg |
Each Uncoated tablet contains: Cinnarizine IP – 25 mg Excipients Dosage: As directed by the Physician |
| 684 | Lisinopril Tablets IP 2.5 mg |
Each Uncoated tablet contains: Lisinopril IP (Eqv. to Anhydrous Lisinopril) – 2.5 mg Excipients Dosage: As directed by the Physician |
| 685 | Lisinopril Tablets IP 5 mg |
Each Uncoated tablet contains: Lisinopril IP (Eqv. to Anhydrous Lisinopril) – 5 mg Excipients Dosage: As directed by the Physician |
| 686 | Lisinopril and Amlodipine Besylate Tablets IP |
Each Uncoated tablet contains: Lisinopril IP (Eqv. to Anhydrous Lisinopril) – 5 mg Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Excipients Dosage: As directed by the Physician |
| 687 | Metformin Hydrochloride Tablets IP 850 mg |
Each uncoated tablet contains: Metformin Hydrochloride IP – 850 mg Excipients Dosage: As directed by the Physician |
| 688 | Fenofibrate Tablets IP 145 mg |
Each film-coated tablet contains: Fenofibrate IP – 145 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 689 | Chlorthalidone Tablets IP 12.5 mg |
Each film-coated tablet contains: Chlorthalidone IP – 12.5 mg Excipients Colours: Sunset Yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 690 | Atorvastatin Tablets IP 5 mg |
Each film-coated tablet contains: Atorvastatin Calcium IP (Eqv. to Atorvastatin) – 5 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 691 | Azathioprine Tablets IP 50 mg |
Each Uncoated tablet contains: Azathioprine IP – 50 mg Excipients Dosage: As directed by the Physician |
| 692 | Bisoprolol Fumarate Tablets USP 2.5 mg |
Each uncoated tablet contains: Bisoprolol Fumarate IP – 2.5 mg Excipients Dosage: As directed by the Physician |
| 693 | Benidipine Hydrochloride Tablets 4 mg |
Each film-coated tablet contains: Benidipine Hydrochloride – 4 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 694 | Donepezil Hydrochloride Tablets IP 5 mg |
Each film-coated tablet contains: Donepezil Hydrochloride – 5 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 695 | Alfuzosin Hydrochloride Extended-release Tablets IP 10 mg |
Each film-coated Extended-release tablet contains: Alfuzosin Hydrochloride IP – 10 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 696 | Glucosamine Tablets USP 500 mg |
Each film-coated tablet contains: Glucosamine Sulphate Potassium Chloride USP – 500 mg (Eqv. to Glucosamine – 296 mg) Excipients Colours: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 697 | Glibenclamide, Metformin and Pioglitazone Tablets |
Each film-coated tablet contains: Glibenclamide IP – 5 mg Metformin Hydrochloride IP – 500 mg Pioglitazone Hydrochloride IP (Eqv. to Pioglitazone) – 15 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 698 | Chlorthalidone Tablets IP 6.25 mg |
Each film-coated tablet contains: Chlorthalidone IP – 6.25 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 699 | Benidipine Hydrochloride Tablets 8 mg |
Each film-coated tablet contains: Benidipine Hydrochloride IP – 8 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 700 | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 20 mg Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Hydrochlorothiazide IP – 12.5 mg Excipients Colours: Sunset Yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 701 | Moxonidine Tablets 0.3 mg |
Each film-coated tablet contains: Moxonidine BP – 0.3 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 702 | Glipizide Tablets IP 5 mg |
Each uncoated tablet contains: Glipizide IP – 5 mg Excipients Dosage: As directed by the Physician |
| 703 | Moxonidine Tablets 0.2 mg |
Each film-coated tablet contains: Glipizine IP – 0.2 mg Excipients Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 704 | Nebivolol Hydrochloride and Amlodipine Tablets |
Each uncoated tablet contains: Nebivolol Hydrochloride IP (Eqv. to Nebivolol) – 5 mg Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Excipients Dosage: As directed by the Physician |
| 705 | Frusemide and Spironolactone Tablets |
Each film-coated tablet contains: Frusemide IP – 20 mg Spironolactone IP – 50 mg Excipients Colour: Titanium Dioxide IP |
| 706 | Pioglitazone and Metformine Hydrochloride |
Each uncoated bilayered Tablet contains: (Sustained-release) Tablets Pioglitazone Hydrochloride IP – Eqv. to Pioglitazone – 15 mg Metformin Hydrochloride IP – 500 mg (Sustained-release form) Excipients qs Colour: Red oxide of Iron Dosage: As directed by the Physician |
| 707 | Montelukast Sodium Tablets IP 10 mg |
Each film-coated tablet contains: Montelukast Sodium IP – Eqv. to Montelukast – 10 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 708 | Nebivolol Tablets IP 2.5 mg |
Each uncoated tablet contains: Nebivolol Hydrochloride IP – Eqv. to Nebivolol – 2.5 mg Excipients qs Dosage: As directed by the Physician |
| 709 | Nebivolol Tablets IP 5 mg |
Each uncoated tablet contains: Nebivolol Hydrochloride IP – Eqv. to Nebivolol – 5.0 mg Excipients qs Dosage: As directed by the Physician |
| 710 | Glibenclamide and Metformin Hydrochloride |
Each uncoated tablet contains: Glibenclamide IP – 5 mg Metformin Hydrochloride IP – 500 mg Excipients qs Dosage: As directed by the Physician |
| 711 | Levetiracetam Tablets IP 500 mg |
Each film-coated tablet contains: Levetiracetam IP – 500 mg Excipients qs Colours: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 712 | Topiramate Tablets IP 25 mg |
Each film-coated tablet contains: Tipiramate IP – 25 mg Excipients qs Colours: Indigo Carmine and Titanium Dioxide IP Dosage: As directed by the Physician |
| 713 | Ornidazole Tablets IP 5 mg |
Each film-coated tablet contains: Ornidazole IP – 5 mg Excipients qs Colours: Quinoline Yellow WS and Titanium Dioxide IP Dosage: As directed by the Physician |
| 714 | Vildagliptin & Metformin Hydrochloride |
Each film-coated tablet contains: Vildagliptin IP – 50 mg Metformin Hydrochloride IP – 850 mg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 715 | Cilnidipine Tablets IP 5 mg |
Each film-coated tablet contains: Cilnidipine IP 5 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 716 | Sitagliptin & Metformin Hydrochloride Tablets |
Each film-coated tablet contains: Sitagliptin Phosphate Monohydrate IP (Eqv. to Sitagliptin) – 50 mg Metformin Hydrochloride IP – 1000 mg Excipients Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 717 | Cilostazol Tablets IP 50 mg |
Each uncoated tablet contains: Cilostazol IP 50 mg Excipients qs Dosage: As directed by the Physician |
| 718 | Losartan Potassium Tablets IP 50 mg |
Each film-coated tablet contains: Losartan Potassium IP 50 mg Excipients qs Colours: Sunset yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 719 | Labetalol Hydrochloride Tablets IP 100 mg |
Each film-coated tablet contains: Labetalol Hydrochloride IP 100 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 720 | Telmisartan and Cilnidipine Tablets |
Each film-coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 12.5 mg Excipients qs Colours: Sunset yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 721 | Hydrochlorothiazide Tablets IP 25 mg |
Each uncoated tablet contains: Hydrochlorothiazide IP 25 mg Excipients qs Dosage: As directed by the Physician |
| 722 | Teneligliptin and Metformin Hydrochloride (ER) Tablets |
Each uncoated bilayered tablet contains: Teneligliptin Hydrobromide hydrate IP (Eqv. to Teneligliptin) – 20 mg Metformin Hydrochloride IP (as Extended-release) – 500 mg Excipients qs Colours: Ponceau 4R & Titanium Dioxide IP Dosage: As directed by the Physician |
| 723 | Leflunomide Tablets IP 10 mg |
Each film-coated tablet contains: Leflunomide IP 10 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 724 | Bisoprolol Fumarate and Hydrochlorothiazide |
Each film-coated tablet contains: Tablets IP Bisoprolol Fumarate IP – 2.5 mg Hydrochlorothiazide IP – 6.25 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 725 | Pantoprazole gastro-resistant Tablets IP 20 mg |
Each gastro-resistant Tablets contains: Pantoprazole Sodium IP – Eqv. to Pantoprazole – 20 mg Excipients qs Colours: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 726 | Nebivolol and Hydrochlorothiazide Tablets IP |
Each uncoated tablet contains: Nebivolol Hydrochloride IP – Eqv. to Nebivolol – 5 mg Hydrochlorothiazide IP – 12.5 mg Excipients qs Dosage: As directed by the Physician |
| 727 | Esomeprazole gastro-resistant Tablets IP 20 mg |
Each gastro-resistant Tablets contains: Esomeprazole magnesium Trihydarate IP – Eqv. to Esomeprazole – 20 mg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 728 | Methylcobalamin tablets 1500 mcg |
Each film-coated tablet contains: Methylcobalamin IP – 1500 mcg Excipients qs Colours: Sunset yellow FCF and Titanium Dioxide IP Dosage: As directed by the Physician |
| 729 | Tolvaptan Tablets 15 mg |
Each uncoated tablet contains: Tolvaptan IP – 15 mg Excipients qs Dosage: As directed by the Physician |
| 730 | Amlodipine Besylate Tablets IP 2.5 mg |
Each uncoated tablet contains: Amlodipine Besylate IP – Eqv. to Amlodipine – 2.5 mg Excipients qs Dosage: As directed by the Physician |
| 731 | Amlodipine Besylate Tablets IP 5 mg |
Each uncoated tablet contains: Amlodipine Besylate IP – Eqv. to Amlodipine – 5 mg Excipients qs Dosage: As directed by the Physician |
| 732 | Bisoprolol Fumarate Tablets USP 5 mg |
Each uncoated tablet contains: Bisoprolol Fumarate IP – 5 mg Excipients qs Dosage: As directed by the Physician |
| 733 | Ranolazine Extended-release Tablets 500 mg |
Each film-coated Extended-release tablet contains: Ranolazine – 500 mg Excipients qs Colours: Yellow Oxide of Iron and Titanium Dioxide IP Dosage: As directed by the Physician |
| 734 | Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 40 mg Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Hydrochlorothiazide IP – 12.5 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 735 | Acarbose Tablets IP 25 mg |
Each uncoated tablet contains: Acarbose IP 25 mg Excipients qs Dosage: As directed by the Physician |
| 736 | Glimepiride Tablets IP 3 mg |
Each uncoated tablet contains: Glimepiride IP 3 mg Excipients qs Colour: Yellow Oxide of Iron Dosage: As directed by the Physician |
| 737 | Levetiracetam Tablets IP 750 mg |
Each film-coated tablet contains: Levetiracetam IP 750 mg Excipients qs Colours: Yellow Oxide of Iron and Titanium Dioxide IP Dosage: As directed by the Physician |
| 738 | Cilostazol Tablets IP 100 mg |
Each uncoated tablet contains: Cilostazol IP 100 mg Excipients qs Colour: Yellow Oxide of Iron Dosage: As directed by the Physician |
| 739 | Ferrous Ascorbate, Folic Acid, Zinc Sulphate, and Cyanocobalamin Tablets |
Each film-coated tablet contains: Ferrous Ascorbate IP (Eqv. to Elemental Iron) – 100 mg Folic acid – 1.5 mg Zinc Sulphate Monohydrate (Eqv. to elemental Zinc) – 22.5 mg Cyanocobalamin IP – 15 mcg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 740 | Vildagliptin & Metformin Hydrochloride Tablets |
Each film-coated tablet contains: Vildagliptin IP – 50 mg Metformin Hydrochloride IP – 1000 mg Excipients qs Colours: Red Oxide of Iron, Yellow Oxide of Iron, and Titanium Dioxide IP Dosage: As directed by the Physician |
| 741 | Olmesartan Medoxomil and Amlodipine Tablets |
Each film-coated tablet contains: Olmesartan Medoxomil IP – 40 mg Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 742 | Cilnidipine Tablets IP 10 mg |
Each film-coated tablet contains: Cilnidipine IP – 10 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 743 | Hydroxyzine Hydrochloride Tablets IP 10 mg |
Each film-coated tablet contains: Hydroxyzine Hydrochloride IP – 10 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 744 | Metformin Hydrochloride Tablets IP 500 mg |
Each uncoated tablet contains: Metformin Hydrochloride IP – 500 mg Excipients qs Dosage: As directed by the Physician |
| 745 | Teneligliptin Hydrobromide Hydrate tablets |
Each film-coated tablet contains: Tablets IP Teneligliptin Hydrobromide hydrate IP – Eqv. to Teneligliptin – 20 mg Excipients qs Colours: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 746 | Ivabradine tablets 5 mg |
Each film-coated tablet contains: Ivabradine Hydrochloride IP – Eqv. to Ivabradine – 5 mg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 747 | Prasugrel Tablets 10 mg |
Each film-coated tablet contains: Prasugrel Hydrochloride IP – Eqv. to Prasugrel – 10 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 748 | Torsemide Tablets IP 40 mg |
Each uncoated tablet contains: Torsemide IP – 40 mg Excipients qs Dosage: As directed by the Physician |
| 749 | Pioglitazone Hydrochloride Tablets IP 30 mg |
Each uncoated tablet contains: Pioglitazone Hydrochloride IP – Eqv. to Pioglitazone – 30 mg Excipients qs Dosage: As directed by the Physician |
| 750 | Telmisartan 80 mg & Amlodipine 5 mg Tablets IP |
Each film-coated tablet contains: Telmisartan IP – 80 mg Amlodipine Besylate IP – Eqv. to Amlodipine – 5 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 751 | Torsemide and Spironolactone Tablets |
Each uncoated tablet contains: Torsemide IP – 5 mg Spironolactone IP – 50 mg Excipients qs Dosage: As directed by the Physician |
| 752 | Tamsulosin Hydrochloride and Dutasteride |
Each film-coated tablet contains: Tablets IP Tamsulosin IP – 0.4 mg Dutasteride IP – 0.5 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 753 | Atenolol Tablets IP 25 mg |
Each uncoated tablet contains: Atenolol IP 25 mg Excipients qs Dosage: As directed by the Physician |
| 754 | Glipizide and Metformin Hydrochloride Tablets |
Each uncoated tablet contains: Glipizide IP 5 mg Metformin Hydrochloride IP 500 mg Excipients qs Dosage: As directed by the Physician |
| 755 | Prazosin Hydrochloride Tablets IP 1 mg |
Each film-coated tablet contains: Prazosin Hydrochloride IP 1 mg (Eqv. to Prazosin) Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 756 | Prazosin Hydrochloride Tablets IP 2 mg |
Each film-coated tablet contains: Prazosin Hydrochloride IP 2 mg (Eqv. to Prazosin) Excipients qs Colour: Ponceau 4R and Titanium Dioxide IP Dosage: As directed by the Physician |
| 757 | Prazosin Hydrochloride Tablets IP 5 mg |
Each film-coated tablet contains: Prazosin Hydrochloride IP 5 mg (Eqv. to Prazosin) Excipients qs Colour: Red oxide of Iron and Titanium Dioxide IP Dosage: As directed by the Physician |
| 758 | Naproxen Tablets IP 500 mg |
Each film-coated tablet contains: Naproxen IP 500 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 759 | Escitalopram Tablets IP 20 mg |
Each film-coated tablet contains: Escitalopram Oxalate (Eqv. to Escitalopram) – 20 mg Excipients qs Colours: Brilliant Blue FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 760 | Metformin Hydrochloride Prolonged-release 500 mg and Glimepiride 3 mg Tablets IP |
Each uncoated bilayered Tablet contains: Metformin Hydrochloride IP 500 mg (As Prolonged-release) Glimepiride IP 3 mg Excipients qs Colour: Ponceau 4R Dosage: As directed by the Physician |
| 761 | Metformin Hydrochloride Prolonged-release 500 mg and Glimepiride 4 mg Tablets IP |
Each uncoated bilayered Tablet contains: Metformin Hydrochloride IP 500 mg (As Prolonged-release) Glimepiride IP 4 mg Excipients qs Colour: Erythrosine Dosage: As directed by the Physician |
| 762 | Metformin Hydrochloride Prolonged-release |
Each uncoated bilayered Tablet contains: 1000 mg and Glimepiride 3 mg Tablets IP Metformin Hydrochloride IP – 1000 mg (As Prolonged-release) Glimepiride IP – 3 mg Excipients qs Colour: Ponceau 4R Dosage: As directed by the Physician |
| 763 | Metformin Hydrochloride Prolonged-release |
Each uncoated bilayered Tablet contains: 1000 mg and Glimepiride 4 mg Tablets IP Metformin Hydrochloride IP – 1000 mg (As Prolonged-release) Glimepiride IP – 4 mg Excipients qs Colour: Erythrosine Dosage: As directed by the Physician |
| 764 | Metformin Hydrochloride Prolonged-release |
Each uncoated bilayered Tablet contains: 850 mg and Glimepiride 1 mg Tablets IP Metformin Hydrochloride IP – 850 mg (As Prolonged-release) Glimepiride IP – 1 mg Excipients qs Colour: Ponceau 4R Dosage: As directed by the Physician |
| 765 | Metformin Hydrochloride Prolonged-release |
Each uncoated bilayered Tablet contains: 850 mg and Glimepiride 2 mg Tablets IP Metformin Hydrochloride IP – 850 mg (As Prolonged-release) Glimepiride IP – 2 mg Excipients qs Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 766 | Metformin Hydrochloride Prolonged-release |
Each uncoated bilayered Tablet contains: 850 mg and Glimepiride 4 mg Tablets IP Metformin Hydrochloride IP – 850 mg (As Prolonged-release) Glimepiride IP – 4 mg Excipients qs Colour: Brilliant Blue FCF Dosage: As directed by the Physician |
| 767 | Atorvastatin 20 mg and Clopidogrel 150 mg |
Each film-coated tablet contains: Atorvastatin Calcium IP – Eqv. to Atorvastatin – 20 mg Clopidogrel Bisulphate IP – Eqv. to Clopidogrel – 150 mg Excipients qs Colours: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 768 | Atorvastatin 10 mg and Clopidogrel 150 mg |
Each film-coated tablet contains: Atorvastatin Calcium IP – Eqv. to Atorvastatin – 10 mg Clopidogrel Bisulphate IP – Eqv. to Clopidogrel – 150 mg Excipients qs Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 769 | Melatonin Tablets 3 mg |
Each uncoated tablet contains: Melatonin BP – 3 mg Excipients qs Colour: Quinoline Yellow WS Dosage: As directed by the Physician |
| 770 | Melatonin Tablets 5 mg |
Each uncoated tablet contains: Melatonin BP 5 mg Excipients qs Colour: Ponceau 4R Dosage: As directed by the Physician |
| 771 | Melatonin Tablets 10 mg |
Each uncoated tablet contains: Melatonin BP 10 mg Excipients qs Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 772 | Azathioprine Tablets IP 50 mg |
Each uncoated tablet contains: Azathioprine IP 50 mg Excipients qs Dosage: As directed by the Physician |
| 773 | Carvedilol Tablets IP 25 mg |
Each film-coated tablet contains: Carvedilol IP 25 mg Excipients qs Colour: Quinoline Yellow WS & Titanium Dioxide IP Dosage: As directed by the Physician |
| 774 | Vildagliptin Tablets IP 100 mg |
Each uncoated tablet contains: Vildagliptin IP 100 mg Excipients qs Dosage: As directed by the Physician |
| 775 | Lacosamide Tablets 100 mg |
Each film-coated tablet contains: Lacosamide 100 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 776 | Lacosamide Tablets 50 mg |
Each film-coated tablet contains: Lacosamide 50 mg Excipients qs Colour: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 777 | Oxcarbazepine Extended-release Tablets 450 mg |
Each film-coated Extended-release tablet contains: Oxcarbazepine IP 450 mg Excipients qs Colour: Red oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 778 | Metformin Hydrochloride Prolonged-release 850 mg and Glimepiride 1 mg Tablets IP |
Each uncoated bilayered Tablet contains: Metformin Hydrochloride IP 850 mg (As Prolonged-release) Glimepiride IP 1 mg Excipients qs Colour: Quinoline Yellow WS Dosage: As directed by the Physician |
| 779 | Metformin Hydrochloride Prolonged-release 850 mg and Glimepiride 2 mg Tablets IP |
Each uncoated bilayered Tablet contains: Metformin Hydrochloride IP 850 mg (As Prolonged-release) Glimepiride IP 2 mg Excipients qs Colour: Tartrazine Dosage: As directed by the Physician |
| 780 | Mebeverine Hydrochloride Tablets IP 200 mg |
Each film-coated tablet contains: Mebeverine Hydrochloride IP – 200 mg Excipients qs Colour: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 781 | Metformin Hydrochloride Tablets IP 250 mg |
Each uncoated tablet contains: Metformin Hydrochloride IP – 250 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 782 | Tadalafil Tablets IP 10 mg |
Each film-coated tablet contains: Tadalafil IP – 10 mg Excipients qs Colour: Ponceau 4R and Titanium Dioxide IP Dosage: As directed by the Physician |
| 783 | Sulfasalazine Gastro-resistant Tablets IP 500 mg |
Each gastro-resistant tablet contains: Sulfasalazine IP – 500 mg Excipients qs Colour: Yellow Oxide of Iron Dosage: As directed by the Physician |
| 784 | Promethazine Theoclate Tablets IP 25 mg |
Each uncoated tablet contains: Promethazine Theoclate IP – 25 mg Excipients qs Dosage: As directed by the Physician |
| 785 | Telmisartan & Chlorthalidone Tablets |
Each film-coated tablet contains: Telmisartan IP – 80 mg Chlorthalidone IP – 12.5 mg Excipients qs Colour: Erythrosine & Sunset Yellow FCF Dosage: As directed by the Physician |
| 786 | Metformin Hydrochloride Prolonged-release |
Each uncoated bilayered Tablet contains: 850 mg and Glimepiride 3 mg Tablets IP Metformin Hydrochloride IP – 850 mg (As Prolonged-release) Glimepiride IP – 3 mg Excipients qs Colour: Tartrazine Dosage: As directed by the Physician |
| 787 | Metformin Hydrochloride Prolonged-release |
Each uncoated Bilayered Tablet contains: 500 mg and Gliclazide 60 mg Tablets Metformin Hydrochloride IP – 500 mg (As Prolonged-release) Gliclazide IP – 60 mg Excipients qs Colours: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 788 | Dapagliflozin Tablets 10mg |
Each film-coated tablet contains: Dapagliflozin Propanediol Monohydrate – Eqv. to Dapagliflozin – 10 mg Excipients qs Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 789 | Metoprolol Succinate Prolonged-release and Amlodipine Tablets IP |
Each film-coated Bilayered tablet contains: Metoprolol Succinate IP (eqv. to Metoprolol Tartrate) – 47.5 mg (As Prolonged-release tablets) Amlodipine Besylate IP (Eqv. to Amlodipine) – 5 mg Excipients qs Colour: Ponceau 4R Dosage: As directed by the Physician |
| 790 | L-Methylfolate 1mg Tablets |
Each film-coated tablet contains: L-methylfolate – 1 mg Excipients qs Colour: Erythrosine & Titanium Dioxide IP Dosage: As directed by the Physician |
| 791 | L-Methylfolate 1mg Tablets |
Each film-coated tablet contains: L-methylfolate – 1 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 792 | Biotin, L-Methionine, Cysteine Hydrochloride, Zinc, Folic Acid, and Calcium Pantothenate Tablets |
Each film-coated tablet contains: Biotin IP – 10 mg L-Methionine BP – 40 mg Cysteine Hydrochloride BP – 100 mg Zinc Sulphate Monohydrate IP (eqv. to elemental Zinc) – 22.5 mg Folic Acid IP – 1.5 mg Calcium Pantothenate IP – 100 mg Excipients qs Colour: Ponceau-4R & Titanium Dioxide IP Appropriate overages Added Dosage: As directed by the Physician |
| 793 | Gliclazide 60 mg and Metformin Hydrochloride 500 mg Prolonged-release Tablets |
Each uncoated bilayered Tablet contains: Gliclazide IP 60 mg (As Prolonged-release) Metformin Hydrochloride IP 500 mg (As Prolonged-release) Excipients qs Colour: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 794 | Methylcobalamin & Vitamin D3 Sublingual Tablets |
Each uncoated sublingual tablet contains: Methylcobalamin IP 1500 mcg Vitamin D3 IP 2000 IU (As stabilized) Excipients qs Colour: Ponceau 4R Appropriate overages Added Dosage: As directed by the Physician |
| 795 | Gabapentin and Nortriptyline Hydrochloride Tablets |
Each film-coated tablet contains: Gabapentine IP 400 mg Nortriptyline Hydrochloride IP (eqv. to Nortriptyline) – 10 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 796 | Dapagliflozin Tablets 10 mg |
Each film-coated tablet contains: (FOR EXPORT) Dapagliflozin Propanediol Monohydrate – Eqv. to Dapagliflozin – 10 mg Colour: Yellow oxide of Iron & Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 797 | Tadalafil Dispersible Tablets 10 mg |
Each uncoated tablet contains: (FOR EXPORT) Tadalafil BP – 10 mg Colour: Ponceau 4R Excipients qs Dosage: As directed by the Physician |
| 798 | Rosuvastatin Tablets 10 mg |
Each film-coated tablet contains: (FOR EXPORT) Rosuvastatin Calcium BP – Eqv. to Rosuvastatin Calcium – 10 mg Colour: Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 799 | Diclofenac Gastro-resistant Tablets BP 50 mg |
Each gastro-resistant tablet contains: (FOR EXPORT) Diclofenac Sodium BP – 50 mg Colour: Sunset Yellow FCF & Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 800 | Aceclofenac Tablets 100 mg |
Each film-coated tablet contains: (FOR EXPORT) Aceclofenac BP – 100 mg Colour: Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 801 | Atorvastatin Tablets IP 10 mg |
Each film-coated tablet contains: (FOR EXPORT) Atorvastatin Calcium Trihydrate BP – Eqv. to Atorvastatin – 10 mg Colour: Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 802 | Sitagliptin & Metformin Hydrochloride Tablets |
Each film-coated tablet contains: (FOR EXPORT) Sitagliptin Phosphate Monohydrate BP – Eqv. to Sitagliptin – 50 mg Metformin Hydrochloride BP – 500 mg Colour: Sunset Yellow FCF & Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 803 | Atorvastatin Tablets USP 10 mg |
Each film-coated tablet contains: (FOR EXPORT) Atorvastatin Calcium USP – Eqv. to Atorvastatin – 10 mg Colour: Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 804 | Losartan Potassium Tablets BP 50 mg |
Each film-coated tablet contains: (FOR EXPORT) Losartan Potassium BP – 50 mg Colour: Sunset Yellow FCF & Titanium Dioxide Excipients qs Dosage: As directed by the Physician |
| 805 | Pantoprazole Dual-release Gastro-resistant Tablets 80 mg |
Each Dual-release Gastro-resistant tablet contains: Pantoprazole Sodium IP (Eqv. to Pantoprazole) – 80 mg Excipients qs Colour: Red Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 806 | Telmisartan 40 mg & Chlorthalidone 12.5 mg Tablets |
Each uncoated tablet contains: Telmisartan IP – 40 mg Chlorthalidone IP – 12.5 mg Excipients qs Dosage: As directed by the Physician |
| 807 | L-methylfolate Calcium 1 mg Tablets |
Each film-coated tablet contains: L-methylfolate Calcium – 1 mg Excipients qs Colour: Titanium Dioxide IP Appropriate overages Added Dosage: As directed by the Physician |
| 808 | Diazepam Tablets BP 10mg |
Each uncoated tablet contains: Diazepam BP – 10 mg (For Export) Excipients qs Colours: Indigo Carmine & Brilliant Blue FCF Dosage: As directed by the Physician |
| 809 | Diclofenac Potassium Tablets USP 50mg |
Each film coated tablet contains: Diclofenac Potassium BP – 50 mg (For Export) Excipients qs Colours: Sunset yellow FCF & Titanium Dioxide Dosage: As directed by the Physician |
| 810 | Telmisartan and Cilnidipine Tablets |
Each film-coated tablet contains: Telmisartan IP – 40 mg Cilnidipine IP – 10 mg Excipients qs Colours: Red Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 811 | Escitalopram oxalate and Clonazepam Tablets IP 20 mg |
Each film-coated tablet contains: Escitalopram Oxalate IP (Eqv. to Escitalopram) – 20 mg Clonazepam IP – 0.5 mg Excipients qs Colours: Red Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 812 | Telmisartan 80mg & Hydrochlorothiazide 12.5mg Tablets |
Each film-coated tablet contains: Telmisartan IP – 80 mg Hydrochlorothiazide IP – 12.5 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 813 | Torsemide & Spironolactone Tablets |
Each uncoated tablet contains: Torsemide IP – 5 mg Spironolactone IP – 25 mg Excipients qs Dosage: As directed by the Physician |
| 814 | Metoprolol Succinate prolonged-release and Amlodipine Tablets IP |
Each film-coated Bilayered tablet contains: Metoprolol Succinate IP – Eqv. to Metoprolol Tartrate – 25 mg Amlodipine Besylate IP – Eqv. to Amlodipine – 2.5 mg Excipients qs Colours: Yellow Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 815 | Montelukast Sodium and Desloratadine Tablets |
Each film-coated tablet contains: Montelukast Sodium IP – Eqv. to Montelukast – 10 mg Desloratadine BP – 5 mg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 816 | Desloratadine Tablets USP 5mg |
Each film-coated tablet contains: Desloratadine BP – 5 mg Excipients qs Colours: Quinoline Yellow WS Dosage: As directed by the Physician |
| 817 | Pregabalin, Methylcobalamin & Nortryptiline Tablets |
Each film-coated tablet contains: Pregabalin IP – 75 mg Methylcobalamin IP – 1500 mcg Nortryptyline Hydrochloride IP – Eqv. to Nortryptiline – 10 mg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 818 | Acebrophylline, Fexofenadine & Montelukast Bilayered Tablets |
Each film-coated Bilayered tablet contains: Acebrophylline – 200 mg (As Sustained Release) Fexofenadine Hydrochloride IP – 120 mg Montelukast Sodium – Eqv. to Montelukast – 10 mg Excipients qs Colours: Yellow Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 819 | Chlordiazepoxide and Clidinium Bromide Tablets |
Each film-coated tablet contains: Chlordiazepoxide IP – 5 mg Clidinium Bromide BP – 2.5 mg Excipients qs Colours: Yellow Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 820 | Phenytoin Sodium Tablets IP 100 mg |
Each film-coated tablet contains: Phenytoin Sodium IP – 100 mg Excipients qs Colours: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 821 | Chlordiazepoxide and Clidinium Bromide Tablets (For Export) |
Each film-coated tablet contains: Chlordiazepoxide IP – 5 mg Clidinium Bromide USP – 2.5 mg Excipients qs Colours: Yellow Oxide Of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 822 | Phenytoin Sodium Tablets BP 100 mg |
Each film-coated tablet contains: Phenytoin Sodium BP – 100 mg Excipients qs Colours: Sunset Yellow FCF & Titanium Dioxide IP Dosage: As directed by the Physician |
| 823 | Amisulpiride Tablets IP 200 mg |
Each uncoated tablet contains: Amisulpiride IP – 200 mg Excipients qs Colours: Sunset Yellow FCF Dosage: As directed by the Physician |
| 824 | Benfotiamine Tablets 300 mg |
Each film-coated tablet contains: Benfotiamine – 300 mg Excipients qs Colours: Titanium Dioxide IP Dosage: As directed by the Physician |
| 825 | Thiamine Hydrochloride Tablets IP 100 mg |
Each film-coated tablet contains: Thiamine Hydrochloride IP – 100 mg Excipients qs Colours: Red Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 826 | Rabeprazole & Itopride Tablets |
Each gastro-resistant tablet contains: Rabeprazole Sodium IP – 20 mg Itoride Hydrochloride – 50 mg Excipients qs Colours: Yellow Oxide of Iron and Titanium Dioxide IP Dosage: As directed by the Physician |
| 827 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine Hydrochloride, Thiamine Mononitrate and Vitamin D3 Tablets |
Each film-coated tablet contains: Methylcobalamin IP – 750 mcg Alpha Lipoic Acid IP – 50 mg Folic Acid IP – 1.5 mg Pyridoxine Hydrochloride IP – 3 mg Thiamine Mononitrate IP – 10 mg Vitamin D3 IP – 1000 IU Excipients qs Colour: Red oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 828 | Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride and Caffeine Tablets |
Each uncoated tablet contains: Paracetamol IP – 500 mg Phenylephrine Hydrochloride IP – 5 mg Diphenhydramine Hydrochloride IP – 25 mg Caffeine IP – 30 mg (Anhydrous) Excipients qs Colour: Tartrazine Dosage: As directed by the Physician |
| 829 | Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride and Caffeine Tablets |
Each uncoated tablet contains: Paracetamol IP – 500 mg Phenylephrine Hydrochloride IP – 5 mg Diphenhydramine Hydrochloride IP – 25 mg Caffeine IP – 30 mg (Anhydrous) Excipients qs Colour: Erythrosine Dosage: As directed by the Physician |
| 830 | Ibuprofen Tablets IP 200mg |
Each film-coated tablet contains: Ibuprofen IP – 200 mg Excipients qs Colour: Ponceau 4R & Titanium Dioxide IP Dosage: As directed by the Physician |
| 831 | Ibuprofen Tablets IP 400mg |
Each film-coated tablet contains: Ibuprofen IP – 400 mg Excipients qs Colour: Brilliant Blue FCF & Titanium IP Dosage: As directed by the Physician |
| 832 | Amlodipine Besilate IP 10 Tablets |
Each uncoated tablet contains: Amlodipine Besylate IP – Eqv. to Amlodipine – 10 mg Excipients qs Dosage: As directed by the Physician |
| 833 | Metoprolol Succinate prolonged-release tablets |
Each film-coated Prolonged-release tablet contains: Metoprolol Succinate IP – Eqv. to Metoprolol Tartrate – 12.5 mg Excipients qs Colour: Red oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 834 | Bisoprolol Tablets IP 2.5 mg |
Each uncoated tablet contains: Bisoprolol Fumarate IP – 2.5 mg Excipients qs Dosage: As directed by the Physician |
| 835 | Bisoprolol Tablets IP 5 mg |
Each uncoated tablet contains: Bisoprolol Fumarate IP – 5 mg Excipients qs Colour: Tartrazine Dosage: As directed by the Physician |
| 836 | Bisoprolol Tablets IP 10 mg |
Each uncoated tablet contains: Bisoprolol Fumarate IP – 10 mg Excipients qs Colour: Tartrazine Dosage: As directed by the Physician |
| 837 | Furosemide Tablets IP 20 mg |
Each uncoated tablet contains: Furosemide IP – 20 mg Excipients qs Dosage: As directed by the Physician |
| 838 | Furosemide Tablets IP 40 mg |
Each uncoated tablet contains: Furosemide IP – 40 mg Excipients qs Dosage: As directed by the Physician |
| 839 | Paroxetine Prolonged-release Tablets IP 12.5 mg |
Each film-coated Prolonged-release tablet contains: Paroxetine Hydrochloride Hemihydrate IP – Eqv. to Paroxetine – 12.5 mg Excipients qs Colour: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 840 | Paroxetine Prolonged-release Tablets IP 12.5 mg |
Each Enteric-coated Prolonged-release tablet contains: Paroxetine Hydrochloride Hemihydrate IP – 12.5 mg Excipients qs Colour: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
| 841 | Deflazacort tablets 18 mg |
Each uncoated tablet contains: Deflazacort – 18 mg Excipients qs Dosage: As directed by the Physician |
| 842 | Nitrazepam Tablets IP 10 mg |
Each uncoated tablet contains: Nitrazepam IP – 10 mg Excipients qs Dosage: As directed by the Physician |
| 843 | Nitrazepam Tablets IP 5 mg |
Each uncoated tablet contains: Nitrazepam IP – 5 mg Excipients qs Colour: Quinoline Yellow Dosage: As directed by the Physician |
| 844 | Paracetamol and Tramadol Hydrochloride Tablets IP |
Each film-coated tablet contains: Paracetamol IP – 325 mg Tramadol Hydrochloride IP – 37.5 mg Excipients qs Colour: Yellow Oxide of Iron & Titanium Dioxide IP Dosage: As directed by the Physician |
External Applications
| No. | Generic Name | Composition | |
|---|---|---|---|
| 1 | Ethyl Alcohol Hand Sanitizer | Ethyl Alcohol 95% (Denatured) IP 70%v/v In an aqueous base containing glycerin Propylene Glycol & Aloevera gel. Colour : Brilliant Blue FCF & Tartrazine | As directed by the physician |
| 2 | Ethyl Alcohol Hand Sanitizer | Ethyl Alcohol 95% (Denatured) IP 70%v/v In a gel base containing glycerin Propylene Glycol & Aloevera gel. Colour : Brilliant Blue FCF & Tartrazine | As directed by the physician |
| 3 | Ketoconazole Cream 2% w/w | Ketoconazole IP 2% w/w Cream base qs Preservative Methylparaben IP 0.1% w/w Propylparaben IP 0.025% w/w | As directed by the physician |
| 4 | Sertaconazole Nitrate Cream 2% w/w | Sertaconazole Nitrate IP 2% w/w Cream base qs Preservative Benzyl Alcohol IP 1% w/w | As directed by the physician |
| 5 | Povidone-Iodine Ointment U.S.P. 5% w/w | Povidone-Iodine IP 5 % w/w (available iodine 0.5% w/w) Water soluble Ointment base qs | As directed by the physician |
| 6 | Mometasone Furorate & Clotrimazole Cream | Mometasone Furoate IP 0.1% w/w Clotrimazole IP 1% w/w Cream base qs Preservative Methylparaben IP 0.1% w/w Propylparaben IP 0.025% w/w | As directed by the physician |
| 7 | Luliconazole Cream 1% w/w | Luliconazole 1% w/w Cream base Preservative Benzyl Alcohol IP 1% w/w | As directed by the physician |
| 8 | Luliconazole Lotion 1% w/w | Luliconazole 1% w/w Lotion base qs Preservative Benzyl Alcohol | As directed by the physician |
| 9 | Terbinafine Hydrochloride Cream IP 1% w/w | Terbinafine Hydrochloride IP 1% w/w Cream base qs Preservative Methylparaben IP 0.1% w/w Propylparaben IP 0.025% w/w | As directed by the physician |
| 10 | Isopropyl Alcohol Hand Sanitizer | Isopropyl Alcohol IP 70% v/v In an aqueous base containing glycerin Colour : Brilliant Blue FCF | Not specified |
| 11 | Ketoconazole Shampoo 2% w/v | Ketoconazole IP 2% w/v Lotion base qs Colour: Erythrosine | As directed by the physician |
| 12 | Clindamycin & Benzoyl Peroxide Gel | Clindamycin Phosphate IP eq. to Clindamycin 1% w/w Hydrous Benzoyl Peroxide BP eq. to Anhydrous Benzoyl Peroxide 5% w/w Gel Base | As directed by the physician |
| 13 | Tacrolimus Ointment 0.03% w/w | Each gram of ointment contains: Tacrolimus USP 0.3 mg Ointment Base qs | As directed by the physician |
| 14 | Tacrolimus Ointment 0.1% w/w | Each gram of ointment contains: Tacrolimus USP 1 mg Ointment Base qs | As directed by the physician |
| 15 | White Soft Paraffin & Light Liquid Paraffin lotion | White Soft paraffin IP 13.2% w/w Light Liquid Paraffin IP 10.2% w/w Lotion base containing aloe vera gel qs | As directed by the physician |
| 16 | Hydroquinone, Tretinoin & Mometasone Furoate Cream | Hydroquinone IP 2% w/w Tretinoin BP 0.025% w/w Mometasone Furoate IP 0.1% w/w Cream base qs | As directed by the physician |
| 17 | Clobetasol Propionate & Salicylic Acid Ointment | Cloberasol Propionate IP 0.05% w/w Salicylic Acid IP 6% w/w Ointment Base qs | As directed by the physician |
| 18 | Fluticasone Cream IP | Fluticasone Propionate IP 0.05% w/w Cream base qs Preservative: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w | As directed by the physician |
| 19 | Calamine & Light Liquid Paraffin Lotion | Calamine IP 8% w/w Light Liquid Paraffin IP 10% w/w Lotion base containing aloe vera gel qs | As directed by the physician |
| 20 | Clotrimazole & Lignocaine Hydrochloride Ear drop | Clotrimazole IP 1% w/v Lignocaine Hydrochloride IP 2% w/v Glycerine & Propylene Glycol base qs | As directed by the physician |
| 21 | Sodium Chloride Nasal Drop | Sodium Chloride IP 0.74% w/v Aqueous base qs Preservative: Benzalkonium Chloride solution IP 0.022% w/w | As directed by the physician |
| 22 | Chlorhexidine & Cetrimide Cream | Chlorhexidine Gluconate Solution IP 0.3% w/w Cetrimide IP 0.6% w/w Cream base qs Preservative: Methylparaben IP 0.15% w/w, Propylparaben IP 0.03% w/w | As directed by the physician |
| 23 | Clotrimazole & Beclomethasone Dipropionate Cream IP | Clotrimazole IP 1% w/w Beclomethasone Dipropinonate IP 0.025% w/w Cream base qs Preservative: Methylparaben IP 0.15% w/w, Propylparaben IP 0.03% w/w, Benzyl Alcohol IP 1% w/w | As directed by the physician |
| 24 | Metronidazole Gel IP 2% w/w | Metronidazole IP 2% w/w Gel Base qs | As directed by the physician |
| 25 | Mometasone Cream IP | Mometasone Furoate IP 0.1% w/w Cream base qs Preservative: Chlorocresol IP 0.1% w/w | As directed by the physician |
| 26 | Clobetasol Propionate & Fusidic Acid Cream | Clobetasol Propionate IP 0.05%w/w Fusidic Acid IP 2% w/w Cream base qs Preservative: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w | As directed by the physician |
| 27 | Fusidic Acid Cream IP 2% w/w | Fusidic Acid IP 2% w/w Cream base qs Preservative: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w | As directed by the physician |
| 28 | Clobetasol Propionate, Salicylic Acid Ointment | Clobetasol Propionate IP 0.05% w/w Salicylic Acid IP 3% w/w Urea IP 10% w/w Lactic Acid IP 3% w/w Sodium Lactate Solution USP eqv. To lactic Acid 2% w/w Ointment Base qs | As directed by the physician |
| 29 | Permethrin Lotion 5% w/v | Permethrin 5% w/v Lotion base qs | As directed by the physician |
| 30 | Gamma Benzene Hexachloride Lotion 1% w/v | Gamma Benzene Hexechloride 1% w/v Lotion base qs | As directed by the physician |
| 31 | Clarithromycin Gel 1% w/w | Clarithromycin IP 1% w/w Aqueous gel base qs | As directed by the physician |
| 32 | Mupirocin Ointment IP 2% w/w | Mupirocin IP 2% w/w In a non-greasy ointment base qs | As directed by the physician |
| 33 | Chlorhexidine Mouthwash BP | Chlorhexidine Gluconate Solution IP 1% v/v Aqueous base qs Colour: Brilliant Blue FCF & Tatrazine | As directed by the physician |
| 34 | Clotrimazole, Beclomethasone & Choline Salicylate Mouth Paint | Clotrimazole IP 1% w/v Beclomethasone Dipropinonate IP 0.025 w/v Choline Salicylate Solution BP eqv. To Choline Salicylate 9% w/v In Propylene Glycol & Glycerin base qs Preservative: Benzalkonium Chloride solution IP 0.022% w/v | As directed by the physician |
| 35 | Mometasone & Salicylic Acid Ointment | Mometasone Furoate IP 0.1% w/w Salicylic Acid IP 3% w/w Ointment Base qs | As directed by the physician |
| 36 | Mometasone & Fusidic Acid Cream | Mometasone Furoate IP 0.1% w/w Fusidic Acid IP 2% w/w Cream base qs Preservative: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w | As directed by the physician |
| 37 | Ketoconazole & Zinc Pyrithione Shampoo | Ketoconazole IP 2% w/w Zinc Pyrithione 1% w/w Lotion base qs Preservative: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w | As directed by the physician |
| 38 | Salicylic Acid Ointment IP 12% w/w | Salicylic Acid 12% w/w Ointment Base qs Preservatives: As directed by the physician | As directed by the physician |
| 39 | Clindamycin and Nicotinamide Gel | Clindamycin Phosphate IP Eqv. to Clindamycin 1% w/w Nicotinamide IP 4% w/w Aloe, Allantoin base qs | As directed by the physician |
| 40 | Clotrimazole Vaginal Gel 2% w/w | Clotimazole IP 2% w/w Gel Base qs Preservative: Benzyl Alcohol IP 2% w/w, Chlorocresol IP 0.1% w/w | As directed by the physician |
| 41 | Salicylic Acid Ointment IP 12% w/w | Salicylic Acid IP 12% w/w Ointment base qs | As directed by the physician |
| 42 | Beclomethasone, Neomycin and Clotrimazole Cream | Beclomethasone Dipropionate IP 0.025% w/w Neomycin Sulphate IP Eqv. to Neomycin 0.5% w/w Clotrimazole IP 1.0% w/w Cream base qs Preservatives: Methyl Paraben IP 0.1% w/w, Propylparaben IP 0.025% w/w | As directed by the physician |
| 43 | Metronidazole Gel IP 2% w/w | Metronidazole IP 2% w/w Water Soluble Gel base qs | As directed by the physician |
| 44 | Metronidazole and Providone-iodine Ointment | Metronidazole IP 1.5% w/w Providone-iodine IP 10% w/w (Available iodine 1.0% w/w) Water Soluble ointment base | As directed by the physician |
| 45 | Fusidic Acid and Beclomethasone Dipropionate Cream | Fusidic Acid IP Eqv.to Anhydrous Fusidic Acid 2.0% w/w Beclomethasone Dipropionate IP 0.025% w/w Cream Base qs Preservatives: Chlorocresol IP 0.1% w/w | As directed by the physician |
| 46 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate, Menthol and Capsaicin Gel | Diclofenac Diethylamine BP 1.16% w/w Eqv. to Diclofenac Sodium 1.0% w/w Linseed Oil BP 3.0% w/w Methyl Salicylate IP 10.0% w/w Capsaicin USP 0.025% w/w Menthol IP 5.0% w/w Gel base qs Preservatives: Benzyl Alcohol IP 1.0% w/w | As directed by the physician |
| 47 | Diclofenac Sodium, Methyl Salicylate, Menthol and Absolute Alcohol Gel | Each gram of gel contains: Diclofenac Sodium IP 10 mg Methyl Salicylate IP 150 mg Menthol IP 50 mg Absolute Alcohol (Ethanol 95%) IP 50 mg Gel base qs | As directed by the physician |
| 48 | Povidone-iodine, Metronidazole and Sucralfate Ointment | Povidone-iodine IP 5.0% w/w (Available iodine 0.5% w/w) Metronidazole IP 1.0% w/w Sucralfate USP 7.0% w/w Ointment base qs | As directed by the physician |
| 49 | Ketoconazole and Coal Tar Solution | Ketoconazole IP 2% w/v Prepared Coal Tar IP 2% w/v Aqueous base qs Colour: Sunset Yellow FCF | As directed by the physician |
| 50 | Clobetasol Propionate, Miconazole Nitrate and Neomycin Sulphate Cream | Clobetasol Propionate IP 0.05% w/w Miconazole Nitrate IP 2% w/w Neomycin Sulphate IP 0.5% w/w Cream base qs Preservatives: Methylparaben 0.1% w/w, Propylparaben 0.025% w/w | As directed by the physician |
| 51 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate, Lignocaine Hydrochloride and Menthol Gel | Diclofenac Diethylamine IP 1.16% w/w Eqv. to Diclofenac Sodium 1.0% w/w Linseed Oil BP 1.0% w/w Methyl Salicylate IP 10.0% w/w Lignocaine Hydrochloride IP 2.5% w/w Menthol IP 5.0% w/w Gel base qs Preservatives: Benzyl Alcohol 1.0% w/w | As directed by the physician |
| 52 | Amorolfine Hydrochloride Cream | Amorolfine Hydrochloride IP eq. to Amorolfine 0.25% w/w Preservatives: Phenoxyethanol IP 1.0% w/w In a Cream qs | As directed by the physician |
| 53 | Choline Salicylate and Lignocaine Hydrochloride Gel | Choline Salicylate Solution BP eqv. to Choline salicylate 8.7% w/w Lignocaine Hydrochloride IP 2.0% w/w Preservatives: Benzalkonium Chloride Solution IP 0.20% w/w in a Pleasant flavoured base containing glycerine IP | As directed by the physician |
| 54 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate and Menthol Gel | Diclofenac Diethylamine IP 1.16% w/w Eqv. to Diclofenac Sodium 1.0% w/w Methyl Salicylate IP 10.0% w/w Linseed Oil BP 3.0% w/w Menthol IP 5.0% w/w Gel base Application: As directed by the physician | As directed by the physician |
| 55 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate, Lignocaine Hydrochloride and Menthol Gel | Diclofenac Diethylamine IP 1.16% w/w Eqv. to Diclofenac Sodium 1% w/w Linseed Oil BP 3.0% w/w Methyl Salicylate IP 10.0% w/w Lignocaine Hydrochloride 2.5% w/w Menthol IP 5.0% w/w Gel Base qs Preservatives: Benzyl Alcohol 1.0% w/w | As directed by the physician |
| 56 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate and Menthol Gel | Diclofenac Diethylamine IP 1.16% w/w Eqv. to Diclofenac Sodium 1% w/w Linseed Oil BP 3.0% w/w Methyl Salicylate IP 10.0% w/w Menthol IP 5.0% w/w Gel base qs Preservatives: Benzyl Alcohol 1.0% w/w | As directed by the physician |
| 57 | Itraconazole Cream 1% w/w | Itraconazole IP 1.0% w/w In a cream base qs Preservatives: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025 % | As directed by the physician |
| 58 | Hydrocortisone Cream IP 1% w/w | Hydrocortisone Acetate IP 1.0% w/w In a cream base Preservatives: Methylparaben IP 0.15% w/w, Propylparaben 0.05% w/w | As directed by the physician |
| 59 | Ofloxacin, Tinidazole, Terbinafine Hydrochloride, Clobetasol Propionate and Dexpanthenol Cream | Ofloxacin IP 0.75% w/w Tinidazole IP 2.0% w/w Terbinafine Hydrochloride IP 1.0% w/w Clobetasol Propionate IP 0.05% w/w Dexpanthenol USP 0.05% w/w Cream base qs Preservatives: Methylparaben IP 0.20% w/w, Propylparaben IP 0.02% w/w | As directed by the physician |
| 60 | Ketoconazole Cream 2% w/w | Ketoconazole IP 2.0% w/w Cream base qs Preservatives: Methylparaben IP 0.15% w/w, Phenoxyethanol IP 0.05% w/w | As directed by the physician |
| 61 | Beclomethasone Dipropionate, Phenylephrine Hydrochloride and Lignocaine Hydrochloride Cream | Beclomethasone Dipropionate IP 0.025% w/w Phenylephrine Hydrochloride IP 0.10% w/w Lignocaine Hydrochloride IP 2.5% w/w Preservatives: Chlorocresol IP 0.10% w/w Cream base qs | As directed by the physician |
| 62 | Beclomethasone Dipropionate and Neomycin Cream | Beclomethasone Dipropionate IP 0.025% w/w Neomycin Sulphate IP Eqv. to Neomycin 0.5% w/w Preservatives: Chlorocresol IP 0.1% w/w Cream base qs | As directed by the physician |
| 63 | Diclofenac Gel IP | Diclofenac Diethylamine IP 1.16% w/w Eqv. to Diclofenac Sodium IP 1.0% w/w Gel base qs | As directed by the physician |
| 64 | Clindamycin Phosphate Gel | Clindamycin Phosphate IP eqv. to Clindamycin 1.0% w/w Preservatives: Chlorocresol Gel base qs | As directed by the physician |
| 65 | Benzoic Acid, Salicylic Acid, Camphor and Menthol | Benzoic Acid IP 6.0% w/w Salicylic Acid IP 3.0% w/w Camphor IP 0.5% w/w Menthol IP 2.0% w/w Ointment base qs | As directed by the physician |
| 66 | Sodium Fusidate Ointment | Sodium Fusidate IP 2.0% w/w Ointment base qs | As directed by the physician |
| 67 | Aciclovir Cream IP 5.0% w/w | Aciclovir IP 5.0% w/w Cream base qs | As directed by the physician |
| 68 | Hydroquinone, Fluocinolone Acetonide and Tretinoin Cream | Hydroquinone IP 2.0% w/w Fluocinolone Acetonide IP 0.01% w/w Tretinoin BP 0.05% w/w Cream base qs | As directed by the physician |
| 69 | Neomycin Sulphate Cream | Neomycin Sulphate IP 0.5% w/w Cream base qs | As directed by the physician |
| 70 | Permethrin Cream | Permethrin 5.0% w/w Preservatives: Formaldehyde Solution IP 0.1% w/w Cream base qs | As directed by the physician |
| 71 | Beclomethasone, Gentamicin and Clotrimazole Cream | Beclomethasone Dipropionate IP 0.025% w/w Gentamycin Sulphate IP eqv. to Gentamycin 1.0% w/w Clotrimazole Cream base qs | As directed by the physician |
| 72 | Piroxicam Gel IP 0.5% w/w | Piroxicam IP 0.5% w/w Gel base qs | As directed by the physician |
| 73 | Clotrimazole Cream IP 1.0% w/w | Clotrimazole IP 1.0% w/w Preservatives: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w Cream base qs | As directed by the physician |
| 74 | Fradiomycin Sulphate Cream | Each gm contains: Fradiomycin Sulphate JP 5 mg (Neomycin Sulphate) Preservatives: Chlorocresol IP 1 mg Cream base | As directed by the physician |
| 75 | Benzoic and Salicylic Acid Ointment IP | Benzoic Acid IP 6.0% w/w Salicylic Acid IP 3.0% w/w Ointment base qs | As directed by the physician |
| 76 | Miconazole and Fluocinolone Ointment | Miconazole Nitrate IP 2.0% w/w Fluocinolone Acetonide IP 0.01% w/w Water Miscible Base qs | As directed by the physician |
| 77 | Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate and Menthol Gel | Diclofenac Diethylamine IP 2.32% w/w Eqv. to Diclofenac Sodium 2.0% w/w Linseed Oil BP 3.0% w/w Methyl Salicylate IP 10.0% w/w Menthol IP 5.0% w/w Gel base Preservatives: Benzyl Alcohol 1.0% w/w | As directed by the physician |
| 78 | Betamethasone, Gentamicin and Zinc oxide cream | Betamethasone Dipropionate IP eqv. to Betamethasone 0.1% w/w Gentamycin Sulphate IP eqv. to Gentamycin 0.1% w/w Zinc oxide IP 2.0% w/w Cream base qs Preservatives: Methylparaben IP 0.1% w/w, Propylparaben IP 0.025% w/w | |
| 79 | Luliconazole Lotion IP 1% w/v | Luliconazole IP 1.0% w/v in a Lotion base, Preservatives: qs | Application: As directed by the physician |
| 80 | Luliconazole Cream IP 1% w/w | Luliconazole IP 1.0% w/w in a Cream base, Preservatives: qs | Application: As directed by the physician |
| 81 | Clobetasol Propionate Lotion 0.05% w/v | Clobetasol Propionate IP 0.05% w/v in a lotion base | Dosage: As directed by the physician |
| 82 | Meropenem Injection IP 1g (FORM 28) FOR IV USE | Each vial contains: Meropenem Trihydrate IP eqv. to Anhydrous Meropenem – 1000 mg Sodium Carbonate IP eqv. to Sodium – 90.2 mg (A sterile Mixture of Meropenem & Sodium Carbonate) | Dosage: As directed by the Physician. |
| 83 | Ceftriaxone Injection IP 1g (FORM 28) FOR IM/IV USE | Each vial contains: Ceftriaxone Sodium IP eqv. to Ceftriaxone – 1000 mg | Dosage: As directed by the Physician. |
| 84 | Ceftriaxone and Sulbactam For Injection IP 1.5g (FORM 28) FOR IM/IV USE | Each vial contains: Ceftriaxone Sodium IP eqv. to Ceftriaxone – 1000 mg Sulbactam Sodium eqv. to Sulbactam – 500 mg | Dosage: As directed by the Physician. |
| 85 | Piperacillin and Tazobactam Injection IP 2.5g (FORM 28) FOR IV USE | Each vial contains: Sterile Piperacillin Sodium IP eqv. to Piperacillin – 2000 mg Sterile Tazobactam Sodium IP eqv. to Tazobactam – 250 mg | Dosage: As directed by the Physician. |
| 86 | Ceftriaxone and Tazobactam for Injection USP 1.125g (FORM 28) FOR IM/IV USE | Each vial contains: Ceftriaxone Sodium IP eqv. to Ceftriaxone – 1000 mg Tazobactam Sodium IP eqv. to Tazobactam – 125 mg | Dosage: As directed by the Physician. |
| 87 | Ceftriaxone Injection IP 500 mg (FORM 28) FOR IM/IV USE | Each vial contains: Ceftriaxone Sodium IP eqv. to Ceftriaxone – 500 mg | Dosage: As directed by the Physician. |
| 88 | Cefuroxime Injection IP 250 mg (FORM 28) FOR IM/IV USE | Each vial contains: Cefuroxime Sodium IP eqv. to Cefuroxime – 250 mg | Dosage: As directed by the Physician. |
| 89 | Ceftriaxone and Sulbactam For Injection IP 0.75g (FORM 28) FOR IM/IV USE | Each vial contains: Ceftriaxone Sodium IP eqv. to Ceftriaxone – 500 mg Sulbactam Sodium IP eqv. to Sulbactam – 250 mg | Dosage: As directed by the Physician. |
| 90 | Piperacillin and Tazobactam Injection IP 1.125g (FORM 28) FOR IV USE | Each vial contains: – Piperacillin Sodium IP eqv. to Piperacillin: 1000 mg – Tazobactam Sodium IP eqv. to Tazobactam: 125 mg | As directed by the Physician. |
| 91 | Meropenem Injection IP 125 mg (FORM 28) FOR IV USE | Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 125 mg – Sodium Carbonate IP eqv. to Sodium: 11.27 mg (A sterile Mixture of Meropenem & Sodium Carbonate) | As directed by the Physician. |
| 92 | Cefoperazone and Tazobactam Injection (FORM 28) FOR IM/IV USE | Each vial contains: – Cefoperazone Sodium IP eqv. to Cefoperazone: 1000 mg – Tazobactam Sodium IP eqv. to Tazobactam: 125 mg | As directed by the Physician. |
| 93 | Ceftazidime and Tazobactam Injection (FORM 28) FOR IM/IV USE | Each vial contains: – Ceftazidime IP eqv. to Ceftazidime: 1000 mg – Tazobactam Sodium IP eqv. to Tazobactam: 125 mg | As directed by the Physician. |
| 94 | Cefuroxime Sodium Injection IP 750 mg (FORM 28) FOR IM/IV USE | Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 750 mg | As directed by the Physician. |
| 95 | Ceftriaxone Injection IP 250 mg (FORM 28) FOR IM/IV USE | Each vial contains: – Ceftriaxone Sodium IP eqv. to Ceftriaxone: 250 mg | As directed by the Physician. |
| 96 | Ceftriaxone and Tazobactam For Injection USP 281.25 mg (FORM 28) FOR IM/IV USE | Each vial contains: – Ceftriaxone Sodium IP eqv. to Ceftriaxone: 250 mg – Tazobactam Sodium IP eqv. to Tazobactam: 31.25 mg | As directed by the Physician. |
| 97 | Cefoperazone and Sulbactam Injection (FORM 28) FOR IM/IV USE | Each vial contains: – Cefoperazone Sodium IP eqv. to Cefoperazone: 500 mg – Sulbactam Sodium IP eqv. to Sulbactam: 500 mg | As directed by the Physician. |
| 98 | Cefoperazone and Sulbactam For Injection 1.5g (FORM 28) FOR IM/IV USE | Each vial contains: – Cefoperazone Sodium IP eqv. to Cefoperazone: 1000 mg – Sulbactam Sodium IP eqv. to Sulbactam: 500 mg | As directed by the Physician. |
| 99 | Meropenem Injection IP 250 mg (FORM 28) FOR IV USE | Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 250 mg – Sodium Carbonate IP eqv. to Sodium: 22.55 mg (A sterile Mixture of Meropenem & Sodium Carbonate) | As directed by the Physician. |
| 100 | Meropenem Injection IP 0.5 g (FORM 28) FOR IV USE | Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 500 mg – Sodium Carbonate IP eqv. to Sodium: 45.1 mg (A sterile Mixture of Meropenem & Sodium Carbonate) | As directed by the Physician. |
| 101 | Ceftriaxone and Sulbactam For Injection IP 375 mg (ON FORM -28) FOR IM/IV USE | Each vial contains: – Ceftriaxone Sodium IP eqv. to Ceftriaxone: 250 mg – Sulbactam Sodium IP eqv. to Sulbactam: 125 mg | As directed by the Physician. |
| 102 | Vancomycin Hydrochloride For Intravenous Infusion IP 1000 mg (ON FORM -28) ONLY FOR USE IV | Each vial contains: – Vancomycin Hydrochloride IP eqv. to Vancomycin: 1000 mg | As directed by the Physician. |
Beta Tablets
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Cefixime Dispersible Tablets I.P. 50 mg |
Each uncoated dispersible tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 50 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 2 | Cefixime Dispersible Tablets I.P. 100 mg |
Each uncoated dispersible tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 100 mg Excipients q.s. Colour: Quinoline Yellow |
| 3 | Cefixime Dispersible Tablets I.P. 200 mg |
Each uncoated dispersible tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 200 mg Excipients q.s. Colour: Tartrazine |
| 4 | Cefpodoxime Proxetil Tablets I.P. 200 mg |
Each film-coated tablet contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 200 mg Excipients q.s. Colour: Tartrazine and Titanium Dioxide I.P. |
| 5 | Cefixime and Ofloxacin Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 200 mg Ofloxacin I.P. 200 mg Excipients q.s. Colour: Tartrazine |
| 6 | Cefixime Tablets I.P. 200 mg |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 200 mg Excipients q.s. Colour: Sunset Yellow |
| 7 | Cefpodoxime Proxetil and Ofloxacin Tablets |
Each film-coated tablet contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 200 mg Ofloxacin I.P. 200 mg Excipients q.s. Colour: Quinoline Yellow WS and Titanium Dioxide I.P. |
| 8 | Cefuroxime Axetil Tablets I.P. 250 mg |
Each film-coated tablet contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 250 mg Excipients q.s. Colour: Quinoline Yellow WS and Titanium Dioxide I.P. |
| 9 | Cefuroxime Axetil Tablets I.P. 500 mg |
Each film-coated tablet contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 500 mg Excipients q.s. Colour: Tartrazine |
| 10 | Cefuroxime Axetil and Potassium Clavulanate Tablets I.P. |
Each film-coated tablet contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 250 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 11 | Cefuroxime Axetil and Potassium Clavulanate Tablets I.P. |
Each film-coated tablet contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 125 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 31.25 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 12 | Cefuroxime Axetil and Potassium Clavulanate Tablets |
Each film-coated tablet contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 250 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 62.5 mg Excipients q.s. Colour: Tartrazine |
| 13 | Cefuroxime Axetil and Potassium Clavulanate Tablets |
Each film-coated tablet contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 500 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 14 | Cefixime and Potassium Clavulanate Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 200 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 15 | Cefixime and Potassium Clavulanate Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 50 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 31.125 mg Excipients q.s. Colour: Tartrazine |
| 16 | Cefixime and Potassium Clavulanate Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 100 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 62.5 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 17 | Cefpodoxime Proxetil and Ofloxacin Tablets |
Each film-coated tablet contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 100 mg Ofloxacin I.P. 100 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 18 | Cefpodoxime Proxetil Tablets I.P. 100 mg |
Each film-coated tablet contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 100 mg Excipients q.s. Colour: Tartrazine |
| 19 | Amoxycillin Trihydrate Dispersible Tablets I.P. |
Each uncoated dispersible tablet contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 125 mg Excipients q.s. |
| 20 | Amoxycillin Trihydrate Dispersible Tablets I.P. |
Each uncoated dispersible tablet contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 250 mg Excipients q.s. |
| 21 | Amoxicillin and Potassium Clavulanate Tablets I.P. |
Each film-coated tablet contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 500 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 22 | Amoxicillin and Potassium Clavulanate Tablets I.P. |
Each film-coated tablet contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 250 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Tartrazine |
| 23 | Cefaclor Tablets 250 mg |
Each uncoated tablet contains: Cefaclor I.P. 250 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 24 | Cefaclor Tablets 500 mg |
Each uncoated tablet contains: Cefaclor I.P. 500 mg Excipients q.s. Colour: Tartrazine |
| 25 | Cefaclor Tablets 250 mg |
Each uncoated prolonged-release tablet contains: Cefaclor I.P. 250 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 26 | Cefixime and Ofloxacin Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 100 mg Ofloxacin I.P. 100 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 27 | Cefadroxil Tablets IP 500 mg |
Each uncoated tablet contains: Cefadroxil I.P. 500 mg Excipients q.s. Colour: Tartrazine |
| 28 | Cefadroxil Dispersible Tablets 125 mg |
Each uncoated dispersible tablet contains: Cefadroxil I.P. 500 mg Excipients q.s. Colour: Sunset Yellow FCF |
| 29 | Cefadroxil Dispersible Tablets 250 mg |
Each uncoated dispersible tablet contains: Cefadroxil I.P. 500 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 30 | Cephalexin Tablets 500 mg |
Each uncoated tablet contains: Cephalexin I.P. 500 mg Excipients q.s. Colour: Tartrazine |
| 31 | Cefixime and Lactic Acid Bacillus Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 200 mg Lactic Acid Bacillus 60 Million Spores Excipients q.s. Colour: Tartrazine |
| 32 | Cefixime and Lactic Acid Bacillus Tablets |
Each film-coated tablet contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 200 mg Lactic Acid Bacillus 120 Million Spores Excipients q.s. Colour: Quinoline Yellow WS |
| 33 | Cefpodoxime Proxetil and Potassium Clavulanate Tablets |
Each film-coated tablet contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 200 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Quinoline Yellow WS and Titanium Dioxide I.P. |
| 34 | Cefixime Tablets IP 400 mg |
Each film-coated tablet contains: Cefixime I.P. 400 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 35 | Amoxycillin and Potassium Clavulanate Tablets IP |
Each film-coated tablet contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 875 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 36 | Amoxycillin and Potassium Clavulanate Tablets IP |
Each film-coated tablet contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 1000 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 125 mg Excipients q.s. Colour: Quinoline Yellow WS |
| 37 | Moxifloxacin and Cefixime Sustained release |
Each film-coated modified release tablet contains: Moxifloxacin Hydrochloried IP eq. to Moxifloxacin 400 mg Cefixime IP 400 mg Excipients q.s. Colour: Red Oxide of Iron Dose: As directed by the physician |
| 38 | Cefpodoxime Dispersible Tablets 100 mg |
Each Uncoated Dispersible tablet contains: Cefpodoxime Proxetil IP 100 mg eq. to Cefpodoxime Excipients qs Dosage: As directed by the Physician |
| 39 | Cefpodoxime Dispersible Tablets 200 mg |
Each Uncoated Dispersible tablet contains: Cefpodoxime Proxetil IP 200 mg eq. to Cefpodoxime Excipients qs Dosage: As directed by the Physician |
| 40 | Amoxycillin and Potassium Clavulanate Tablets IP |
Each film-coated tablet contains: Amoxycillin Trihydrate IP Eq. to Amoxycillin 500 mg Potassium Clavulanate Diluted IP Eq. to Clavulanic acid 125 mg Excipients qs Colour: Titanium Dioxide IP Dosage: As directed by the Physician |
| 41 | Amoxycillin Trihydrate Dispersible Tablets IP 125 mg |
Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP 125 mg Eqv. to Amoxycillin Excipients: qs Colour: Sunset Yellow FCF Dosage: As directed by the Physician |
| 42 | Amoxycillin Trihydrate Dispersible Tablets IP 250 mg |
Each uncoated dispersible tablet contains: Amoxycillin Trihydrate IP 250 mg Eqv. to Amoxycillin Excipients: qs Colour: Erythrosin Lake Dosage: As directed by the Physician |
| 43 | Amoxycillin, Potassium Clavulanate and Lactic Acid Bacillus Tablets |
Each film-coated tablet contains: Amoxycillin Trihydrate IP Eqv. to Amoxycillin 500 mg Potassium Clavulanate Diluted IP eqv. to Clavulanic Acid 125 mg Lactic Acid Bacillus 60 million spores Excipients: qs Colour: Quinoline Yellow & Titanium Dioxide IP Dosage: As directed by the Physician |
Beta Capsules
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Cephalexin Capsules IP 500 mg | Each hard gelatin capsule contains: Cephalexin I.P. 500 mg Excipients q.s. Approved colour used in empty hard gelatin capsule shells. |
| 2 | Amoxicillin Capsules I.P. 250 mg | Each hard gelatin capsule contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 250 mg Excipients q.s. Approved colour used in empty hard gelatin capsule shells. |
| 3 | Amoxicillin Capsules I.P. 500 mg | Each hard gelatin capsule contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 500 mg Excipients q.s. Approved colour used in empty hard gelatin capsule shells. |
| 4 | Cefixime Capsules 400 mg | Each hard gelatin capsule contains: Cefixime IP 400 mg Excipients q.s. Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the Physician. |
| 5 | Cefixime Capsules 400 mg FOR EXPORT | Each hard gelatin capsule contains: Cefixime USP 400 mg Excipients q.s. Approved colour used in empty hard gelatin capsule shells. Dosage: As directed by the Physician. |
Beta Dry Syrup
| No. | Generic Name | Composition |
|---|---|---|
| 1 | Cefixime Oral Suspension I.P. 50 mg |
Each 5 ml suspension after reconstitution contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 50 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 2 | Cefixime Oral Suspension I.P. 100 mg |
Each 5 ml suspension after reconstitution contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 100 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 3 | Cefuroxime Axetil Oral Suspension 125 mg |
Each 5 ml suspension after reconstitution contains: Cefuroxime Axetil I.P. eq. to Cefuroxime 125 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 4 | Amoxycillin IP Oral Suspension 125 mg |
Each 5 ml suspension after reconstitution contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 125 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 5 | Amoxycillin IP Oral Suspension 250 mg |
Each 5 ml suspension after reconstitution contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 250 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 6 | Cefixime and Lactic Acid Bacillus Suspension |
Each 5 ml suspension after reconstitution contains: Cefixime I.P. (as Trihydrate) eq. to anhydrous Cefixime 50 mg Lactic Acid Bacillus 60 Million Spores Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 7 | Amoxycillin and Potassium Clavulanate IP Oral Suspension |
Each 5 ml suspension after reconstitution contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 200 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 28.5 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 8 | Amoxycillin and Potassium Clavulanate IP Oral Suspension |
Each 5 ml suspension after reconstitution contains: Amoxycillin Trihydrate I.P. eq. to Amoxycillin 400 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 57 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 9 | Cefpodoxime Proxetil and Potassium Clavulanate Suspension |
Each 5 ml suspension after reconstitution contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 50 mg Potassium Clavulanate Diluted I.P. eq. to Clavulanic Acid 28.5 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 10 | Cefpodoxime Proxetil IP oral Suspension 50 mg |
Each 5 ml suspension after reconstitution contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 50 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 11 | Cefpodoxime Proxetil IP oral Suspension 100 mg |
Each 5 ml suspension after reconstitution contains: Cefpodoxime Proxetil I.P. eq. to Cefpodoxime 100 mg Excipients q.s. In a palatable base Dose : As directed by the Physician. |
| 12 | Cefixime and Potassium Clavulanate Suspension |
Each 5 ml suspension after reconstitution contains: Cefixime I.P. 50 mg Potassium Clavulanate Diluted I.P. Eq. to clavulanic Acid 31.25 mg Excipients q.s. In a palatable base Colour:- Sunset Yellow Dosage:- As directed by the Physician. |
| 13 | Cefixime Oral Suspension IP 50 mg/5ml. |
Each 5 ml reconstitution suspension contains: Cefixime IP (As trihydrate) Eqv. to anhydrous Cefixime 50 mg Excipients qs Colour:- Sunset Yellow FCF Dosage:- As directed by the Physician. |
| 14 | Cefuroxime Axetil and Potassium Clavulanate Oral Suspension |
Each 5ml of reconstituted Suspension Contains: Cefuroxime Axetil IP evq. to Anhydrous Cefuroxime 125 mg Potassium Clavulanate Diluted IP eqv. To Clavulanic Acid 31.25 mg In a flavoured base Colour:- Quinoline Yellow Dosage:- As directed by the Physician |
| 15 | Rifaximine Oral Suspension |
Each 5ml Suspension Contains: Rifaximin BP 100 mg In a flavoured suspension base Dosage:- As directed by the Physician |
| 16 | Cefodoxime Proxetil and Potassium Clavulanate Oral Suspension |
Each 5ml Suspension after reconstitution Contains: Cefpodoxime Proxetil IP eqv. to Cepodoxime 100 mg Potassium Clavulanate Diluted IP eqv. To Clavulanic Acid 62.5 mg In a palatable base Dosage:- As directed by the Physician |
Dry Injections
| No. | Generic Name | Composition | |
|---|---|---|---|
| 1 | Meropenem and Sulbactam For Injection 1.5g (ON FORM -28) FOR IV USE | Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 1000 mg – Sodium Carbonate IP eqv. to Sodium: 90.2 mg – Sulbactam Sodium IP eqv. to Sulbactam: 500 mg (A sterile Mixture of Meropenem, Sodium Carbonate & Sulbactam Sodium) | As directed by the Physician. |
| 2 | Cefuroxime Sodium Injection IP 1 g (ON FORM-28) FOR IV USE ONLY | Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 1000 mg | As directed by the Physician. |
| 3 | Cefuroxime Sodium Injection IP 750 mg (ON FORM-28) FOR IV USE ONLY | Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 750 mg | As directed by the Physician. |
| 4 | Cefuroxime and Sulbactam For Injection IP 1.5 g (ON FORM-28) FOR IV USE ONLY | Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 1000 mg – Sulbactam Sodium IP eq. to Sulbactam: 500 mg | As directed by the Physician. |
| 5 | Amoxycillin & Potassium Clavulanate Injection IP 1.2 g (ON FORM-28) FOR IV USE ONLY | Each vial contains: – Amoxycillin Sodium IP eqv. to Amoxycillin: 1000 mg – Potassium Clavulanate IP eqv. to Clavulanate acid: 200 mg | As directed by the Physician. |
| 6 | Amoxycillin & Potassium Clavulanate Injection IP 300 mg (ON FORM-28) FOR IV USE ONLY | Each vial contains: – Amoxycillin Sodium IP eqv. to Amoxycillin: 250 mg – Potassium Clavulanate IP eqv. to Clavulanate acid: 50 mg | As directed by the Physician. |
| 7 | Amoxycillin & Potassium Clavulanate Injection IP 600 mg (ON FORM-28) FOR IV USE ONLY | Each vial contains: – Amoxycillin Sodium IP eqv. to Amoxycillin: 500 mg – Potassium Clavulanate IP eqv. to Clavulanate acid: 100 mg | As directed by the Physician. |
| 8 | Ceftazidime for Injection IP 125 mg (ON FORM-28) FOR IM/IV USE | Each vial contains: – Ceftazidime IP eqv. to Ceftazidime: 125 mg (A sterile Mixture with Sodium Carbonate) | As directed by the Physician. |
| 9 | Piperacillin and Tazobactam Injection IP 1.125g (FORM 28) FOR IV USE |
Each vial contains: – Piperacillin Sodium IP eqv. to Piperacillin: 1000 mg – Tazobactam Sodium IP eqv. to Tazobactam: 125 mg |
As directed by the Physician. |
| 10 | Meropenem Injection IP 125 mg (FORM 28) FOR IV USE |
Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 125 mg – Sodium Carbonate IP eqv. to Sodium: 11.27 mg (A sterile Mixture of Meropenem & Sodium Carbonate) |
As directed by the Physician. |
| 11 | Cefoperazone and Tazobactam Injection (FORM 28) FOR IM/IV USE |
Each vial contains: – Cefoperazone Sodium IP eqv. to Cefoperazone: 1000 mg – Tazobactam Sodium IP eqv. to Tazobactam: 125 mg |
As directed by the Physician. |
| 12 | Ceftazidime and Tazobactam Injection (FORM 28) FOR IM/IV USE |
Each vial contains: – Ceftazidime IP eqv. to Ceftazidime: 1000 mg – Tazobactam Sodium IP eqv. to Tazobactam: 125 mg |
As directed by the Physician. |
| 13 | Cefuroxime Sodium Injection IP 750 mg (FORM 28) FOR IM/IV USE |
Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 750 mg |
As directed by the Physician. |
| 14 | Ceftriaxone Injection IP 250 mg (FORM 28) FOR IM/IV USE |
Each vial contains: – Ceftriaxone Sodium IP eqv. to Ceftriaxone: 250 mg |
As directed by the Physician. |
| 15 | Ceftriaxone and Tazobactam For Injection USP 281.25 mg (FORM 28) FOR IM/IV USE |
Each vial contains: – Ceftriaxone Sodium IP eqv. to Ceftriaxone: 250 mg – Tazobactam Sodium IP eqv. to Tazobactam: 31.25 mg |
As directed by the Physician. |
| 16 | Cefoperazone and Sulbactum Injection (FORM 28) FOR IM/IV USE |
Each vial contains: – Cefoperazone Sodium IP eqv. to Cefoperazone: 500 mg – Sulbactum Sodium IP eqv. to Sulbactum: 500 mg |
As directed by the Physician. |
| 17 | Cefoperazone and Sulbactum For Injection 1.5g (FORM 28) FOR IM/IV USE |
Each vial contains: – Cefoperazone Sodium IP eqv. to Cefoperazone: 1000 mg – Sulbactum Sodium IP eqv. to Sulbactum: 500 mg |
As directed by the Physician. |
| 18 | Meropenem Injection IP 250 mg (FORM 28) FOR IV USE |
Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 250 mg – Sodium Carbonate IP eqv. to Sodium: 22.55 mg (A sterile Mixture of Meropenem & Sodium Carbonate) |
As directed by the Physician. |
| 19 | Meropenem Injection IP 0.5 g (FORM 28) FOR IV USE |
Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 500 mg – Sodium Carbonate IP eqv. to Sodium: 45.1 mg (A sterile Mixture of Meropenem & Sodium Carbonate) |
As directed by the Physician. |
| 20 | Ceftriaxone and Sulbactam For Injection IP 375 mg (ON FORM -28) FOR IM/IV USE |
Each vial contains: – Ceftriaxone Sodium IP eqv. to Ceftriaxone: 250 mg – Sulbactam Sodium IP eqv. to Sulbactam: 125 mg |
As directed by the Physician. |
| 21 | Vancomycin Hydrochloride For Intravenous Infusion IP 1000 mg (ON FORM -28) ONLY FOR USE IV |
Each vial contains: – Vancomycin Hydrochloride IP eqv. to Vancomycin: 1000 mg |
As directed by the Physician. |
| 22 | Meropenem and Sulbactam For Injection 1.5g (ON FORM -28) FOR IV USE |
Each vial contains: – Meropenem Trihydrate IP eqv. to Anhydrous Meropenem: 1000 mg – Sodium Carbonate IP eqv. to Sodium: 90.2 mg – Sulbactam Sodium IP eqv. to Sulbactam: 500 mg (A sterile Mixture of Meropenem Sodium Carbonate & Sulbactam Sodium) |
As directed by the Physician. |
| 23 | Cefuroxime Sodium Injection IP 1 g (ON FORM-28) FOR IV USE ONLY |
Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 1000 mg |
As directed by the Physician. |
| 24 | Cefuroxime Sodium Injection IP 750 mg (ON FORM-28) FOR IV USE ONLY |
Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 750 mg |
As directed by the Physician. |
| 25 | Cefuroxime and Sulbactam For Injection IP 1.5 g (ON FORM-28) FOR IV USE ONLY |
Each vial contains: – Cefuroxime Sodium IP eqv. to Cefuroxime: 1000 mg – Sulbactam Sodium IP eqv. to Sulbactam: 500 mg |
As directed by the Physician. |
| 26 | Amoxycillin & Potassium Clavulanate Injection IP 1.2 g (ON FORM-28) FOR IV USE ONLY |
Each vial contains: – Amoxycillin Sodium IP eqv. to Amoxycillin: 1000 mg – Potassium Clavulanate IP eqv. to Clavulanate acid: 200 mg |
As directed by the Physician. |
| 27 | Amoxycillin & Potassium Clavulanate Injection IP 300 mg (ON FORM-28) FOR IV USE ONLY |
Each vial contains: – Amoxycillin Sodium IP eqv. to Amoxycillin: 250 mg – Potassium Clavulanate IP eqv. to Clavulanate acid: 50 mg |
As directed by the Physician. |
| 28 | Amoxycillin & Potassium Clavulanate Injection IP 600 mg (ON FORM-28) FOR IV USE ONLY |
Each vial contains: – Amoxycillin Sodium IP eqv. to Amoxycillin: 500 mg – Potassium Clavulanate IP eqv. to Clavulanate acid: 100 mg |
As directed by the Physician. |
| 29 | Ceftazidime for Injection IP 125 mg (ON FORM-28) FOR IM/IV USE |
Each vial contains: – Ceftazidime IP eqv. to Ceftazidime: 125 mg (A sterile Mixture with Sodium Carbonate) |
As directed by the Physician. |
| 30 | Vancomycin Hydrochloride For Intravenous Infusion IP 500 mg (ON FORM- 28) ONLY FOR USE IV |
Each vial contains: – Vancomycin Hydrochloride IP eqv. to Vancomycin: 500 mg |
As directed by the Physician. |
| 31 | Cefotaxime Sodium Injection IP 250 mg (ON FORM-28) FOR IM/IV USE |
Each vial contains: – Cefotaxime Sodium IP eqv. to Cefotaxime: 250 mg |
As directed by the Physician. |
| 32 | Piperacillin and Tazobactam Injection IP 4.5 g (ON FORM-28) FOR IV USE |
Each vial contains: – Piperacillin Sodium IP eqv. to Piperacillin: 4 gm – Tazobactam Sodium IP eqv. to Tazobactam: 500 mg |
As directed by the Physician. |
| 33 | Cefepime Injection IP 1 g (ON FORM-28) FOR IM/IV USE |
Each vial contains: – Cefepime Hydrochloride IP eqv. to Cefepime: 1000 mg |
As directed by the Physician. |
| 34 | Cefepime Injection IP 0.5 g (ON FORM-28) FOR IM/IV USE |
Each vial contains: – Cefepime Hydrochloride IP eqv. to Cefepime: 500 mg |
As directed by the Physician. |
| 35 | Cefepime Injection IP 2 g (ON FORM-28) FOR IM/IV USE |
Each vial contains: – Cefepime Hydrochloride IP eqv. to Cefepime: 2000 mg |
As directed by the Physician. |
| 36 | Cefepime and Sulbactam For Injection 1.5 g (ON FORM-28) FOR IM/IV USE |
Each vial contains: – Cefepime Hydrochloride IP eqv. to Cefepime: 1000 mg – Sulbactam Sodium IP eq. to Sulbactam: 500 mg |
As directed by the Physician. |
6 Mn
Oral Liquids
18 Mn
Capsules
120 Mn
Tablets
300 Mn
External Applications
Contact Us
- Mfg. Unit : Plot No. 131, Sector- 6A, IIE-SIDCUL, Haridwar-249 403, Uttarakhand, India.
- Mfg. Unit : Plot No. 130B, Sector- 6A, IIE-SIDCUL, Haridwar-249 403, Uttarakhand, India.
- Mumbai Office : 18, 3rd Floor, Shreenath Building, Kalbadevi, Mumbai - 400 002
- Office: +91 - 9520865925
- Email: bdm.bonheurpharma@gmail.com
- https://bonheurpharma.in/
